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INTRODUCTION 
 Siddha system is an ancient system of medicine prevalent in south India. The word 
siddha comes from the Tamil word for perfection. 
Siddhars are the forerunner of this system who are the divine persons attained siddhi 
and siddha system of medicine was inherited by them from Lord siva. 
Thus, the siddhars have set themselves a very high aim for protecting the mortal body 
free from the ravages of old age and death. Therefore the concept of siddha system of 
to treat the man as a wh  
In siddha medicine, the individual is a microcosm of the universe. The human body 
consists of the five primordial elements .These are earth, water, fire, air and space. 
À¡ÃôÀ¡ â¾¨ÁóÐ Áñ¿£÷ §¾Ô 
ÀÃ¢ Å¡Ô Å¡¸¡Â ¨Áó¾¢É¡§Ä 
§ºÃôÀ¡º¼Á¡îº¢... 
                                    - º¾¸¿¡Ê 
According siddha system the human body has the three elements vatha, pitha and 
kapha.  The equilibrium of humours is considered as health and its disturbance or imbalance 
leads to a diseased state. 
Vatha, pitha and kapha have multiple significance and are symbolical in terms. 
 Vatha represents vayu, mind, dryness, pain, flatulence, sensitiveness, 
lightness, and also air. 
 Pitha represents gastric juice, bile, energy, heat, inflammation, anger and 
irritation. 
 Kapha represents feeling of cold, heaviness, running of the nose, passing of 
mucoid discharge and also the saliva.  
According to the siddha medicine various psychological and physiological functions 
of the body attributed to the combination of seven elements.  
First is saaram (plasma) responsible for growth, development and nourishment. 
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Second is Cheneer (blood) responsible for nourishing muscles, imparting colour and 
improving intellect.  
The third is Oon (muscle) responsible for shape of the body.  
Fourth is Kolluppu (fatty tissue) responsible for oil balance and lubricating joints.  
Fifth is Enbu (bone) responsible for body structure, posture and movement. 
Sixth is Moolai (nerve) responsible for strength and the last is Sukila (semen) 
responsible for reproduction. 
Siddha medicine aims at the immortality of the body and soul. 
Siddhars classified the diseases into 4448 and established a separate chapter which 
deals with Renal Diseases on the basis of Vatha, Pitha, and Kabha humours.One such clinical 
entity is kalladaippu mentioned in Yugi Vaithiya Chindhamani. Yugi munivar further 
classified kalladaippu into 4 types and Azhal kalladaippu is one among them. 
Nephrolithiasis or urolithiasis is formation of urinary calculi at any level of the 
urinary tract. Urinary calculi are worldwide in distribution but are particularly common in 
some geographic locations such as in parts of the United States, South Africa, India and 
South- East Asia. 
 Dehydration from low fluid intake is a major factor in stone formation. High dietary 
intake of animal protein, sodium, refined sugars, fructose, high fructose corn syrup, oxalate 
and grapefruit juice may increase the risk of kidney stone formation. 
It is estimated that approximately 2% of the population experience renal stone disease 
at sometime in their life with male-female ratio of 2:1. 
The peak incidence is observed in 2nd to 3rd decades of life. 
The incidence of urinary tract stone disease is increasing. According to the National 
Health and Nutrition Examination Survey, as of 2012, 10.6% of men and 7.1% of women in 
the United States are affected by renal stone disease, compared to just 6.3% of men and 4.1% 
of women that were affected in 1994. 
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The main Ingredients of the siddha formulation are Venpoosani (Benincasa hispida), 
Shanpaga poo (Mychelia champaca), Seeragam (Cuminum cyminum), Kadukkai (Terminalia 
chebula)   is well known for its  Diuretic and Lithotriptic action.  
The preparation is simple, easily available and cost effective. So I have chosen 
KOOZHPAANA CHOORANAM in the treatment of AZHAL KALLADAIPPU for my 
dissertation work. 
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                                               AIM AND OBJETIVES 
 
AIM:  
the treatment of Azhal kalladaippu noi (Renal calculi). 
OBJECTIVES:  
1. Primary objective:  
To study the siddha 
treatment of AZHAL KALLADAIPPU (RENAL CALCULI) for the 
Clearance/reduction in the size of renal calculus.    
2. Secondary objective: 
To study azhal kalladaippu, on the basis of Envagai thervu, mukkutram, 
kalam, naadi, neerkuri, neikuri, etc,, in order to evaluvate the pathology. 
To Study the siddha cofactors related to the diseases such as age, sex, food 
 
 
 
 
                                                   
                                             
  
  
 
 
REVIEW OF LITERATURE 
  
  
 
 
SIDDHA ASPECT 
 
 
 
 
 
 
 
 
5 
 
SIDDHA ASPECT 
AZHAL KALLADAIPPU 
Siddhars classified the diseases into 4448 and described each one separately and 
elaborately. They classified the disease on the basis of Vatha, Pitha and Kabha humours.  
The disease kalladaippu is placed under Neerinai Arukkal noi (Oligurial 
 
                      ¿£Ã¢Õ Å¢¨É Ì½ò¨¾ ¿£ÂÈ¢Å¢òÐ ¦º¡øÅ¡õ 
           ¿£Ã¢¨É ¦ÀÕì¸¦Ä¡ýÚ ¿£Ã¢¨ÉÂÕì¸ ¦Ä¡ýÚ                                                                   
           ¿£Ã¢Æ¢×¼§É ¦¸¡øÖõ ¿£÷ì¸ðÎ Å¢¨É¸¦ª¡ýÚ                                             
                                                  -§¾Ãý ¸Ã¢ºø   
 As per Yugi Vaithiya Chinthaamani, Kalladaippu is classified into 4 types. Azhal 
Kalladaippu is one among the four types of Kalladaippu.  
           §¾¡ýÈ¢É§¾¡÷ ¿¡Ä¢É¢¼ ¿¡Áí §¸ª¡ö  
              º¢Õì¸¡É Å¡¾ò¾¢ý ¸øÄ ¨¼ôÒ 
           âýÈ¢Â§¾¡÷ À¢ò¾ò¾¢ý ¸øÄ ¨¼ôÒ  
              ÒÃñ¼§¾¡÷ §ºòÐÁò¾¢ý ¸øÄ ¨¼ôÒ                            
                                   -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢                                  
Kalladaippu:  
Definition:                             
thor: Dr.Kuppusamy), there 
is gradual or  sudden obstruction to the flow of urine, pain with burning sensation in the 
urethral tract, low back pain, renal angle pain and sand like crystal deposit in the urine  are 
the characteristic features of kalladaippu.   
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Pothu Kurikunangal:            
    According to the text of siddha maruthuvam  (pothu)  
 Gradual or sudden obstruction to flow of urine. 
 Unbearable pain (agonizing pain) in the penis.  
 Excruciating pain and swelling is experienced at tip of penis if the calculus 
attempts to expel.      
 Burning and scanty micturition and haematuria. 
  Colicky pain radiating from loin to groin, lower abdomen,urethra, and 
genitalia if the calculus  irregular with sharp projection.  
Etiology: 
              According to Yugi Vaithiya Chinthamani, 
                             ¸Äí¸¢É §¾¡÷¾ñ½£÷¾¡ý ÌÊò¾ §À÷ìÌõ      
                 ¸ø¦ÄÖõÒ ÁÂ¢÷Áñ¾¡ý ¸Äó¾ý Éò¾¢ø      
              «Äí¸¢É §¾¡ÃýÉí¸ ªÕó¾ Ä¡Öõ 
                  «Ø¸§Ä¡Î ÓüÈÀñ¼ ÁÕó¾ Ä¡Öõ   
              ÁÄí¸¢É §¾¡÷Á¡ôÀñ¼ ÁÕó¾Ä¡Öõ   
                  Áó¾ò¾¢ø Å¡öÅ¡ÉÀ ¾¡÷ò¾ó ¾ý¨É      
              ÐÄí¸¢É §¾¡Õº¢¾ýÉ¢ü Í¨Åò¾ Ä¡Öõ       
                   ÍÕì¸¡ö ¸øÄ¨¼ôÒÅóÐ §¾¡ýÚó ¾¡§É     
                                               -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢.    
                                                                                                 
As per yugi vaithiya  Chinthamani, Kalladaippu is due to,                                    
    - Intake of turbid water,                                   
    - Food contaminated with stones, bones, hair and sand,                               
    - Intake of putrified food stuff and starch substances,                               
    - Eating flatulence producing food while indigestion.  
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                      ¦¾ª¢ó¾§¾¡÷ ¸øÄ¨¼ôÒü Àò¾¢ §¸ª¡ö    
             º¢È¢Ð¿¡ð Î¼í¸¢§Â §Á¸ó ¾ýÉ¡ø  
           ¾ª¢ó¾§¾¡÷ ºÄô¨ÀÂ¢Ö ¾¢Ãó §¾¡öóÐ   
             ºó¾ ºó¾¡¸§Å ÀÕòÐì ¦¸¡ûÙõ  
           Åª¢ó¾§¾¡÷ Å¡¾À¢ò¾í §¸¡À¢ò ¾ì¸¡ø    
             ÅóÐ ¦ÀÕí¸øÄ¡ö ¿£÷ÅÆ¢ Â¨¼òÐ                     
           ¿ª¢ó¾§¾¡÷ ¿¡ÖÅ¢¾ì ¸øÄ¨¼ôÒ                         
             ¿ñÀ¡É ÅÃÄ¡Ú ¿¡ð¼ì §¸§ª                                          
                                 - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢  
             Yugi Mamunivar has revealed about this disease since 14th century. Yugi 
Mamunivar Mentioned   the following   symptoms, blood clot in the urinary bladder due to 
urinary tract diseases followed by distension of urinary bladder, urinary stone formation  in 
urinary tract  by humour of Vatham and Pitham. 
                 ¿¡ð¼Á¡ö ¸üÀÆ¢òÐì ¸¼¨É Å¡í¸¢    
                    ¿Ä¢Àñ ½¢ì¦¸¡¼¡Áø ÅÆìÌ §Àº¢  
                 Üð¼Á¡ö ÌÕ×¨¼Â ¸¼¨Á ¾ý¨Éì            
                    ¦¸¡¼¡Á§Ä ¨¸ì¦¸¡ñ¼ ¦¸¡Î¨Á §Â¡÷ìÌõ                       
                 Å¡ð¼Á¡ö ÅÃõÒ¾ôÀ¢ ¾¢Ã¢ó¾ §À÷ìÌõ       
                    Á¡ÚÀ¡¼¡ ¦ÂÎòÐô¦À¡ Õû¸ ¼¨Éì                     
                 ¸¡ðÊ§Â ¨¸ì¦¸¡ñÎ¸ ÀÎ ÀñÏõ     
                    ¸¡Ä¡ó¾÷ ¸øÄ¨¼ôÀ¢ü ¸ÄíÌ Å¡§Ã                                       
                                           - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢          
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             The above mentioned poem explains the status of  mind  plays a major role in 
causing many diseases and connection between body and soul is established .i.e. the 
mukkutram deranged by internal forces such as sexual perversion,anger and robbery.               
              According to siddha maruthuvanga churukkam,  
                                 
                 ¿£÷ì¸ðÎò ÐÅ¡Ãõ Òñ½¡õ  
                 À¡È¢Îï ºóÐ ºó¾¢ø  
                 ÀñÒÚ §¿¡Å¾¡Ìõ  
                 §¿Ã¢Äí¸ÂÕí ¸¡Á¢Âõ 
                 ¿¢îºÂ §¿¡¾ø ¦ºöÔõ  
                 À¡Ã¢É¢ ÄÀ¡É Å¡Ô  
                  
                                         -º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ           
Siddha maruthuvanga churukkam explained that urination is one of the 14 visceral 
refelexes.  When one suppresses the visceral reflex it lapses into manifestation of morbidty, 
which comprises the inflammation of bladder, Anuria, Arthralgia, pain in genital region and 
deranged keezhnokkum kaal leads to the formation of Calculus.  
                   
                  ÍÃÓ¼É£÷ì ¸ð¼¡Ìõ  
                  Àì¸Á¡í ¨¸¸¡ø ºóÐ  
                  À¡Ã§¿¡ö ÅÆ¢Â¢ÈíÌõ  
                  Á¢ì¸Á¡÷ §¿¡Ôñ¼¡Ìõ  
                  Á¢Ìó¾¢Îõ À¢Ã§Á¸ó¾¡ý  
                  ¾ì¸§¾¡÷ §À¡ÐÁ¡¸¢ý  
                   
                                   -º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ         
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                   The author explains that ejaculation of semen is one of the 14 visceral 
reflexes.When one suppresses this visceral reflex , it causes fever, retention of urine which 
favours urinary calculi, chest pain, arthralgia and white discharge.  
According to Noi Vilakkam,  
      ¸Õ ¿£Ã¼ì¸ø Å¢¨ÃÂ¢ø «ÊÀ¼ø  
         ¿£Ã¢Âó¾¡ì ¸ø º¢Ú¿£Ã¼ì¸ø      
      Åª¢ §¿¡ö Á¢ÕìÌ Ó½×õ ´Øì¸Óõ       
         ¸¨¼ô À¢Êò¾¢Î¾ø §Á¸Ó¾ü ÀÄ   
      À¢½¢ÔÈø ±ØÁ¢¨Å ÂÊôÀ¨¼Â¡¸ì              
         ¸øÄ¨¼ôÒ ¦ÂýÛí ¸ÎõÀ¢½¢ Å¢¨ªÔõ                          
      Åª¢ÂÐ Á£È¢§Â ¦Â¡Î ÁøÄ¡Ð     
         ¸Õ¿£ ¦Ã¡Îí ¸ÄóÐ ¿£Ã¸òÐî   
      º¢Ú¿£÷ì ¸Æ¢× ¦¾¡Îò¾Ä¡Öõ       
         «ýÉ¨Å ¸ø¦ÄÉò ¾¢ÃÙ¦ÁýÀ                      
                                 -§¿¡ö Å¢ªì¸õ  
 Trauma on testes, Suppression of urine and semen  
 Derangement of humour in blood  
 Excessive indulgence in sexual activity or sexual perversion  
 Inflammation of bladder  
 Syphilis(Mega Noi), Stagnation of urine in urinary tract  
 Dryness of semen causes the formation of stones  
 Increased intake of food that cause flatulence.        
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Classification:  
Classification Of  kalladaippu In Yugi Vaithiya Chinthamani:   
        §¾¡ýÈ¢É§¾¡÷ ¿¡Ä¢É¢¼ ¿¡Áí §¸ª¡ö  
           ÍÚì¸¡É Å¡¾ò¾¢ý ¸øÄ ¨¼ôÒ                    
        âýÈ¢Â§¾¡÷ À¢ò¾ò¾¢ý ¸øÄ ¨¼ôÒ       
           ÒÃñ¼§¾¡÷ §ºòÐÁò¾¢ý ¸øÄ ¨¼ôÒ  
        ¾£ýÈ¢Â§¾¡÷ ¦¾¡ó¾Á¡í ¸øÄ ¨¼ôÒ  
           §¾¸ò¾¢ü ÀüÈ¢§Âº¢ È¢Ð ¸¡Äõ                    
        ¾¡ýÈ¢§Â ºÄô¨ÀÂ¢ø Åó¾¢ Æ¢óÐ    
           ºÕÅ¢§Â Ä¢í¸ò¾¢üÈ Ã¢ìÌó ¾¡§É                                                  
                                  - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢          
There are four types of Kalladaippu according to Yugi Vaithiya Chinthamani                                 
   1. Vali kalladaippu                                 
   2. Azhal kalladaippu                                 
   3. Iyya kalladaippu                                
  4. Thontha kalladaippu  
Å¡¾ ¸øÄ¨¼ôÒ  
              ¾Ã¢òÐ ¿¡À¢ìÌí¸£ú ÍÕì¸¡ö ÌüÈ¢î  
                 ºÄÁÄó¾¡ý Å£Æ¡Áü ÈõÀ Á¡¸¢                    
              ÅÃ¢òÐ§Á Ä¢í¸ò¾¢ø ÅÄ¢Ô Á¡¸¢          
                 ÁÕÅ¢Â§¾¡÷ ¦À¡ò¾¢¦ÂÄ¡ï ÍÃóÐ ¸ðÊ  
              ¾¢Ã¢ò¾¢§Â ¸¢¨¼¦¸¡¼¡ô À¢Ãð¼ Ä¡¸¢ò  
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                 §¾õÀ¢§Â ãîÍÁ¡ö ÅÂ¢Ú ÓôÒõ  
               ¯Ã¢ò¾§¾¡÷ º¨¾§À¡Ä ¯Å÷ôÒ Á¡Ìõ        
                 µí¸¢Â§¾¡÷ Å¡¾ì¸øÄ ¨¼ôÒ ¾¡§É  
                                             - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢                     
In Vali Kalladaippu, pain is felt just below the umbilical region and penis. It is      
characterized by Severe colic pain, Dyspnoea, Abdominal distension, Oliguria and       
Constipation.     
À¢ò¾ ¸øÄ¨¼ôÒ                  
                «¨¼ôÀ¡¸¢ ºÄó¾¡Û ÁÕÅ Ä¡¸¢         
                    «Âí¸¡îº¢î ¦º¡Õ¸¢É¡ü §À¡§Ä ¸¡Ïõ  
                Ò¨¼ôÀ¡¸ ¦À¡üÈ¢¦Âí ÌõÒ Øì¸Á¡¸¢ô      
                    âðÎ§À¡ø À¢ÌÅ¡¸¢ô À¢Ãð¼Ä¡Ìõ                  
                Á¨¼ôÀ¡¸¢ ¯¾¢Ã¿¢È Á¡öì¸ø Ä¡¸¢           
                    Åó¾¢Æ¢óÐ Ä¢í¸ò¾¢ø Á¡ðÊì ¦¸¡ûÙõ                               
                Ì¨¼ôÀ¡¸¢ ÌüÈÄ¡öì ÜîºÄ¡¸¢ì      
                   Ì¾ðÎ§Á À¢ò¾ì¸ø Ä¨¼ôÒ ¾¡§É 
                                      - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢             
Azhal Kalladaippu is characterized by, reduced urine output with characteristic 
burning sensation (similar to introducing  a red-hot iron needle into the urethra),blood stained 
coloured stones which blocks the ureter causing pricking pain and tenderness.  
§ºòÐÁ ¸øÄ¨¼ôÒ  
                   ¾¡É¡É ¦¾¡ôÒª¢§Ä Å¢øÖ §À¡Äî       
                      ºÄ¢Â¡Áü ÍÃóÐ§Á ºü§È ÌüÚõ                 
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                   ²É¡É ¸¡§Ä¡Î ¨¸¸û ºóÐ         
                      ­ÎôÒ¾¡ý Ì¨¼îºÄ¡Â¢ º¢× ¸¡Ïõ 
                    §ÅÉ¡É Ä¢í¸ò¾¢ý ¦Åñ¨Á ¾ýÉ¢ø          
                      Å¢ÚÅ¢¦Èý §È¸ÎôÀ¡¸¢ Å¢Â÷¨Å Â¡Ìõ                       
                    §¾É¡É ¦ÅÙôÒì¸ø º¢Ú¸ø Ä¡¸î                            
                      º¢ì¸Ä¡ö Åó¾¢ÈíÌî §ºðÀó                                                    
                                         - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢.                     
           Iyya Kalladaippu is characterized by excruciating pain in the umbilical region, Pain in 
the joints  of upper and lower extremities, Low-backache, Spasmodic pain, Sweating and 
gradual passing out of white coloured stone granules in the urine. 
 ¦¾¡ó¾ ¸øÄ¨¼ôÒ                     
                   Åó¾¢ÈíÌõ ¿£÷ò¾¡¨Ã ÂÊÂ¢ü È¡Ûõ   
                      Á¡ÅÕò¾ Óñ¼¡¸¢ ÅÄ¢Ô Á¡¸¢                      
                   ¦¿¡ó¾¢Èí¸¢ ¿£÷¾¡Û ÁÕÅ¢ À¡Ôõ                
                      ¦¿¡ö¾¡É º¢ÚÁ½ø §À¡ø ¦¿¡Úí¸¢ì ¸øÄ¡ý  
                   ºó¾¢Èí¸¢ ¿£÷ÅÆ¢Â¢ø ÅóÐ Å£Øõ                       
                       ¾¡ì¸¡É º¢Èí¨¸ì¸ø ¾¢É¦Á¡ý ÚìÌ       
                   Ðó¾¢Èí¸¢ò ¾¢Éó¾¢ÉÓ Á¢ÆóÐ ¦¸¡øÖõ          
                       ¦¾¡ó¾Á¡í ¸øÄ¨¼ôÒî ÝðÊ ¼¡§Â.                            
                                                -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢                      
           In Thontha Kalladaippu, Severe pain is felt just below the urethral region with excess 
urination. It is characterized by disintegration of stones in to small, sand like granules in the 
urine.  
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Classification According To Noi Vilakkam:  
           Åª¢ Ó¾ø ãýÈ¢Ûó §¾¡ýÈÄ¡Öõ  
                 ¸Õ¿£÷ ¾ýÉ¢ü §¾¡ýÈÄ¡Öõ                                                                 
            ¸øÄ¨¼ ¿¡ø Å¨¸ô ÀÎ¦ÁÉ¦Á¡Æ¢§Â"                      
                                                      -§¿¡ö Å¢ªì¸õ            
   There are four types of Kalladaippu according to Noi vilakkam                          
                              1. Vali  kalladaippu                         
                              2. Azhal  kalladaippu                          
                              3. Iyya  kalladaippu                         
                              4. Karuneer  kalladaippu    
  Åª¢ ¸øÄ¨¼ôÒ (Vali kalladaippu):  
               
                ¿Îí¸ø ¯ó¾¢Ôõ ÌÈ¢Ôõ À¢¨º¾ø  
              ¸ºÎ¸£ú ºª¢¦Â¡Î ¸ÆÄø «Ø¾ø     
                º¢Ú¿£÷ Ðª¢ò¾ø ±ýÀ×õ À¢È×õ     
              Åª¢Â¢ý ¸øÄ¨¼ì ÌÈ¢¦ÂÉ ¦Á¡Æ¢Â                                                      
                 ¸ÚòÐï º¢ÅóÐõ Ó¨É¸û ÀÃóÐõ  
              Åª¢Â¢ý ¸øÄÐ ÅÊ×Û ¦ÁýÀ"                                                              
                                      -§¿¡ö Å¢ªì¸õ 
 Tongue biting, palpitation and shivering  
 Lower abdominal colic and pain in the external genitalia  
 Dribbling of Urine, The Stones are blackish red in colour.  
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«Æø ¸øÄ¨¼ôÒ (Azhal Kalladaippu):  
            Á¢¸¦ÅÐõÀ¢Î¾Öõ 
                §¿¡¾Öõ «¨Åì ¸øÄ¨¼ìÌÈ¢§Â                        
           º¢ÅóÐí ¸ÚòÐ Áïºª¡¸¢Ôõ  
                §ºíÌÕ ÅÊÅ¢ø ¸øÄÐ §¾¡ýÚõ"                                                                
                                       -§¿¡ö Å¢ªì¸õ 
 Burning micturition, Dysuria  
 Passing reddish black or yellow coloured stones.  
 
          ¿£Ã¢Âí Ìò¾ø ¾¢½¢ò¾ø Ìª¢÷ò¾ø  
              ±ÛÁ¢¨Å ³Âì ¸øÄ¨¼ì ÌÈ¢§Â  
          ¦ÅÙòÐõ §¾É¢ÈÁ¡¸¢Â ¦Á¡ª¢÷óÐõ  
              ¦ÀÕ ÅÊ×¨¼ò¾¡õ ³Â ¸øÄ¨¼ôÒ"                                   
                                       -§¿¡ö Å¢ªì¸õ  
 Pricking  pain with severe intensity when passing urine  
 Fever with rigors 
 White or honey coloured shining or luminant large size stone expelled.  
¸Õ¿£÷ ¸øÄ¨¼ôÒ (Karuneer kalladaippu) 
                    ¸Õ ¿£÷ì¸øÄ¢ý Åª¢ º¢Éó¦¾ØóÐ     
             Å¢¨Ã¸ª¢ ÉÎÅ¢ø «Ð¾¨Éò ¾Îò¾Ä¢ý  
         ¸Õ¿£÷ì ¸øÄ¨¼ ÁÕÅ¢Î ¦ÁýÀ    
             ¿£Ã¢Âõ §¿¡¾ø º¢Ú¿£÷ ¾¨¼À¼ø  
         Å¢¨Ã Å£í¸¢Â¢Õò¾ø ±ÛÁ¢¨Å À¢È×õ     
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             ¸Õ¿£÷ ¸øÄ¨¼ì ÌÈ¢¦ÂÉ ¦Á¡Æ¢Â  
         ¸Õ¿£÷ì ¸øÄ¢¨É Åª¢ÂÐ ÓÎ¸¢î     
           º¢È¢Â×õ ¦ÀÃ¢Â×ó ÐñÎ¸ª¡¸ ¦¿¡Úì¸¢Îõ  
         «¨Å º¢Ú¿£÷ ÅÆ¢ ¦Åª¢ôÀ¼Å¡Ìõ      
           «¨Å º¢Ú¿£Ã¢¨Éò ¾Îò¾ø ¿¢üÌõ  
         º¡üÈ¢Â ¿£Ã¢¨Éò ¾ÎòÐ ¿¢üÀ¢ý       
           ¬üÈø Ì¨È¾ø ÅÂ¢Ú §¿¡¾ø  
         Í¨Å¦¸¼ø ¦Åª¢Ú ÁÚôÒ ¿£÷§Åð¨¸       
          ¦ÅøÅª¢ ¦ÂÛÁ¢¨Å Å¢¨ªó¾¢Î ¦ÁóÀ... 
- §¿¡ö Å¢ªì¸õ  
 Sudden or gradual obstruction to flow of urine  
 Excessive Vali kutram breaks the stones into small and large size crystals and 
expels along with urine, Sudden stoppage of urine stream  
 Retention of urine, Abdominal pain, Loss of taste,excessive thirst.  
In Dhanvanthiri vathiyam, Klladaippu is classified into four types, they are 
1.Kallerippan 
2.Pitha achmari 
3.Silethuma achmari 
4.Sukila achmari 
 In Siddhar Aruvai Maruthuvam, Klladaippu is classified into four types, they are 
 1. Vali Kalladaippu  
2.  Azhal Kalladaippu  
3. Iyya Kalladaippu  
4. Venneer Kalladaippu  
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Classification In Jeevaratchamirtham And Anubhava vaithiya Devaragasiyam:  
Types Of Kalladaippu:  
1. Vatha Achmari  
2. Pitha Achmari  
3. Kabha Achmari  
4. Shukila Achmari  
5. Swagara Achmari  
Syndrome Associated With Kalladaippu:   
                       ¯ì¸¡Ã Ý¨Ä  
                 
                 §¸¡÷¨ÅÂ¡ö Å¢Ä¡Å¾É¢ø ÓÐ¸¢ø ¦¿ïº¢ø  
                 «ò¾¢Â¢É¢ø ¿¡À¢Â¢Ä À¡ÉÁ¡í Ì¾ò¾¢ø  
                 «¾¢¸òÐý Á¡í¸¢ºó¾¡ý Åª÷óÐ §ÁÅ¢ô    
                 ÀòÐÁ½ü ÀÎì¨¸ô§À¡ü ºÄòÐ Å¡Ãô  
                 À¾¢¦¿Õì¸¢ ãò¾¢ÃÁ¡í ¸¢Ã¢îº¢ Ôñ¼¡öò  
                 ¾òÐº¼í ¸Îô¦ÀÎòÐ Á¾¢¸ Äí¸¢ò  
                 
                               -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢                                         
             Excessive growth of muscles in chest region, back of trunk, umbilicus, anal and 
urethral orifice followed by structure of urethral orifice like a sand like crystals blocked in 
urethra, Dysuria, body pain, tiredness and giddiness occurs.  
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Mukkutra Verupadukal (Siddha Pathology)  
 
kutram dries up the body fluid and urine resulting in concentration of salts, this further affects 
the Keezh nokku kaal. One of the functions of the Keezh nokku kaal is to excrete urine. So 
when this Keezh nokku kaal is affected, the urine will be obstructed within urinary tract. This 
favours the deposition of urinary salts to develop into calculi anywhere in the kidney or 
urinary tract.  
Diagnostic Methodology:                      
The Diagnostic methodology in Siddha system is unique as it is made purely on the 
basis of clinical acumen of the physician. The diagnosis is arrived from,   
Pulanal Arithal (examination of sense organs) and  Poriyal Arithal                           
                       Vinaathal (Interrogation)                           
                       Envagai thervu (eight fold examination)  
Pulanal Arithal           
The physician should examine origal & Pulangal                              
Hearing - Ear                              
Vision - Eye  
Taste - Tongue                            
Sensation - Skin                             
Smell - Nose  
  Poriyal Aridhal:                  
 
                       Mei - To feel all types of sensation                    
                       Vaai - For knowing taste                    
                       Kan - For vision                    
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                       Mooku - For knowing the smell                    
                       Sevi - For hearing  
Vinaadhal (Interrogation)                      
               occupation, native place, 
Socio economic status, dietary habits, present complaints, history of present illness, 
aggravating factors, history of previous illness etc..  
Envagai Thervugal:   
''¿¡Ê ÀÃ¢ºõ ¿¡¿¢Èõ ¦Á¡Æ¢Å¢Æ¢           
            ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ''                          
                                           -§¾¨ÃÂ÷           
            
            ÀÌò¾È¢Å£÷ ¿¡Êô ÀÃ¢ºõ - ¦¾¡Ìò¾ ¿¢Èõ  
            ¸ðÎÅ¨¸î ¦º¡ø¦Á¡Æ¢ ¸ñ¼ ÁÄ ãò¾¢Ãõ ¿¡ 
             
                                  -«¸ò¾¢Â÷ ¨Åò¾¢Â º¢ó¾¡Á½¢ ¦ÅñÀ¡ 4000   
''¦ÁöÌÈ¢ ¿¢Èó¦¾¡É¢ Å¢Æ¢¿¡Å¢ÕÁÄõ ¨¸ìÌÈ¢''                                                           
                                           -§¾¨ÃÂ÷                            
According to Agathiyar Vaithiya Sinthaamani Venba  4000, and saint therayar  the 
Envagaithervu(Eight types of diagnostic tools) Includes Naadi (Pulse), Naa (Tongue), Niram 
(Colour), Mozhi (Voice), Vizhi (Eyes),Malam (Faeces), Neer (Urine) and Sparisam (Touch 
& palpation).  
Naadi: (Pulse)                         
examined in the Right hand for male and the left hand for female. The pulse can be recorded 
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at the radial artery. By keenly observing the pulsation, the diagnosis of diseases well as its 
prognosis can be assessed clearly.    
                     "§¸ªôÀ¡ ÒÕ¼ÕìÌ ÅÄÐ ¨¸¨Âì 
              ¸¢Õ¨ÀÔ¼ý ¾¡ýÀ¢ÊòÐ ¦¿ð¨¼ Å¡í¸¢, 
          ÝªôÀ¡ ¦ÀÕÅ¢Ã§Ä¡ ÃíÌÄòÐì ¸ôÀ¡ü 
              Í¸Á¡¸ ãÅ¢ÃÄ¡ ÄØò¾¢ô À¡÷ì¸" 
                                              - ÀÃ¢âÃ½ ¿¡Ê 
          "À¡÷ì¸§Å ¦ÀñÎ¸Ùì ¸¢¼Ð Àì¸õ" 
                                              -ÀÃ¢âÃ½ ¿¡Ê 
Naadi is nothing but the manifestation of the vital energy that sustains the life within 
our body. Naadi plays an most important role in Envagai thervu and it has been considered as 
foremost thing in assessing the prognosis and diagnosis of various diseases. Any variation 
that occurs in the three humors is reflected in the Naadi. These three humors organize, 
regularize and integrate basic functions of the human body. So, Naadi serves as a good 
indicator of all ailments. Aggravation of Valinaadi and Azhal naadi produces symptoms of 
Kalladaippu. This is emphasized in Agathiyar naadi, Sathaga naadi and Rathina churukka 
naadi.                       
                          
            «Ê¸ñ Ó¸Óõ ÀÄÁÄÓõ                      
            ¿¢¨Èó¾ Å¢Æ¢Â¢ø ¿£÷ÅÊÔõ                          
            ¿£ñ¼ ¿¡× ¸Úò¾¢¼×õ                      
            ¿¢¨Èó¾ Óûª¡ö ¾¡É¢ÕìÌï                          
            º¢Ú¿£÷ ¦À¡ÕÁ¢ ¸ÕòÐ ÅÕõ                        
            ¯¨Èó¾ ¿£Õí¸Õ ¸ÕòÐ                          
            Ó¨ÈÂ¡ö §Ã¡¸Ó Óñ¼¡ö"               
                                        -«¸ò¾¢Â÷ ¿¡Ê                     
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            Å¡¾ ¦ÁÛõ ¿¡ÊÂÐ §¾¡ýÈ¢ø                          
            º£¾Áó¾¦Á¡Î ÅÂ¢Ú¦À¡ÕÁø ¾¢Ãðº¢Å¡Ô                       
            º£¾ÓÕí ¸¢Ã¡½¢ Á§¸¡¾Ãõ ¿£Ã¡¨Á                          
            ¾¢ÃûÅ¡Ô Ý¨Ä ÅÄ¢ì¸ÎôÒò¾£¨Ã                       
            ¿£¾ÓÕí ¸¢ÕÁ¢ÌýÁõ «ñ¼Å¡¾õ     
            ¿¢¨ÄÔí¿£÷ì ¸¢Ã¢îºÃí¸û ¾óÐ §Á¸õ"                  
                                          -º¾¸ ¿¡Ê  
            
               §¸¡ø§Åø Å¢Æ¢º¢ÅóÐ Ìª¢÷ó¾¢ÕìÌ ÁøÄ¡ø  
            º£Ä§Å ¿£÷¸ÕòÐ ¦¿¡óÐ ÍÕì¦¸É ÅóÐÅ£Øõ      
                »¡Ä§Á ¸¢Ú¸¢¦ÈýÚ ¿¡×Ä÷ó¾¢ÕìÌó¾¡§É"  
                                          -­Ãò¾¢Éî ÍÕì¸ ¿¡Ê  
As per Sathaga naadi Derangement of Valiazhal naadi also produces symptoms of    
Kalladaippu.                
             ¦À¡Õª¡É Å¡¾ò¾¢ø À¢ò¾ï §º÷óÐ           
                   
             ¦ºÃ¢Â¡¨Á Òª¢ò§¾ôÀõ ¦À¡ÕÁø ¿£Ã¢ü        
                  º¢ÅôÒÁÄõ À¢Êò¾ÖÕó ¾¡Ð ¿ð¼õ"                            
                                           -º¾¸ ¿¡Ê   
   Sparisam (Touch):                       
By Sparisam, the temperature of the skin (Thatpam-cold or veppam-hot ) , 
smoothness, roughness, sweating, dryness ,hard patches ,swelling, abnormal growth of organs 
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and tenderness can be felt. In Kalladaippu patient feels tenderness over the lower abdomen, 
renal angle and lumbar region, swelling can be felt in case of Hydronephrosis.  
Naa (Tongue):                       
              By the examination of the tongue,its colour ,size, coating, moisture, movement, 
ulcer, fissure, crust can be examined. In Kalladaippu, if there is constipation, the coated 
tongue would be the feature. Loss of taste occurs in Karuneer kalladaippu.  
                    
                   Í¨Å¦¸¼ø ¦Åª¢Ú ÁÚôÒ ¿£÷§Åð¨¸"                        
                                               -§¿¡ö Å¢ªì¸õ  
Niram (Colour):  
Colour of the skin, conjunctiva, tongue, nail bed and hair etc..  
Vali udal- Dark Complexion 
Azhal udal -Wheatish yellow Complexion  
Iyya udal -Fair Complexion  
Mozhi (Speech):        
               By examining mozhi (speech), the various characters are to be noted such as 
hoarseness, slurring etc.. and various disorders of speech such as dysarthria can also be noted 
in Kalladaippu. There is low pitched voice due to agonizing pain in the lower abdomen and 
burning sensation in urethra.     
Vizhi (Eye):         
             Examine the colour of eye like reddish or yellowish discolouration and characters 
like dryness and Lacrimation. Tiredness and redness is observed in patients with Renal colic.   
Malam (Stool):                  
            By examining malam, its nature (consistency), colour, quantity and presence of blood 
can be noted. 
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 Neerkuri (Urine Examination): 
           Urine examination is one of the good diagnostic tool when compared to other Envagai 
thervugal.  
 ¿£÷ÌÈ¢î º¢ÈôÒ :     
                    
                    ¾í¸ª¢ü §È÷óÐ ¿¡Ê   
                    Å÷ì¸Á¡õ ¿¡Ê ¾ýÉ¢ø   
                    ÅÕÅÐ ÁÂì¸ ¦Áý§È     
                     
                    Ô¨Ãò¾É Ã¢¾üÌ §¿Ã¡ö     
                    Áü¦È¡Õ Å¢¾¢á Ä¢ø¨Ä        
                    ÁÕòÐÅì ¸¨ÄÅø§Ä¡÷ì§¸"                                               
                                      -«í¸¡¾¢ À¡¾õ.                     
              In order to shed off the ambiguity in the diagnosis of disease through pulse 
perception. The exponents have charted out a method called Neerkuri - an incomparable 
method of diagnosis.     
                                          
                     «·¸ø «Ä÷¾ø «¸¡Äçñ ¾Å¢÷ó¾Æü   
                     ÌüÈª ÅÕó¾¢ ¯Èí¸¢ ¨Å¸¨È   
                     ¬Êì ¸Äºò ¾¡Å¢§Â ¸¡Ð¦Àö         
                     ¦¾¡ÕÓÜ÷ò ¾ì¸¨Äì ÌðÀðÎ ¿£Ã¢ý         
                      
-§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ                                     
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            On the day before the urine test one should have  food  of all the six  tastes in 
anharmoniou
sound overnight sleep, Urine should be collected in a crystal bowl and the test  should be 
done  90 minutes before dawn.  
   Characters of urine:  
  
 
                                     -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ  
1. Niram (Colour)  
2. Edai (Specific gravity)  
3. Nurai (Froth)  
4. Naatram (Smell)  
5. Enjal (Deposits)  
     Urine sample should be examined for the above mentioned five parameters.  
Niram (Colour):  
   Nira Thogai:  
 
 
                                   -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ  
1. Yellow  
2. Red  
3. Green  
4. Black  
5. White  
            Urine may be of any colour mentioned above according to the disease condition. 
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¸øÄ¨¼ôÒ ¿£Ã¢ý Ì½õ (Colour Indicating Urinary Stones):  
                 The colour of the urine look like  decomposed flesh cleaned water indicates the 
presence of   Kidney stone.  
            
               ¸¡öòÐ÷ô ÀÄò¾¡ø ¸¾¢ò¾ ¿£Ã¡Áò 
            Ð÷ôÀÄì ¸ÀÓõ §º¡Ã¢Ôõ ¦¸¡¾¢ôÒÈô     
                
-§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ  
          "¸¡½¢¾¢ø º£Øí ¸Äó¾¢Æ¢ Á½ÓÈ¢ý  
          ¸ÕôÀ ¿¡À¢¸Ù Ùí ¸¡Á ¿¡ªòÐÙõ 
          Å¢Ã½Óý Êý§Èø ±öÐ¸ø ÁÈ¢ÂÄ 
          ¾¢Õò¾§Ä ¾¢ñ½ ¦ÁÉÁÉò Ðý¦É" 
                                       -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ 
 Edai (Specific Gravity):  
            Urine which is not thick is considered to be healthy one.  
  
 
-§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ  
Nurai (Froth):  
           
           ¾ó¾¡÷ â¾Á¡ö «É¢Ä ãò¾¢Ãò¾¢ø   
            
-§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ           
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         Urine may be frothy in nature. Reduced froth in the urine indicates derangement of 
Vali, Azhal and Iyyam.  
Naatram (Odour):   
 
º£¾ªí ¸õÁ¢Â §¾¸¢¸Ùì§¸  
 
"¦ÅöÂ Ð÷ì¸ó¾õ Å£Í¿£÷ Óò¾¢Ãô 
¨À¿¡ªÁ¢ü¨Èô ÀüÚ ÒñÌÈ¢§Â 
«õ¦Á¡Æ¢Â¢ý¦ÈÉ¢ÉÉ¢Ä§Á Ó¾Ä¢Â 
ÓõÁÄî Í¾§Á ãÄ¦Áý Ú½§Ã" 
                            -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ   
Enjal (Deposits):  
               If the colour of the urine excreted looks like curd water or milk and the presence of 
white colour and sand like deposits in urine indicates stones in the  Kidney. It is mentioned in 
the following poem,  
           ¿£÷À¡ø §À¡Ä  
           ¿¨ÅÔüÈ ¸¢Æ¢Ô Á¡É¡ø  
           Á¡ÃüÀ ÓüÈ¡ ¿£Ã¢  
           ÄÊ ÁñÊì ¸¢¼ó¾ ¾¡É¡ø  
           À¡Ã¢ò¾ ¦ÁØÌ Á¡í¸¡ö  
           ÀüÈ¢Â ¸øÄ¢ ¿¡§Ä  
           º£ÕüÈ ¦ºö¨¸ ¦ÂýÚ  
            
                                -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ   
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Neikkuri:  
                The urine was kept in the Kidney tray and exposed to sunlight under non wind 
condition.The urine  should be examined after dropping a drop of Gingelly oil gently in it 
with a glass rod.  If the oil spreads like snake, it indicates Valineer, like a ring indicates Azhal 
neer, and  float like a pearl indicates Iyya neer and if it sinks in urine, it indicates Mukkutram.  
¿¢ÈìÌÈ¢ì Ì¨Ãò¾ ¿¢ÕÁ¡½ ¿£Ã¢ü 
º¢Èì¸ ¦Åñ¦½ö§Â¡÷ º¢ÚÐª¢ ¿ÎÅ¢Îò 
¦¾ýÚÈò ¾¢Èó¦¾¡Ä¢ ²¸¡¾¨Áò¾¾¢ 
É¢ýÈ¾¢Å¨Ä §À¡õ ¦¿È¢Å¢Æ¢ÂÈ¢×õ 
¦ºýÈÐ  
                                     -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ                       
 
 
 
                               -§¾¨ÃÂ÷ ¿£÷ìÌÈ¢ ¦¿öìÌÈ¢ ¨Åò¾¢Âõ  
In Kalladaippu patients, either  oil spreads like a ring (Azhal neer) or like a snake  ( Vali  
Neer).  
º¡ò¾¢Â «º¡ò¾¢Âõ: (Prognosis)  
                 ÝðÊÂ º¡ò¾¢Âò¨¾î ¦º¡øÄì §¸ª¡ö  
                 ÍÙì¸¡Ìõ Å¡¾ò¾¢ý ¸øÄ ¨¼ôÒ                       
                 âðÊð¼ À¢ò¾ò¾¢ý ¸øÄ ¨¼ôÒô  
                 Ò¸Æ¡É §ºðÎÁò¾¢ý ¸øÄ ¨¼ôÒ  
                 ãðÊð¼ ­ÐãýÚ Áº¡òÂ Á¡¸¢       
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                 Ó¨ÉÂ¡É ÁÕóÐ¸ª¢ü ¦ºõ¨Á Â¡Ìõ      
                 §¾¡ðÊð¼ ¦¾¡ó¾Á¡í ¸øÄ ¨¼ôÒò        
                 ¦¾¡ÎÍÈ§Å ¦¸¡øÖÁ¢Ð Ýðºó ¾¡§É                          
                                               -ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢                        
According to Yugi Mamunivar,Vali, Azhal and Iyya Kalladaippu are curable whereas 
Thontha Kalladaippu is incurable.   
ÁÕòÐÅõ (Line Of Treatment) :                        
                
                                               - ¾¢ÕãÄ÷ 800            
The main object of treatment is to bring down the deranged mukkutrams to natural 
equilibrium by giving purgatives, which cure derangement of Vatham, this is one of the cause 
for kalladaippu.  
                  
                  
                  
                                          -Å¢Â¡º À¸Å¡ý ºÃ£Ã Ýò¾¢Ãõ             
             As per the above mentioned poem, the author gave Agasthiyar Kuzhambu 130 mg 
with sangankuppi leaves juice as purgative drug to all patients as per their body condition.  
              In Siddha system, treatment is not only for treating the disease but also for  
preventing and improving the body condition .This has been mentioned as Kaapu, Neekam 
and Niraivu.   
Diet :   
                  "ÁÕó§¾ ¯½×, ¯½§Å ÁÕóÐ"  
                                         - ¾¢ÕãÄ÷. 
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 "Á¡ÚÀ¡ ÊøÄ¡ ¯ñÊ ÁÚòÐñ½¢ý 
                   °ÚÀ¡ Êø¨ÄÔ Â¢÷ìÌ" 
                                        - ¾¢ÕìÌÈû.  
  
 Drink 3 to 4 litres of Water, a day.  
 Take more amount of  Barley rice porridge, Tender coconut, Stalk of the greens, 
Spadix of the Plaintain, Nerunjil kudineer, Koolu kudineer 
 Fruits: Water melon, Cucumber, Pineapple, lemon, Guava 
 Cereals:Dal, Black gram, Green gram, Dried pea  
 Vegetables , White pumpkin.  
 Seeds: Cumin seed, Cucumber seed 
 
 Tomato, Cabbage, Cauliflower, Coffee, Tea, Chocolate, Meat, Greens, Egg, Grapes, 
Strawberry, Caustic soda, Tamarind, Betle, Areca nut, Tobacco, Liquor  
 Preserved beverages, Foods rich in salts, Salty water, Milk and milk products, Spicy 
and fried foods                   
 
 
 
  
  
 
 
MODERN ASPECT 
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MODERN ASPECT 
RENAL CALCULUS 
ANATOMY OF THE KIDNEY:  
Kidney is one of the major excretory organ of the body.The kidneys are two bean 
shaped organs situated on the posterior abdominal wall, on either side of the lumbar vertebral 
column. Each kidney weighs about 120 to 150gms and is enclosed in thin but tough fibrous 
capsules, and concave medial side of kidney is the hilum where the renal artery enters and 
renal vein and ureter leave the kidney.The components of kidney are arranged in three layers.  
 1. Outer cortex  
This is dark and granular appearance. It contains renal capsules and convoluted 
tubules,at intervals cortical tissues penetrate medulla in this form of columns is called column 
of Bertini.  
 2. Inner medulla  
This gives radially striated appearance as it contains tubular and vascular structures. 
Medulla mass is divided into 8 to 18 medullary or malphigian pyramids, the base of pyramids 
are connected with cortex and apex projects into major calyx.  
 3. Renal sinus  
 It consists of upper expanded part of ureter called renal pelvis. It is subdivided into 2 
or 3 major calyces and 8 minor calyces. It also consists of branches of nerves and arteries and 
the tributaries of veins.   
  Nephron  
Structural and functional unit of the kidney is Nephron. Each kidney has millions of 
nephrons. Each Nephron begins in cortex as fun
capsule, which encloses a tuft of capillaries, the glomerulus
with glomerulus is called the malphigian corpuscule or renal corpuscle.  
ecomes convoluted to form the 
proximal convoluted tubule (PCT). It then becomes straight and passes down the medulla as 
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the descending limb of the loop of Henle, after varying distances before reaching the end of 
papilla, it turns round in the form of U-shaped bend, forming loop of Henle, and passes 
upwards towards the cortex, parallel with its former course as the ascending limb of the loop 
of Henle. Each limb has an outer thick and inner thin portion.  
 
CROSS SECTION OF KIDNEY 
 
STRUCTURE OF NEPHRON 
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RENAL CIRCULATION:  
               Renal artery arises from the aorta, enters the kidney at the hilum and divided into an 
anterior and aposterior branch, which gives rise to about five segmental arteries. The 
segmental artery divided into interlobar arteries,which pass outward in the medulla between 
the pyramids to reach boundary zone between the medulla and cortex.Here they turn to take a 
horizontal course uniting with adjacent arteries to form arterial arches called arcuate 
arteries.Several straight arteries arises from these arches and run radially outward through the 
cortex.These are called interlobular arteries.From each interlobular arter, numerous afferent 
arteries arise,and enter 
arterioles divide into 4 to 5 large capillaries,which from the loop,and capillary loop unite to 
 
                The efferent arterioles give rise to renal portal system. The efferent arterioles form 
a second capillary network surrounding the tubular portion of the nephron, the capillaries of 
second set are called peritubular capillaries.  
                 Some specialized peritubular capillaries called Vasa recta supply the tubular 
portion of juxramedullary nephron. Vasa recta arise directly from the efferent arteriole of the 
juxtamedullary nephron. Vasa recta supply the tubular portion of juxtamedullary nephrons. 
The peritubular capillaries drain into the venous system, which include the peritubular 
venules, interlobular veins, segmental vein and final the renal vein.  
URINE FORMATION:  
                 Kidney excretes the unwanted substances including metabolic end products and 
those substances, which are present in excessive quantities in the body, through 
urine.Normally, about 1-1.5 litres of urine is formed every day.                    
                 The mechanism of urine formation includes various processes. First, when blood 
When this filtrate passes through the tubular portion of the nephron, it undergoes various 
changes both in quality and in quantity.   
                Many wanted substances like glucose, amino acids, water and electrolytes are 
reabsorbed from the tubules. This process is called tubular reabsorption and some unwanted 
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substances are secreted into the tubule from peritubular blood vessels. This process is called 
tubular secretion or excretion.              
 The urine formation includes the following three processes:  
        1. Glomerular filteration 
        2. Tubular reabsorption  
        3. Tubular secretion  
1. GLOMERULAR FILTERATION 
When blood passes through the glomerular capillaries the plasma filtered into the 
filtered fluid is called glomerular filtrate. During filteration the substances passes through the 
three layer of filtrating memberane such as,  
           1. The endothelium of capillary memberane  
           2. Basement memberane and   
           3. Endothelium of viscer  
The glomerular filtration is called ultra filtration because minute particles are filtered, 
but the plasma proteins are not filtered due to larger molecular size than size of the slit pores. 
The composition of glomerular filtrate is similar to that of plasma except in the absence of 
plasma proteins.  
Glomerular filtrate rate (GFR)  
The total quantity of filtrate formed in all the nephron of both the kidneys in the given 
unit of time is called glomerular filtrate rate. The normal value of glomerular filtrate is 
125ml/ minute or about 180 litre /day.  
   2.TUBULAR REABSORPTION  
When the glomerular filtrate passes through the tubular portion of nephron, both 
quantitative and qualitative changes occur. The tubular epithelial cells reabsorb large quantity 
of water, electrolytes and other substances. The substances, which are reabsorbed, pass into 
the interstitial fluid of renal medulla, and from here, the substances more into the blood in 
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peritubular capillaries. As the substances are taken back into the blood, the entire process is 
called tubular reabsorption.  
Selective reabsorption  
         The tubular cells of kidney selectively reabsorb the substances present in the glomerular 
filtrate, according to the needs of the body. So, the tubular reabsorption is called the selective 
absorption.  
Mechanism of reabsorption  
                The mechanisms involved in tubular reabsorption are of two types  
                     1. Active reabsorption  
                     2. Passive reabsorption  
   1. Active reabsorption  
The movement of molecules is against the electrochemical gradient. This needs 
liberation of energy and the energy is derived from ATP. The substances reabsorbed actively 
from the renal tubule are sodium, calcium and potassium, phosphates, sulphates, 
bicarbonates, glucose, amino acids, ascorbic acid, uric acid and ketone bodies.  
   2. Passive reabsorption  
In this process, the movement of molecules is more along the electrochemical 
gradients. This process does not need energy, the substances reabsorbed by passive transport 
are chloride, urea and water.   
3. TUBULAR SECRETION:  
           Some substances secrete into the lumen from the peritubular capillaries through the 
tubular epithelial cells. These known as tubular secretion or tubular excrertion.  
1. Potassium is secreted actively by sodium  potassium pump in distal convoluted 
tubule and collecting duct.  
2. Ammonia is secreted in the proximal convoluted tubule.  
3. Hydrogen ions are secreted in the proximal and distal convoluted tubles, Maximum 
hydrogen ion is secreted in proximal tubule.  
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         Thus by the process of glomerular filtration, selective reabsorption and tubular secretion 
urine is formed in the nephron. It is also concentrated by counter current mechanism and anti 
diuretic hormone. Finally, it passes through the ureter into the urinary bladder and is stored 
there until it is voided out.  
                                                     RENAL CALCULUS:  
DEFINITION:  
             A kidney stone, also known as a renal calculus.In Latin ( ren- "kidney" and calculus- 
"pebble"). It is a solid concretion or crystal aggregation formed in the kidneys from dietary 
minerals in the urine. Kidney stones form when there is a decreased in urine volume and/or 
an excess of stone-forming substances in the urine. Until the 1980s, urinary stones were a 
major problem, with a significant proportion of patients requiring extensive surgical 
procedures and a sizable losing their kidney. The advent of extra corporeal techniques for 
stone destruction and refinements in endoscopic surgery, however have greatly decreased the 
morbidity associated with stone surgery.  
LOCATION: 
 Urolithiasis refers to stones originating anywhere in the urinary system, including 
the kidneys and bladder.  
 Nephrolithiasis refers to the presence of such calculi in the kidneys. 
 Calyceal calculi refers to aggregations in either the minor or major calyx, parts of 
the kidney that pass urine into the ureter.  
 Ureterolithiasis refers to calculus or calculi are located in the ureter. Stones may   
also or pass into the bladder, a condition referred to as Cystolithiasis. 
EPIDEMOLOGY  
INTRINSIC FACTORS  
Hereditary  
            Several disorders that cause renal stones are hereditary. Familial renal tubular acidosis 
are associated with nephrolithiosis in almost 70 % of patients. Cystinuria, Xanthinuria and 
Dehydroxydenuria are disorders cause renal stone.  
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Age and Sex  
          The peak incidence of urinary calculus occurs in the twenties to fourties. About three 
males are affected for every female because increased serum testosterone causes increased 
endogenous oxalate production in male, increased urinary citrate in women.  
EXTRINSIC FACTORS  
Geography:  
        The prevalence of urinary calculi is higher in those who live in mountainous, desert, and 
tropical areas.  
Climate and seasonal factors: 
        Price and associates found that the incidence of urinary calculi was higher during the 
summer months. High temperatures increase perspiration, which may result in concentrated 
urine. This promotes increased urinary crystallization. Parry and lister suggest that increased 
exposure of sunlight cause increased production of 1, 25- dichydroxyvitamin D3 and 
increased urinary calcium excretion. This may cause higher incidence of urolithiosis in 
summer months.  
Water Intake: 
        Urine dilution by increased water intake may increased ion activity coefficients and 
hence urinary crystallization, water diuresis reduces the average time of residence of free 
crystal particles in urine dilutes compononents of urine that may crystals. Minerals contents 
of water may contribute to cause stone disease, (E.g Sodium Chlorides) zinc in an inhibitor of 
calcium crystallization.   
 Dehydration:  
        Not drinking enough water each day can increase your risk of kidney stones. People who 
live in warm climates and those who sweat a lot may be at higher risk than others.  
Diet:  
       Eating a die and sugar may increase the risk of some type 
of kidney stones. This is especially true with a high sodium diet.Too much sodium in diet 
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increases the amount of calcium in kidneys must filter and significantly increases risk of 
kidney stones.  
Animal Protein:  
         Western nations typically contain large propotion of animal protein,consumption of 
animal protein creates an acid load that increases excretion of calcium and uric acid and 
reduced citrate.Urinary excretion of excess sulfurous amino acids (cysteine and methionine) 
and uric acid and other acidic  metabolites from animal protein acidifies  the urine,which 
promote the formation of kidney stones.Low urinary citrate excretion is also commonly 
found in those with a high dietary intake of animal protein.Where as vegetarians tend to have 
higher levels of citrate excretion.Low urinary citrate to promotes stone formation.  
Vitamins:  
      The evidence linking vitamin C supplements with an increased rate of kidney stones is 
inconclusive. The excess dietary intake of vitamin might increase the risk of calcium oxalte 
stone formation. The link between vitamin D intake and kidney stone also  tenuous. 
Excessive vitamin D supplementation may increase the risk of stone formation by increasing 
the intestinal absorption of calcium.  
Electrolytes:  
          Calcium is not the only electrolyte that influence the formation of kidney stones .For 
example, by increasing urinary calcium excretion, high dietary sodium may increase the risk 
of stone formation.Drinking fluoridated tap water may increase the risk of kidney stones by 
similar mechanism.   
ETIOLOGY: 
Predisposing factors for kidney stones 
Environmental and dietary 
 Low urine volumes: High ambient temperatures, low fluid intake 
  Diet: 
 High protein intake, high sodium, low calcium 
 High sodium excretion 
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 High oxalate excretion 
 High urate excretion 
 High citrate excretion 
   Acquired causes 
 Hypercalcaemia of any cause 
 Renal tubular acidosis type 1 
   Congenital and inherited causes 
                 Familial hypercalciuria 
                 Primary hyperoxaluria 
                 Cystinuria 
                 Medullary sponge kidney 
 
SITE OF  CALCULUS: 
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CLINICAL SYMPTOMS:  
 Kidney stones typically leave the body by passage in the urine stream, and 
many stones are formed and passed without causing symptoms.If stones grow 
to sufficient size (usually at least 3 millimeters (0.12 in)) they can  cause 
obstruction of the ureter.  
 Ureteral obstruction causes postrenal azotemia and hydronephrosis 
(distension and dilation of the renal pelvis and calyces), as well as spasm of 
the ureter.  
 This leads to pain, most commonly felt in the flank (the area between the ribs 
and hip) lower abdomen and groin (a condition called renal colic). Renal 
colic can be associated with 
 Nausea,  
 Vomiting,  
 Fever, 
 Blood in the urine, 
 Pus in the urine,  
 Painful urination.                                 
Renal colic typically comes in waves lasting 20  60 minutes, beginning in the flank 
or lower back and often radiating to the groin or genitals.  
ABDOMINAL PAIN IN CALCIUM STONE:  
 The most common symptom of calcium-based kidney stones is a sharp, stinging  or 
cramp-like pain in the abdomen, back or side. This pain may occur in waves  as a 
kidney stone passes through the urinary tract.  
 Calcium kidney stones take on a variety of shapes and sizes and pain may vary  with 
these parameters. Some calcium-containing stones may be large enough to block the 
urinary tract altogether, preventing the flow of urine and causing further pain and 
discomfort.  
ABDOMINAL PAIN IN STRUVITE STONES: 
 Struvite stones are typically associated with a burning-like abdominal pain, similar   
to pain of a kidney or urinary tract infection. The pain associated with a struvite stone 
may not be stinging and cramping like the pain associated with calcium stones.  
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 Struvite stone pain tends to be less localized, dull, burning and aching and less likely 
to come in waves of pain.  
BLOOD IN URINE:  
 As larger calcium-based kidney stones pass through the urinary tract, they can scrape 
and damage the inner lining of the urinary tract and cause bleeding. 
 Struvite stones and an accompanying infection may damage the inner lining of the 
urinary tract and lead to the appearance of blood in the urine.  
FEVER, CHILLS AND NAUSEA: 
 Struvite stones are formed from magnesium and ammonia through the action of 
bacteria during a kidney infection or UTI.  
 Struvite stone symptoms include  
 fever,  
 chills,   
 loss of appetite 
  nausea.      
 Physical signs  
Pulse rate and blood pressure may be elevated because of pain and agitation. 
Examination of the abdomen reveals moderate deep tenderness on palpation over the location 
of the calculus and the area of the loin.  
TYPES OF CALCULUS  
Kidney stones are tpically classified by the location and the chemical composition  
CALCIUM OXALATE STONES:  
This is most common type of stones, 39% of patients are calcium oxalate type stone. 
14% of patients are combined with calcium phosphate.They are irregular in shape and 
covered with sharp projection, which tends to cause bleeding. The surface of the stone is 
discoloured by pigments of altered blood.It is very hard and absorbs X- rays well.   
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PATHOPHYSIOLOGY OF STONE FORMATION  
 1. HYPERCALCIURIA  
              Between 30% and 60% of all patients with calcium Oxalate kidney stones have 
increased urinary calcium excretion in the absence of raised serum calcium levels. 
Hypercalciuria has been defined as the excretion of greater than 4mg calcium per kg body 
weight per day or greater than 7 mmol in men and 6 mmol in women (Parks and coe.1986) 
Final definition is the excretion of urinary calcium of greater than 0.11 mg/ 100ml of 
glomerular filtrate.  
            Hypercalciuric nephrolithiasis suffer from multiple disturbances in renal tubular 
function a disturbance in phosphates transport and accelerated 1, 25- dihydroxyvitamin D3 
synthesis, resulting in increased intestinal calcium absorption.  
            Hypercalciuria has three types, such as   
              1. Absorptive hypercalciuria  
              2. Renal hypercalciuria  
              3. Resorptive hypercalciuria     
    1. Absorptive Hypercalciuria  
             In absorptive hypercalciuria, the primary abnormality is increased calcium 
absorption. In absorptive hypercalciuria type 1.Intestinal Hyper absorption of calcium exists, 
whether or not the patient is on a calcium restricted diet. Intestinal magnesium absorption is 
normal in patients with absorptive hypercalciuria, but not oxalate, absorption in both the 
jejunum and ileum. Absorptive hypercalciuria type 2 is a variant of this disorder wherein 
on a low calcium, low sodium diet. In the 
final subcategory, absorptive hypercalciuria type 3, the serum phosphate is low, suggesting 
that the increased intestinal calcium absorption is the result of stimulation in vitamin D 
production as the result of the lowered serum phosphate.  
  2. Renal hypercalciuria  
           In this condition the underlying abnormally is a primary renal wasting of calcium. The 
consequent reduction in circulating serum calcium stimulates PTH production. Two facts 
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must be stressed: first, intestinal absorption of calcium is increased in both absorptive and 
renal hypercalciuria but stimulated in renal hypercalciuria. These two criteria elevated fasting 
urinary calcium levels and stimulated parathyroid function serve to distinguish renal from 
absorptive hypercalciuria.  
  3. Resorptive Hypercalciuria  
          This syndrome is synonymous with subtle hyperparathydroism. Hypercalciuria results 
from excessive PTH dependent bone resorption well as enhanced intestinal absorption of 
calcium.  
  4. Idiopathic Hypercalciruria  
          The syndrome of renal phosphate leak elevated 1, 25 dihydroxyvitamin D3 and 
absorptive hypercalciuria has been demonstrated in members of a Bedouin tribe in which 
intermarriage is common, idiopathic hypercalciuria may be inherited as an autosomal trait, 
although the pattern can reflect polygenic control of calcium excretion as well.  
II. HYPERCALCAEMIA NEPHROLITHIOSIS CAUSES  
1.  Primary hyperparathydroidism  
           These patients are between 39% and 78% with early presented of renal calculi. These 
patients with higher level of 1, 25- dihydroxyvitamin D3 and greater calcium absorption tend 
to have renal stones.  
2. Malignancy associated hypercalcemia  
           Malignancy  associated hyper calciuria is an exceedingly rare cause of renal stones. 
The most common cause of malignancy- associated Hypercalcaemia, even in patients with 
skeletal metastasis, is production by the tumour of a bone resorpting substance called PTH- 
related polypeptide.  
3. Sarcoidosis and other granulomatous diseases   
            The sarcoid granuloma produces 1, 25- dihydroxy vitamin D3, it causing increased 
calcium absorption, hypercalcaemia and hypercalciuria.  
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4. Hyperthyroidism  
             About 5% to 10% of patients with hyperthyroidism develop hypercalcaemia. 
Hypercalcaemia and hypercalciuria result from a stimulation of bone resorption mediated by 
thyroxine and tri- iodothyronine.  
5. Glucocorticoid  induced hypercalcemia  
           Glucocorticoid excess leads to increased bone resorption, decreased bone formation, 
and osteopenia, Glucocorticoid also has direct stimulatory effect on parathyroid gland.  
6. Pheochromocytoma  
           Hypercalcaemia when seen in patients with pheochromocytoma, occur most often in 
patient with multiple endocrine neoplasma type 2, in which primary hyperparathyroidism, 
medulary carcinoma of thyroid, adrenal gland tumour coexist.  
7. Immobilization  
           Prolonged bed rest can lead to hypercalcaemia, as the result of increased bone 
 with accelerated bone turnover primary hyperthyroidism, or malignancy, coexist in an 
immobilized patient.   
III. HYPEROXALURIA  
CAUSES:  
           Primary hyperoxaluria is a rare genetic disorder resulting from increased hepatic 
production of oxalate. Enteric hyperoxaluria occurs in patients with short bowel syndrome or 
malabsorption. Finally, a group of patients with recurrent idiopathic calcium oxalate lithiasis 
exhibits mild hyperoxaluria or increased transport of oxalated by red blood cells.  
1. Primary hyperoxaluria  
        Two types of primary hyperoxuluria exist. Primary hyperoxaluria type1 is an autosomal 
ressive inborn error of metabolism characterized by nephrocalcinosis and oxalosis. The 
diseases are characterized by increased urinary excretion of oxalic, glycolic and glycolic 
acids.Primary hyperoxaluria type 1 is due to a defect of the enzyme alanine- glyoxylate 
aminotransferase (AGT) in the liver.  
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       In normal human liver, AGT catalyzes the transamination or detoxification of glyoxylate 
to glycine, a function that it can perform only if it is located in peroxisome. Its deficiency in 
 oxalate.  
        Primary hyperoxaluria type II or L-glyceric aciduria is a much rarer variant of the 
disease. Deficiencies of the hepatic enzymes D- Glycerate dehydrogenase and gyloxylate 
reductase lead to increase in urinary oxalate and glycerate excretion.  
2. Enteric hyperoxaluria  
        Ingested oxalate is absorbed through the stomach and the colon. Malabsorption from any 
cause, including small bowel resection, intrinsic disease, or jejunoileal bypass, increases the 
colonic permeability of oxalate as the result of exposure of the colonic epithelium to bile 
salts. Furthermore, loss of calcium in the feces results in the presence of less calcium in the 
intestinal lumen, allowing oxalate to exist in a soluble form. The hyperoxaluria from small 
bowel malabsorption often exceeds 1 mmol/day and causes recurrent nephrolithiasism, 
nephrocalcinasis, and renal oxalate deposition.  
 3. Mild metabolic hyperoxaluria  
      Mild hyperocaluria is as least as important a factor in the pathogenesis of idiopathic 
calcium oxalate stones as hypercalciuria. Baggio and colleagues are found an increase in 
oxalate self exchange across red blood cell memberane in 79% of patients with idiopathic 
calcium oxalate stones. The oxalate absorption was increased with increased calcium 
absorption. Dietary restriction of oxalate results in decreased oxalate excretion.  
IV. HYPERURICOSURIA  
         Uric acid promotes calcium oxalate crystallization by facilitating the formation nuclei. 
Sodium acid urate may produce calcium oxalate stone disease by nullifying the effectiveness 
of naturally occurring inhibitors of calcium oxalate crystal growth. Excessive dietary intake 
of purine is main cause of hyperuricosuria. Between 80% and 90% of patients with 
hyperuricosuria nephrolithiosis are men. Patients with mixed with uric acid and oxalate 
stones have lower urinary pH than patients with pure calcium oxalate stones.  
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V. HYPOCITRATURIA  
        Hypocitraturia has been reported in 15% to 63% of patients with stones. Urinary citrate 
is normally greater in women than in men. Hypocitraturia define as citrate excretion of less 
than 0.60 mmol (115 mg) in men and 1.03 mmol (200 mg) in women. Acidosis is probably 
the most important etiologic factors in hypocitraturia. In patients with inflammatory bowel 
disease and chronic diarrhea, intestinal alkali loss results in metalbolic acidosis. Thiazide- 
induced hypokalaemia and intracellular acidosis are the other cause of decreased urinary 
citrate excretion. A diet rich in animal protein may produce an acid load. Strenuous physical 
exercise and sodium intake can likewise produce hypocitraturia. Urinary tract infection with 
bacteria degrading citrate lowers urinary citrate excretion.  
      The primary mechanism of action of citrate is as a complexing agent for calcium. 
Calcium citrate complexes are considerably more soluble than calcium oxalate. Citrate 
inhibits the spontaneous nucleation of calcium oxalate, crystal growth and aggregation of 
calcium oxalate and phosphate.  
 VI. HYPOMAGNESURIA  
       Many experimental studies have suggested that administration of magnesium salts 
prevents stones disease. The most common cause of hypomagnesuria is inflammatory bowel 
disease associated with malabsorption. Most patients with hypomagnesuria also have 
hypocitraturia.   
  VII. SEX HORMONES AND RENAL STONES  
       Calcium oxalate renal stones occur much more frequently in men than in women because 
increased endogenous oxalates production by liver and increased intestinal absorption of 
calcium in men, increased urinary citrate concentration in urine in women.  
CALCIUM PHOSPHATE STONES  
        Calcium phosphate stones composed predominantly around 10% of stones of renal 
origin. Although some amount of calcium phosphate is often found in calcium oxalate 
calculi, pure calcium phosphate stone are rare. It is usually smooth and dirty white, and easy 
to see on radiopaqhic film.  
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 Causes:  
         Renal tubular acidosis is common cause for this type of stone. Upto 70% of adults with 
renal tubular acidosis have kidney stones. This stone may seen with oxalate and struvite 
stones. Stone formation typically occurs in papillary tips and in medulla. Stone formation is 
result of hypercalciuria, Hypocitraturia and increased urinary pH. Hypercalciuria is result of 
systemic acidosis on bone demineralisation and secondary hyperthyroidism. Hypocitraturia 
result from a primary defect in renal tubular citrate transport, again, the result of metabolic 
acidosis. Hypocitraturia is probably the most important metabolic factor for stone formation 
in patient with renal tubular acidosis. The defect in proximal tubular bicarbonate resorption is 
associate with this type of stone.  
   Diagnosis: the patient has hypokalaemia, Hyper chloremia, Metabolic acidosis and urinary 
pH of 5.5.  
URIC ACID STONE  
       About 5 10% of all stones are formed from uric acid. People with certain metabolic 
abnormalities, including obesity may produce uric acid stones.These are hard, smooth and 
often multiple. Their colour varies from yellow to reddish brown. The pure uric acid stone are 
radiolusent most of stone with calcium so they radiolucent shadow.   
 Causes:  
         The principal cause of uric acid crystallization is supersaturation of urine with respect to 
undissociate uric acid. The normal 24- hour urinary uric acid excretion is between 500 and 
600 mg per litre of urine. Patient with uric acid stone often have prolonged periods of acidity 
in urine.  
          The pH of urine in patient with uric acid stones was 5.5±0.4 as compared with 6.0±0.4 
in patients who form calcium oxalate stones. Three factors are involved in uric acid 
urolithiosis. First, patients tend to excrete excessively acid urine at relatively fixed, low 
urinary pH. Second, they may absorb produce or excrete more uric acid than patients without 
gout or uric acid stones.   
          Third, urinary volume is diminished in these patients. The combination of these factors 
is ideal for the crystallization of uric acid in the urine. The frequency of uric acid stones in 
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gout is about 20%. Myeloproliferative disorders such as acute leukemia are an important 
cause of severe hyperuricosuria particularly in childhood.  
STRUVITE STONES (INFECTION STONES)  
         About 10 15% of urinary calculi are composed of struvite (ammonium magnesium 
phosphate). Struvite stones ("infection stones", urease or triple-phosphate stones), form most 
often in the presence of infection by urea-splitting bacteria.                                                                                                          
   Pathogenesis  
         Two conditions must coexist for the crystallization of struvite a urine pH of 7.2 or 
above and the presence of ammonia in the urine. A second mechanism by which bacterial 
infection may induce stone formation is by increasing crystal adherence. Urease producing 
bacteria hydrolyze urea to carbondioxide and ammonium molecules. Two molecules of 
molecules of ammonia are produced from one molecule of urea: neutralization of the base is 
incomplete. As a result of this, the urinary pH rises.  
  Clinical presentation:  
          Struvite calculus accounts are the majority of staghorn stones observed in most 
countries. They can grow quite large and may fill the collecting system. Struvite stones can 
form on a nidus of calcium oxalate stones and can grow quite rapidly. Most infection stones 
are radiopaque, but poorly mineralized matrix stones are faintly radiopaque or radiolucent. 
Women, perhaps because of their increased susceptibility to urinary tract infection, are more 
commonly affected than men.   
         The presence of a foreign body in the urinary tract and neurogenic bladder are main 
causes for struvite calculi.  Patients with struvite stones may present acutely with fever, loin 
pain, dysuria, frequency and hematuria. Metabolic abnormalities are present in patient with 
mixed calciumoxalate and struvite stones but not in patients with pure struvite stones.  
Cystine Stones:  
        They are uncommon cystine stones account for about 1% of all urinary calculi in the 
United States and occur only in patients who have cystinuria. Cystinuria is an autosomal 
recessive disorder of transmembrane cystine transport manifested in the intestine and in the 
kidney. Cystine stones are radiopaque, although less so than calcium oxalated stones. The 
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radiopacity is the result of the disulfide bond in cystine. The stones are hexagonal, 
Translucent while colour appear in acid urine and it is yellowish or pinkish colour when first 
removed but greenish hue colour when exposed to air and have a waxy appearance and very 
hard. They are often multiple, are large an may form staghorns. Cystinuria can cause renal 
stones in childhood, but the peak of clinical expression is in the second and third decades. 
The cystine stones form because cystine is poorly soluble within the range of normal urinary 
pH.  
XANTHINE STONES:  
These are extremely rare. They are smooth and round, brick  red in colour and a 
radiolucent. Xanthinuria is an inborn error of metabolism inherited as an autosomal recessive 
trait and characterized by a deficiency of xanthine oxidase. Serum uric acid levels are low, 
averaging less than 1.5 mg/dl. Serum and urine levels of xanthine and hypoxanthine are 
significantly increased. Xanthine stones develop because xanthine is less soluble than 
hypoxanthine.  
Staghorn Calculi: 
         Struvite, cystine and uric acid stones often grow too large to enter ureter. They 
gradually fill the renal pelvis and may extend outward through the infundibula to the calyces 
themselves.  
 Matrix calculi:  
         Matrix calculi are found predominantly in individuals with infections caused by urease 
producing organisms. Proteus species are especially like to be associated with matrix calculi. 
These stone composed of coagulated mucoids with little crystalline component. They are 
radiolucent and may be confused with uric acid calculi. Their association with alkaline 
urinary tract infection. However, usually assists in making a presumptive diagnosis because 
uric acid calculi are usually - 
microglobulin, a protein that is filtered and appears in the urine, may form in the kidneys of 
uremic patients.  
  Inhibitors of stone formation:  
           Normal urine contain chelating agents,such as citrate,that inhibit the nucleation, 
growth, and aggregation of calcium-containing crystals.Other Endogenous inhibitors include 
 
 
48 
 
calgranulin (an S-100 calcium binding protein).Tamm-horsal 
protein,glycosaminoglycans,uropontine(a form of osteopontin), nephrocalcin(an acidic 
glycoprotein),prothrombin F1 peptide,and bikunin(uronic acid rich protein).  
          The biochemical mechanism of action of these substances have not yet been thoroughly 
elucidated. However,when these substances fall below their normal propotions,stones can 
form from an aggregation of crystals.sufficient intake of magnesium and citrate inhibit the 
formation of calcium oxalate and calcium phosphate stones.  
 
FOOD AND DRINKS CONTAINING OXALATE:  
                   High oxalate foods higher to lower  
 Spinach   
 Sweet chard   
 Wheat germ  
 Soybean crackers   
 Peanuts  
 Okra  
 Chocolate   
 Black Indian tea  
 Sweet potatoes  
                     Medium oxalate foods  
 Grapes  
 Celery  
 Green pepper  
 Red raspberries  
 Fruit cake  
 Strawberries  
 liver  
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Being An Adult:  
  Kidney stones are most common in adult age 40 and older, though kidney stones may 
occur at any age.  
Being A Man:  
Men are more likely to develop kidney stones .although an increasing number of 
women are developing kidney stones.  
Being Obese:  
High body mass index (BMI), large waist size and wait gain have been linked to an 
increased risk of kidney stones.  
  Occupation:   
           Lonsdale (1968b.c) indicated that urinary calculi are much more likely to be found in 
individuals who have sedentary occupations. The highest were found in cooks and 
engineering room personnel. The risk of calcium oxalate and uric acid stones formation in 
astronauts because of hypercalciuria, hypocitraturia, decreased pH, and lower urinary 
volumes.  
Digestive diseases and surgery:  
            Gastric bypass surgery, inflammatory bowel disease, such as crohns disease or 
chronic diarrhea can cause changes in the digestive process that affect absorbtion of calcium 
and water, increasing the levels of stone-forming substances in urine.  
DIAGNOSIS:  
                   The diagnosis of kidney stones is made on the basis of 
o Information obtained from the history,  
o Physical examination,  
o Urinalysis, Radiographic studies,  
o Ultrasound examination, Blood tests.  
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LABORATORY INVESTIGATIONS:  
Microscopic examination of the urine, which may show  
 red blood cells,  
 bacteria,  
 leukocytes, 
 urinary casts and crystals.  
 Urine Culture to identify any infecting organisms present in the urinary tract and 
Sensitivity to determine the susceptibility of these organisms to specific   antibiotics.  
 Complete Blood Count (CBC), looking for neutrophilia (increased neutrophil              
granulocyte count) suggestive of bacterial infection , as seen in the setting of struvite 
stones.  
 Renal Function tests to look for abnormally high blood calcium blood levels 
(hypercalcemia).  
 24 Hour Urine Collection to measure total daily urinary volume, magnesium, sodium, 
uric acid, calcium, citrate, oxalate and phosphate. 
 Collection of stones is useful. Chemical analysis of collected stones can establish 
their composition, which in turn can help future preventive and therapeutic 
management. 
IMAGING TECHNIQUES: 
             Various imaging techniques are helpful in determining the presence of kidney stones. 
The best approach uses spiral (or helical) computed tomography scans. 
o If these scans are not available, the patient will need  
o ultrasound or  
o standard  x-rays.  
o If no stones show up, but the patient has severe pain that suggests the 
presence of kidney stones, the next step is an intravenous pyelogram.     
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X-RAY:              
            A standard x-ray of the kidneys, ureters, and bladder may be a good first step for          
identifying stones, since many are visible on x-rays. Calcium stones can be identified on x-
rays by their white color. Cystine crystals can also show up on x-rays. 
EXCRETION UROGRAPHY: 
           It is the most useful investigation to establish the presence of calculus. It also shows 
where the stone is and gives important information about the function of the other kidney. 
 ULTRASOUND:           
           Ultrasound can detect clear uric acid stones and obstruction in the urinary tract. It is 
not useful for finding very small stones.     
INTRAVENOUS PYELOGRAM:            
           In the procedure Intravenous pyelogram (IVP), the patient is injected with dye. X rays 
are taken as the dye travels through the urinary tract. This procedure is done to confirm the 
presence of kidney stones, although some stones may be too small to see. 
RETROGRADE PYLOGRAM 
           It is a urologic procedure where the physician injects contrast into the ureter in order  
to visualize the ureter and kidney. The flow of contrast is opposite the usual flow of urine, 
hence the retrograde name. 
SPIRAL (OR HELICAL) COMPUTED TOMOGRAPHY:    
           A type of computed tomography (CT) scan called a spiral or helical CT scan is 
currently the best method for diagnosing stones in either the kidneys or the ureters. This test 
is fast, does not require instruments or foreign chemicals to enter the body, and provides 
detailed accurate images of even very small stones. If stones are not present, a spiral CT scan 
can often identify other causes of pain in the kidney area. It is better than x-rays, ultrasound, 
and intravenous pyelogram -- the previous standard test for detecting kidney stones.  
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MAGNETIC RESONANCE IMAGING:              
          MRI techniques are showing promise for diagnosing urinary tract obstruction but do 
not yet accurately reveal small stones. Because no radiation is involved with MRI, however, 
it may prove to be a good option for pregnant women.   
MANAGEMENT OF RENAL CALCULI:    
              Stones which are smaller than 5mm can be treated with hydration and pain 
medication. Stones longer than 5mm or stones that fail to pass are treated by Open surgical 
procedures.  
             ESWL  Extra corporeal shock wave lithotripsy for managing renal and uretral 
stones uses shock waves to fragment calculi.  
           Ureteroscopy have been developed for removal of ureteral stones.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
 
 
 
 
MATERIALS AND 
METHODS 
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TITLE:       
 
(internal) in the treatment of Azhal kalladaippu noi (Renal calculi)  
 
STUDY DESIGN AND CONDUCT OF STUDY:   
 Study type  :     Open clinical trial 
 Study place  :     OPD  of Ayothidooss Pandithar Hospital, 
                                              National Institute of Siddha, 
                                                        Tambaram sanatorium,Chennai-47. 
 Study period           :     12 months. 
 Sample size           :      40  
TREATMENT: 
DRUG : KOOZHPAANDA CHOORANAM 
Reference:Aathmaratchamirtham ennum vaidhiya saara sangragam, page no-479, 
published by sri shanpaga .  
    Dosage     : Thirikadi pramanam (moondru viral  
   alavu)  1.5g  (twice/day) after food 
           Vehicle      :  Hot water 
Route of Administration   :  Oral Route 
Duration of the Drug Administration :  48 days. 
SUBJECT SELECTION: 
  As and when patients  reporting at OPD 1 Maruthuvam, Ayothidoss Pandithar 
Hospital, NIS with  symptoms of inclusion criteria will be subjected  to screening  test and 
documentation will be done by using screening  proforma.  
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SELECTION CRITERIA: 
 
INCLUSION CRITERIA: 
Patients who will fulfill any of the following criteria will be included in the study: 
 Age:20-60 yrs 
 Sex: Both sex 
 Patients who are having the classical symptoms of abdominal pain and distension, 
pain from loin to groin, pain in urethra, agonizing pain, dysuria, oliguria, yellow 
coloured urination, burning micturition, haematuria, nausea, vomiting. 
 Patient with renal calculus detected on USG Abdomen,   
 Patient willing to sign the informed consent stating that he/she will conscientiously 
stick to the treatment during 48 days but can opt out of the trial of his/her own 
conscious discretion. 
 Patient who are willing to take Ultrasonography investigation (USG- Abdomen/ 
KUB) and provide blood for lab investigation. 
 
EXCLUSION CRITERIA:  
A patient who will meet any of the following criteria will be excluded from 
participation in this study: 
 Stone size > 10mm 
 Pregnancy & Lactation 
 Presence of any associated severe systemic illness eg.CA 
  DM/HT 
 Chronic kidney disease 
 Cardiac disease   
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of any serious adverse reactions 
during the trial period. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Increase in severity of symptoms.  
 Patient will not take medication regularly.  
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2 ASSESSMENTS AND INVESTIGATIONS: 
a) Clinical assessment 
    Siddha assessment 
b) Routine  investigations: 
1. Modern parameters 
2. Siddha parameters 
c) Specific investigations 
a) CLINICAL ASSESSMENT: 
Abdominal pain and distension, 
Pain from loin to groin, 
Pain in urethra,  Agonising pain,  
Dysuria, oliguria, 
Yellow coloured urination, 
Burning micturition, haematuria, 
Nausea, vomiting. 
                 
SIDDHA ASSESSMENT: 
Enn vagai thervu ( Eight types of Examination): 
 Naadi 
 Sparisam 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram                                                                                                 
 
 Siddha parameters: 
 Malam         -  Niram: 
                     -  Elakal / Erukal: 
                     -  Muraigal (Times / day) : 
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 Moothiram (urine): 
 Neerkkuri (urine signs):                                         Neikkuri: 
i. Niram: 
ii. Edai: 
iii. Manam: 
iv. Nurai: 
v. Enjal 
 
b) ROUTINE INVESTIGATIONS:   
 
 Modern parameters: 
 Haematology 
 Blood sugar level           -  Fasting (mg/dl) 
Post prandial (mg/dl) 
                                              Random (mg/dl) 
 Lipid profile        
 Renal function test    -    Blood Urea (mg/dl) 
                                         Serum total Creatinine (mg/dl) 
                                          Uric acid (mg/dl) 
 Liver function test                   
 Urine test:    Albumin 
Sugar (fastingand post prandial) 
Deposits 
Bile salts 
Bile pigments 
 Motion test:       
               
c) SPECIAL INVESTIGATIONS:  USG Whole Abdomen/KUB 
                                                       X-ray KUB 
                                                       S.calcium, S.phosphorus 
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 STUDY ENROLLMENT: 
 In this clinical trial, patients reporting at OPD, Ayothidoss Pandithar Hospital,NIS 
with the clinical symptoms of  Abdominal pain and distension, pain from loin to 
groin, pain in urethra, agonizing pain, dysuria, oliguria, yellow coloured urination, 
burning micturition, haematuria,  and vomiting, nausea for enrolling in the study 
based on the inclusion and exclusion criteria.  
 The patients enrolled in this study will be informed (Form V) about the objective of 
the study, trial drug, possible outcomes in their own language and terms 
understandable to them. 
 After ascertaining the patientswillingness, informed consent will be obtained in the 
consent form (Form VI). 
 
information regar
Doctors phone number etc. so as to report easily if any adverse reaction arise. 
 Complete clinical history, complaints and duration, examination findings-- all will be 
recorded in the prescribed Proforma in the Clinical research form.  
 Patients will be advised to take the trial drug and appropriate dietary advice 
 
 
CONDUCT OF THE STUDY:    
     Patients who have Satisified Inclusion  Criteria will be Recruited for the Study .Then 
as Per Random Number Envelope which was serially kept and opened one by one for 
Allowing to a Particular Treatment Group. 
         As per siddha literature, before starting the treatment for AZHAL KALLADAIPPU, 
purgation will be given with the OP medicine Agasthiar Kuzhambu 130 mg od with 15ml  of 
sangankuppi juice at early morning in empty stomach for one day. 
           Then The tria KOOZHPAANDA CHOORANAM  at a 
dose of 1.5g twice a day continuously for 48 days. At each clinical visit clinical assessment 
will be done and prognosis will be noted.   
       Laboratory investigations and USG Abdomen will be done on 0th day and 48th day of 
the trial. If any of the trial patient who fails to collect the trial drug on the prescribed day but 
wants to continue in the trial, from the next day or two, he/ she will be allowed, but defaulters 
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of one week and more will not be allowed to continue and be withdrawn from the study with 
fresh case being inducted.   
Follow-up: 
      After the end of the treatment, the patient is advised to visit the OPD  for another 
2months for follow-up. In this follow-
recorded.  
DATA MANAGEMENT:  
 After enrolling the patient in the study, a separate file for each patient will be opened 
and all forms will be filed in the file. Study No. and Patient No. will be entered on the 
top of file for easy identification.Whenever the study patient visits OPD during the 
study period, the respective patient`s file will be taken and necessary recordings will 
be made at the assessment form or other suitable forms. 
 The screening forms will be filed separately. 
 The Data recordings will be monitored for completion by Guide (HOD, Dept. of 
Maruthuvam), SRO (Statistics) and the adverse event will be monitored by the 
members of the  Pharmacovigilance department of NIS . All forms will be further 
scrutinized in presence of Investigator by Sr.Research Officer (Statistics) for logical 
errors and incompleteness of data to avoid any bias. No modification in the results is 
permitted for unbiased reports. 
STATISTICAL ANALYSIS:  
All the datawill be  entered  into computer  using MS Access software with macro for  
logical  errors and manually cross checked  for  data  entry error.Then  the data will be 
exported to 
-Haenszel  chi-square test will be performed  for  determining the 
significance of a particular  effect variable. 
OUT COME OF TREATMENT: 
The study Outcome is  mainly assessed  by,  
Primary out come : Clearance / reduction in the size of renal calculus in X-ray KUB and 
USG Abdomen . 
Secondary out come : Complete reduction of clinical symptoms and improvement in other 
lab investigations. 
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ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
       If the trial patient develops any adverse reaction, he/she will be referred to the 
pharmacovigilance department of NIS. The members of this department will assess the 
adverse event and recorded in the prescribed adverse reaction form. For any AE the 
investigator(PG Scholar) will be given the proper management at NIS OPD with free of cost.  
ETHICAL ISSUES: 
1. Informed consent will be obtained from the patient after explaining in the 
understandable    language to the patient. The patient will be informed about the 
clinical trial, diagnosis, treatment and follow-up.  
2. After the consent of the patient (through consent form) they will be enrolled in the  
study. 
3. Treatment will be provided free of cost. 
4. No other external or internal medicines will be used. There will be no infringement on 
the rights of patient.  
5. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab equipments 
will be used.  
6. The data collected from the patient will be kept confidentially.  
7. The patients who are excluded [as per the exclusion criteria] will be given proper     
treatment, in OPD  at NIS.  
8. All adverse events occurs during the trial period will be recorded by the members of 
Pharmacovigilance department, NIS.  If it is a mild event the patient will be treated at 
OPD of NIS. If the event will be severe the patient will be referred to nearby Govt. 
hospital and taken care of the patient until he/she will recover  from the 
symptoms.The treatment will be provided at free of cost. 
 
ASSESSMENT FORMS: 
 
Form  I Screening and Selection Proforma 
Form - II  Case record form 
Form - III  Laboratory investigation form 
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Form  IV  Drug Compliance form 
Form  V  Information sheet 
Form - VI  Consent form 
Form VII Withdrawal form/ Adverse drug reaction form/  
Pharmacovigilance form 
Form VIII Dietary Advice form. 
 
  
 
 
 
 
PREPARATION & 
PROPERTIES OF TRIAL 
DRUG 
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STANDARD OPERAT  
INGREDIENTS: 
 Venpoosani (Benincasa hispida,Cogn )       - 1 number  
 Kadukkai (Terminalia chebula,Retz )           - 1 kazhanju(5.1gms) 
 Thandrikkai(Terminalia bellirica,Roxb)      - 1 kazhanju(5.1gms) 
 Athimadhuram (Glycyrriza glabra,Linn.)    - 1 kazhaju(5.1gms) 
 Eaelam (Elettaria cardamomum,Maton)      - 1 kazhanju(5.1gms) 
 Lavangam (Syzygium aromaticum,Linn)      - 1 kazhanju(5.1gms) 
 Seeragam (Cuminum cyminum,Linn)           - 1 kazhanju(5.1gms) 
 Chukku (Zingiber officinale,Rosc)               - 1 kazhanju(5.1gms) 
 Milagu (Piper nigram,Linn)                         - 1 kazhanju(5.1gms) 
 Thippili(Piper longum,Roxb)                       - 1 kazhanju(5.1gms) 
 Shanpaga poo (Michelia chambaca.Linn)    -  1 kazhanju(5.1gms)  
 Kalmadam                                                    - 1 kazhanju(5.1gms)             
 Sugar(Saccharum officinarum.Lin )            - Equevalant to the weight 
                                                                       of the Chooranam obtained. 
 Ghee                                                            - Adequate amount 
  
SOURCE OF RAW DRUGS: 
The above said raw drugs are purchased from a well reputed country shop at Chennai 
.The raw drugs are authenticated by Botanist in NIS, Pharmacognosist SCRI Arumbakkam, 
Chennai. The raw drugs had been purified and the medicine had been prepared as per SOP   
in the Gunapadam Laboratory of NIS, Chennai.  
 
PURIFICATION OF INGREDIENTS: 
 
Purification of Venpoosani: 
The seeds and outer skin layer was removed. 
Purification of Kadukkai: 
Seeds are removed. 
Purification of Thandrikkai: 
Seeds are removed. 
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Purification of Chukku: 
The raw drug was purified by soaked in the lime stone water. The outer layer was 
removed. 
Purification of Milagu: 
The raw drug was soaked in butter milk for 1 hour 15 minutes and then it was roasted. 
Purification of Seeragam: 
It was dried in sunlight. 
Purification Thippili: 
It was soaked in lemon juice. 
Purification of Adhimaduram: 
The raw drug was washed with clean water. The outer layer was peeled off and cut 
into small pieces and dried. 
Purification of Eaelam: 
It was dried in sunlight. 
Purification of Lavangam: 
It was dried in sunlight. 
Purification of Shanpaga poo:   
The petels from the flower are separated and dried. 
Purification of Kalmadham: 
Raw drug soaked in fresh milk for everyday (24 hours) 8 days and washed with clean 
water & dried. 
Purification of sugar: 
Dust was removed and powdered well. 
 
METHOD OF PREPARATION: 
PURIFIED INGREDIENTS: 
            1.Venpoosani  (Benincasa hispida,Cogn)  -  1  number  
            2.Kadukkai(Terminalia chebula,Retz)  -  1  kazhanju(5.1gms) 
            3.Thandrikkai(Terminalia bellirica,Roxb)  - 1 kazhanju(5.1gms) 
            4.Athimadhuram (Glycyrriza glabra,Linn)  - 1 kazhaju(5.1gms) 
            5.Eaelam (Elettaria cardamomum,Maton)  - 1 kazhanju(5.1gms) 
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            6.Lavangam (Syzygium aromaticum,Linn)  - 1 kazhanju(5.1gms) 
            7.Seeragam (Cuminum cyminum,Linn)  - 1 kazhanju(5.1gms) 
            8.Chukku (Zingiber officinale,Rose)   - 1 kazhanju(5.1gms) 
            9.Milagu (Piper nigram,Linn)   - 1 kazhanju(5.1gms) 
           10.Thippili(Piper longum,Roxb)   - 1 kazhanju(5.1gms) 
           11. Shanpaga poo (Michelia chambaca.Linn)  -  1 kazhanju(5.1gms)   
           12.Purified Kalmadam     - 1 kazhanju(5.1gms)  
           13.Powdered Sugar(Saccharum officinarum)  -  Equal to the amount of           
                                                                    the Chooranam obtained. 
           14.Ghee     - adequate amount  
           15.C      - sufficient quantity 
            
METHOD OF PREPARATION:  
Step 1: 
The cleaned pumpkin was cut into small pieces & baked with the help of milk in a 
baking pan (Pittaviyal method). Then ghee was sprinkled over it and it was fried well. 
Step 2:  
Kalmadam had been powdered well in the kalvam.All the other purified ingredients 
from 2 to 12 are pulverized by an electric grinder into fine powder separately.  
Step 3: 
Finally all powdered drugs are mixed thoroughly and sieved by using a fine cloth 
(vasthira kayam). 
Step 4:   
Then obtained chooranam was baked again with help of the milk in the baking 
pan.Then it is dried again.  
Step 5:   
Then the powdered sugar is added to the chooranam and mixed well. 
          
DRUG STORAGE: 
          The prepared drug was stored in a clean and dry wide mouthed glass bottle.           
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RAW DRUGS REVIEW 
ATHIMADHURAM 
 
Synonym: Athingam, Atti, Mathugam, Kundri ver  
 
BOTANICAL ASPECT 
         
               Botanical name : Glycyrriza  glabra, Linn 
                Synonym           : Indian or Jamaica liquorice 
                Family               : Papilionaceae 
Organoleptic character: 
                Part used:  Root 
                Taste       : Sweet 
                Potency   : Thatpam 
                Division  : Sweet 
               Actions   : Emollient, Demulcent, Mild Expectorant, Laxative, Tonic 
 
  General character: 
           ¸ò¾¢ÂÃ¢ ÓôÀ¢½¢Â¡ø ÅÕÒñ ¾¡¸í 
              ¸ñ§½¡ö¯ý Á¡¾õÅ¢ì¸ø ÅÄ¢¦Åñ Ìð¼õ 
           À¢ò¾¦ÁÖõ ÒÕì¸¢ ¸¢Ã¢îºÃõ ¬Å÷ò¾ 
              À¢ò¾Á¾ ã÷î¨º Å¢¼ À¡¸õ ¦ÅôÀó 
 
           ¾ò¾¢ÅÕ Å¡¾§º¡ ½¢¾í¸¡ Á¡¨Ä 
             ºÕÅÅ¢¼í ¸¡Á¢§¿¡ö ¾¡Ð ¿ð¼í 
           Ìò¾¢ÕÁø ¬º¢Âí¸õ ­¾ú§¿¡ö ­óÐ 
             ÌÂôÒÏõ §À¡õ Áà¸¦ÁÉì ÜÚí ¸¡§Ä. 
                                                                                            -§¾¨ÃÂ÷ Ì½Å¡¸¼õ 
 Chemical constituents: 
Glycyrrhizin, Liquiritigenin, liquiritin, iso liquritigenin, formonetin, licuraside  
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Medicinal uses: 
                               It is useful in abdominal pains. 
                               Root in infusion, decoction is useful in dysuria. 
      
LAVANGAM 
 
Synonym: Anjugam, Urkadam, Karuvai kirambu, Sosam, Thirali, Vraangam  
 
BOTANICAL ASPECT 
        Botanical name: Syzygium aromaticum,Linn 
        Synonym          : Cloves 
        Family              : Myrtaceae 
  
Organoleptic character: 
       Taste       : Pungent 
       Potency   : Veppam 
       Division  :  Pungent 
       Actions    : Antispasmodic, Carminative, Stomachic 
 
General character: 
            À¢ò¾ ÁÂì¸õ §À¾¢¦Â¡Î Å¡ó¾¢Ôõ§À¡õ 
            Íò¾Å¢Ãò ¾ì¸¸ÎôÒó §¾¡ýÚ§Á¡- ¦Áò¾ 
            ­ÄÅí¸í ¦¸¡ñ¼ÅÕì §¸ü Í¸Á¡Ìõ 
            ÁÄÁí§¸ ¸ðÎ¦ÁÉ Å¡úòÐ. 
 
            Íì¸¢Ä¿ð ¼í¸÷½ Ý÷Å¢Âí¸ Ä¡ïºÉó¾¡ð 
            º¢ì¸øÅ¢¼¡î º÷Å¡ º¢ÂôÀ¢½¢Ô - Áì¸¢ìÌð 
            ¼í¸ô â§Å¡Î ¾Ã¢À¼Õó §¾¡ýÈ¢Ä¢ø 
            Åí¸ôâ §Å¡Î¨ÃòÐ Å¡. 
                                             -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 
Chemical constituents: 
Ellagitanin, Eugenin, Caryophyllene oxide 
 
 
67 
 
Medicinal uses: 
Flower buds and oil extracted from them constitute the drug. The oil of the drug 
possesses insecticidal, antibacterial and antifungal activity. 
                
EAELAM 
 
Synonym: Aanji, Koorangam, Thudi 
 
BOTANICAL ASPECT 
        Botanical name : Elettaria cardamomum, Maton 
        Synonym           : Cardamom seeds 
        Family               : Zingiberaceae 
 
Organoleptic character: 
        Taste     : Pungent 
        Potency : Veppam 
        Division : Pungent 
       Actions   : Stimulant, Carminative, Stomachic 
General character: 
 
                         ¦¾¡ñ¨¼ Å¡ö¸×û ¾¡ÖÌ ¾í¸ª¢ø 
               §¾¡ýÚõ §¿¡Â¡¾¢ º¡ÃõÀý §Á¸ò¾¡ø 
             ¯ñ¨¼ §À¡ø±Øí ¸ðÊ ¸¢Ã¢îºÃõ 
                 
             Àñ¨¼ ¦Åì¨¸ Å¢¾¡¸§¿¡ö ¸¡ºÓõ 
                À¡Øï §º¡Áô À¢½¢Å¢óÐ ¿ð¼Óõ 
            «ñ¨¼ ®¨ªÅý À¢ò¾õ ­¨Åì¦¸øÄ¡õ 
               ¬Ä Á¡í¸Áú ²Ä ÁÕó¾§¾... 
                           -  §¾¨ÃÂ÷ Ì½Å¡¸¼õ                                                                                                                            
Chemical constituents: 
  
terpineol, linalool, linalyl acetate                  
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SHANPAGA POO 
 
BOTANICAL ASPECT 
Botanical name : Michelia champaca.Linn 
Synonym           : Golden champa 
Family               : Magnoliaceae 
 
Organoleptic character: 
Taste    : Pungent 
Potency: Veppam 
Division: Pungent  
Actions: Stimulant, Carminative, Diuretic, Tonic 
 
General character: 
                    Å¡¾ À¢ò¾õ «ò¾¢ÍÃõ Á¡§Á¸õ Íò¾ ÍÃó 
          ¾¡Ð¿ð¼í ¸ñ½Æüº¢ ¾¡í¸§Å - Á¡§¾ §¸û! 
          ¾¢ñÒÚ ÁÉì¸ª¢ô À¡ó ¾¢ùÂÁÉõ ¯ðÊÉï§º÷ 
          ºñÀ¸ô âÅ¾üÌò ¾¡ý 
                                                     -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents: 
Volatile essential oil, fixed oil, resin, tannin, mucilage, starch, sugar 
 
Medicinal uses: 
Flowers used in dyspepsia, nausea, fever and also useful as a diuretic and febrifuge. 
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CHUKKU 
Synonyms: 
           Arukkan, Athagam, Aarthragam, Upakullam, Ularantha inji, Kadupathiram, Sundi 
sondi, Sawpannam, Sawvarnam, Navasuru, Nagaram, Manowshatham, Vichva peshatham, 
Vidamudiya amirtham, Verkombu. 
 
BOTANICAL ASPECT 
        Botanical name : Zingiber officinale,Rosc 
        Synonym           : Ginger 
        Family               : Zingiberaceae 
 
Organoleptic character: 
        Part used : Tuber (dried) 
        Taste       : Pungent 
        Potency   : Veppam 
        Division  : Pungent 
       Actions    : Stimulant, Carminative, Stomachic 
 
General character: 
             Ý¨ÄÁó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô ÀõÁÆ¨Ä 
             ãÄõ ­¨ÃôÀ¢ÕÁø ãìÌ¿£÷ - Å¡Ä¸À 
             §¾¡¼Á¾¢ º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò 
             §¾¡¼õ¬ Áõ§À¡ìÌï ÍìÌ.                                                              
                                                -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents: 
ar     sesqui phellandrene, 
gingerol, zingerone, dehydro gingerol, aspartic acid, threonine, serine, glycine, cystine, 
valine, iso leucine, leucine, arginine 
Medicinal uses: 
 Ginger is extremely useful in the treatment of dyspepsia, flatulence, colic, vomiting, 
spasm and other painful affections of the stomach and the bowels, not accompanied by 
fever.Externally it is used as a rubefacient, that is, counter  irritant for relief of muscular 
pain  
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                                                   KADUKKAI 
 
Synonyms:  
                  Akkoodam, Anganam, Anthan, Abaranam, Apaiyan, Amaritham, Amalai, 
Amutham, Ammai, Amrutha, Arabi, Arithagi, Aliyan, Avviyatha,, Eresagi, Aamavathi. 
  
BOTANICAL ASPECT 
        Botanical name : Terminalia chebula,Retz 
         Synonym           :  Ink nut 
         Family               :  Combretaceae 
 
Organoleptic character: Part used : Fruit 
Taste       : Sour, sweet, pungent, bitter 
Potency   : Veppam 
Division  : Sweet  
 
General character: 
                       ¾¡¨¼ ¸Øò¾ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
            À£¨¼ º¢Ä¢À¾Óü §À¾¢Ó¼õ - ¬¨¼¦Âð¼¡ò 
            àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
            ¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø. 
                                      -  Ì½À¡¼õ - ãÄ¢¨¸ ÅÌôÒ 
Chemical constituents: 
Chebulin, tannin  terchebin 
 
Medicinal uses: 
The fruit is highly nutricious and could be used as an important source of                    
vitamin C, protein and mineral nutrient. 
The fruit is one of the constituents of Triphala, having anti- inflammatory and 
analgesic activities.  
The powder of the fruit is used in vomiting and abdominal distension.  
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SEERAGAM 
 Synonyms:  
Asai, Seeri, Upakupeesam, Narseeri, Thuthasaambalam, Pirathiviga, Pithanasini, 
Poosanakudori, Methiyam. 
 
 
BOTANICAL ASPECT 
        Botanical name : Cuminum cyminum,Linn 
        Synonym           : Cumin seeds 
        Family               : Apiaceae 
 
Organoleptic character: 
        Part used: Seed 
        Taste       : Pungent, Sweet 
        Potency  : Thatpam 
        Division : Sweet 
        Actions  : Carminative, Stimulant, Stomachic, Astringent 
 
General character: 
             À¢ò¾¦ÁÛ Áó¾¢Ã¢¨Âô À¢ýÉô ÀÎò¾¢ÂÅý 
             ºòÐÕ¨Å ÔóÐÈóÐ º¡¾¢òÐ - Áò¾¦ÉÛõ 
             Ã¡º¨ÉÔ Á£¦ÅýÚ ¿ñ¨Àô ÀÄôÀÎò¾¢ 
             §À¡ºÉÌ ¼¡Ã¢¦ºÔõ §À¡÷. 
                                          - §¾Ãý ¦ÅñÀ¡ 
Chemical constituents: 
  - terpinene, limonene, p  cymene, cuminal dehyde 
 
Medicinal uses: 
Cumin fruits are very useful in digestive disorders like biliousness, morning sickness, 
indigestion, atomic dyspepsia, diarrhea and flatulent colic. 
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THANDRIKKAI 
Synonyms:  
Aksham, Akkantham, Akkathan, Amutham, Ambalaththi, Aaraamam, Erikatpalam, 
Kanthakatpalam, Kanthugan, Kulithurumam, Kalanthunri, Sathagam, Thaapamaari, 
Vanthiyam,  
Vithiyam, Vibithagam, Pothavasagam, Thanikkai. 
 
 
BOTANICAL ASPECT 
Botanical name :  Terminalia bellirica,Roxb 
Synonym           :  Belleric myrobalan 
Family                :  Combretaceae 
 
Organoleptic character: 
Part used : Leaves, fruit, seed 
Taste       : Pungent 
Potency   : Veppam 
Division : Sweet 
Actions  : Astringent, Expectorant, Laxative, Tonic 
 
General character: 
            º¢Äó¾¢Å¢¼õ ¸¡Á¢ÂôÒñ º£Æ¡É §Á¸í 
            ¸ÄóÐÅÕõ Å¡¾À¢ò¾í ¸¡§Ä¡ - ¼Ä÷óÐ¼Ä¢ø 
            °ýÈ¢ì¸¡ö ¦ÅôÀ Ó¾¢ÃÀ¢ò Ðí¸ÃìÌó 
            ¾¡ýÈ¢ì¸¡ö ¨¸Â¢¦ÄÎò ¾¡ø. 
 
            ¬½¢ô¦À¡ý §ÁÉ¢ì ¸ÆÌõ ´ª¢ÔÁ¢Ìõ 
            §¸¡½¢ì¦¸¡û Å¡¾À¢ò¾ì¦¸¡û¨¸§À¡õ - ¾É¢ì¸¡ö 
            ¦¸¡ñ¼Å÷ìÌ §Á¸ÁÚõ ÜÈ¡ «ÉüÈ½¢Ôõ 
            ¸ñ¼Å÷ìÌ Å¡¾õ§À¡õ ¸¡ñ. 
                                      Ì½À¡¼õ - ãÄ¢¨¸ ÅÌôÒ  
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 Chemical constituents: 
Cardiac glycoside  belliricanin, gallic acid, ellagic acid, ethyl gallate, mannitol, 
glucose, galactose, fructose and rhamnose. 
Medicinal uses: 
In Jammu and Kashmir, a decoction  of fruit and the stem bark is given in                      
urinary disorders 
 
THIPPILI 
Synonyms:  
Aarkathi, Unsaram, Ulavainaasi, Kaaman, Kudari, Koolagam, Kooli, 
Koozhaiyurukki, Saram, Saadi, Thulavi, Maagathi, Kanai, Sowndi, Thanduli, Kanam, 
Kalini, Paanam, Pippili, Vaitheegi, Ambu, Aathi marunthu. 
 
BOTANICAL ASPECT 
       Botanical name : Piper longum,Roxb 
       Synonym          : Long pepper 
         Family              : Piperaceae 
 
Organoleptic character: 
Part used : Fruit, rice 
Taste        : Sweet 
Potency    : Thatpam 
Division  : Sweet 
 
General character: 
                      ­ÕÁø ÌýÁõ ­¨ÃôÒ ¸ÂôÀ¢½¢ 
                          ®¨ª À¡ñÎ ºóÂ¡ºõ «§Ã¡º¸õ 
                      ¦À¡ÕÁø °¨¾ º¢ÃôÀ¢½¢ ã÷î¨º§¿¡ö 
                          âÃ¢ì ÌïºÄ §¾¡¼õ À£Ä¢¸Óõ 
                      ÅÕÁ Äô¦ÀÌì §¸¡Î Á§¸¡¾Ãõ 
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                          Å¡¾õ ¬¾¢Óò §¾¡¼ï ÍÃíÌª¢÷ 
                      ¦ÀÕÁ¡¨ÄôÒÃ¢ §Á¸ô À¢¼¸Óõ 
                          §ÀÕó ¾¢ôÀ¢Ä¢ô §ÀÃíÌ¨Ãì¸§Å. 
- §¾¨ÃÂ÷ Ì½Å¡¸¼õ                                                                                            
Chemical constituents: 
Pipernonaline, Piper undecalidine 
 
 
Medicinal uses: 
It is used as a general tonic and haematinic, as cholagogue in obstruction of bile duct 
and gall bladder. 
                                               
                      MILAGU 
Synonyms:  
Kalinai, Kari, Kaayam, Koolakam, Thirangal, Mirial, Sarumapantham, Vallisam, 
Maasam, Kurumilagu, Malaiyaali. 
 
BOTANICAL ASPECT 
       Botanical name: Piper nigram, Linn 
                Synonym          : Black pepper 
                Family              : Piperaceae 
Organoleptic character: 
               Part used: Seed, Climber 
               Taste       : Bitter, Pungent 
               Potency  : Veppam 
               Division : Pungent 
               Actions  : Acrid, Carminative, Antiperiodic, Rubefacient, Stimulant, Resolvent,                                 
                               Antivatha, Antidote 
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General character: 
                    º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
                    Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ - µÐºýÉ¢ 
                     
                    ¿¡ºí ¸È¢Á¢ª¸¢É¡ø      
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents: 
                     Guineesine, Pellitorine, Piperidine, Feruperine, Dehydro feruperine, N  trans -  
feruloyl  piperidine 
 
Medicinal uses: 
                             Fruits are used as an excellent carminative and digestive, stomachic in 
atonic dyspepsia, flatulent colic. 
 
VENPOOSANI 
 
Synonyms: Saambal poosani, Thadiyankaai, Perumpoosani, Venpoosanai 
 
BOTANICAL ASPECT 
        Botanical name : Benincasa hispida,Cogn 
        Synonym          : White pupmpkin   
        Family             : Cucurbitaceae 
 
Organoleptic character: 
Part used: Seed, Fruit 
Taste       : Sweet 
Potency  : Thatppam 
Division : Sweet 
Actions  : Diuretic, Styptic, Tonic, Alterative, Nutrient. 
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General character: 
                ¦ÀÕõâ º½¢ì¸¡öìÌô À¢ò¾§Á¡ Îð¸¡öîºø 
                «Õïº¡Ã ¿£÷ì¸ð ¼Õ¸ø - ÁÕó¾¢Îø 
                 
                ¦Áò¾ «É¢ÄÓÚõ Å¢û   
- «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
Chemical constituents: 
- sitosterol and their acetates, Adenine, Trigonelline, Histidine    
 
Medicinal uses: 
The fruits are cooling, diuretic. 
The fruits are useful in haemorrhages from internal organs and fever. 
SUGAR 
Organoleptic character: 
          Taste       : Sweet 
          Potency  : Seetham 
          Division : Sweet 
 
General character: 
                                      º£É¢î º÷ì¸¨ÃìÌò ¾£Ã¡¾ ÅýÍÃÓí 
                   ÜÉ¢ìÌõ Å¡¾ò¾¢ý ÜðÎÈ×õ - ²É¢üÌõ 
                   Å¡ó¾¢ ¦Â¡Î¸¢ÕÁ¢ Á¡È¡¾ Å¢ì¸Ö§Á 
                   §À¡ó¾¢¨º¨Â Å¢ðÎô ÒÃñÎ.   
                                           -«¸ò¾¢Â÷ Ì½Å¡¸¼õ 
   
Chemical constituents: 
Swertisin, Sachaftoside, Iso schaftoside, Trinsin - 7- glucoside 
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KALMADHAM 
 
         ¸ñ¼ À¢½¢§Á¸í ¸ø¦Ä¡Î¿£ åÉ¨¼ôÒ 
          Åñ¼ü ¸¢Ã¢îºÃ§¿¡ö ÁÃÀ¢ÃÁ¢ - Ôñ¼Ä¢É¡ü 
          ÀýÁ¾ï§º÷ ¾¡Ð¿ð¼õ ÀýÛÁ¢ó§¿¡öì Üð¼òÐð 
          ¸ýÁ¾ï§º ÃîºÃìÌì ¸¡ñ. 
     
- À¾¡÷ò¾ Ì½ Å¢ªì¸õ 
 
 Indications: 
It cures urinary symptoms associated with venereal disease, renal 
calculus, anuria, stricture of the urethra, difficulty in passing urine, gonorrrhoea 
and impotence.            
 Actions:    Diuretic 
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THE INGREDIENTS KOOZHPAANDA CHOORANAM 
         
  VENPOOSANI                                 EAELAM                            SEERAGAM 
   
                                                                                          
 
ATHIMADHURAM    CHUKKU         MILAGU  
                                
      
  
             THIPPILI                              KADUKKAI                      THANDRIKKAI 
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              LAVANGAM                             SHANPAGA POO                          SUGAR         
        
 
 
KALMADHAM     KOOZHPAANDA CHOORANAM 
                                       
 
  
 
 
 
 
BIOCHEMICAL ANALYSIS 
OF TRIAL DRUG 
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BIOCHEMICAL ANALYSIS OF KOOZHPAANDA CHOORANAM 
S.NO EXPERIMENT OBSERVATION INFERENCE 
 1.Test For Acid Radicals   
1. 
 
Test For Sulphate :  
       2ml of the above prepared 
extract is taken in a test tube to this 
added 2ml of 4% ammonium oxalate 
solution. 
 
No cloudy     
appearance present 
 
Absence of Sulphate 
2. Test For Chloride: 
      2ml of the above prepared 
extract is added with 2ml of dil- 
HNO3 till the effervescence ceases. 
Then 2 ml of silver nitrate solution is 
added. 
 
Cloudy appearance 
present 
 
Presence of 
Chloride 
3 Test For Phosphate: 
      2ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2ml of con.HNO3 
 
No yellow colour     
appearance 
 
Absence of 
Phosphate 
4. Test For Carbonate:  
    2ml of the extract is treated with 
2ml magnesium sulphate solution 
 
Cloudy appearance 
Present 
 
Presence of  
Carbonate 
5. Test For Fluoride & Oxalate: 
    2ml of extract is added with 2ml 
of dil. Acetic acid and 2ml calcium 
chloride solution and heated. 
No cloudy appearance 
present. 
 
Absence  of     
fluoride and   oxalate 
6. Test For Nitrate: 
   1gm of the substance is heated 
with copper turning and 
concentrated H2So4 and viewed the 
test tube vertically down 
 
No  Brown   gas   is 
evolved 
 
Absence   of   Nitrate 
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7. Test For Sulphide:  
      1gm of the substance is treated 
with 2ml of con. HCLs 
No Rotten Egg 
Smelling gas  evolved 
Absence of   
Sulphide 
8. Test For Nitrite: 
    3 drops of the extract is placed on a 
filter paper, on that - 2 drops of acetic 
acid and 2 drops of Benzidine 
solution is placed. 
No   Characteristic    
changes 
Absence  of  Nitrite 
9. Test For Borate: 
     2 Pinches of the substance is made 
into paste by using sulphuric acid and 
alcohol (95%) and introduced into the 
blue flame. 
Bluish  green  colour  
flame  not  appeared 
Absence   of   Borate 
 II. Test For Basic Radicals   
1. Test For Lead: 
      2ml of the extract is added with 
2ml of potassium iodine solution. 
No yellow precipitate 
is obtained. 
Absence  of   Lead 
2. Test For Copper: 
     2ml of extract is added with 
excess of ammonia solution. 
No blue color    
precipitate formed. 
 
Absence   of   Copper 
 
3. Test For Aluminium: 
    To the 2ml of extract sodium 
hydroxide is added in drops to 
excess. 
No characteristic 
changes. 
Absence   of 
Aluminium 
4. Test For Iron: 
    To the 2ml of extract add 2ml of 
ammonium thiocyanate solution. 
Mild red colour appear 
 
 
Presence of Iron 
 
 
55 Test For Zinc:  
        To 2ml of the extract sodium 
hydroxide solution is added in drops 
to excess  
 
White  precipitate   is   
not formed 
 
Absence of  Zinc 
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6. Test For Calcium:  
        2ml of the extract is added with 
2ml of 4% ammonium oxalate 
solution  
 
Cloudy appearance 
and white precipitate 
is not obtained 
Absence of  Calcium 
7. Test For Magnesium:  
     To 2ml of extract sodium 
hydroxide solution is added in drops 
to excess. 
White precipitate is  
not obtained 
Absence    of 
Magnesium 
8. Test For Ammonium: 
      To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are added. 
No Brown colour 
appeared 
 
Absence     of 
Ammonium 
9. Test For Potassium:  
   A pinch of substance is treated with 
2ml of sodium nitrite solution and 
then treated with 2ml of cobalt nitrate 
in 30% glacial acetic acid. 
 
No Yellowish 
precipitate is 
obtained. 
 
Absence of  
Potassium 
10. Test For Sodium: 
    2 pinches of the substance is made 
into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner. 
 
Yellow   colour    
flame is not appeared 
 
Absence of   Sodium 
11. Test For Mercury:  
      2ml of the extract is treated with 
2ml of sodium hydroxide solution.  
 
No yellow precipitate 
is obtained 
 
Absence of  Mercury 
12. Test For Arsenic:  
      2ml of the extract is treated with 
2ml of sodium hydroxide solution. 
 
No brownish red 
precipitate is 
obtained 
 
Absence  of   Arsenic 
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S.NO EXPERIMENT OBSERVATION INFERENCE 
 III.Miscellaneous   
1.  Test For Starch:  
    2ml of extract is treated with weak 
iodine solution  
 
Blue   colour 
developed 
 
Presence of   Starch 
2.  Test For Reducing Sugar:  
    5ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The 
colour changes are noted. 
 
Brick   red  colour 
developed 
 
Presence of  
Reducing sugar 
3.  Test For The Alkaloids: 
a)  2ml of the extract is treated with 
2ml of potassium lodide solution. 
b)  2ml of the extract is treated with 
2ml of picric acid. 
c)  2ml of the extract is treated with 
2ml of phosphotungstic acid. 
 
 
 
Yellow   colour 
developed 
 
 
 
Presence of   
Alkaloid 
4.  Test For Tannic Acid:  
    2ml of extract is treated with 2ml 
of ferric chloride solution  
 
Block precipitate   is 
obtained 
 
Presence of  Tannic 
acid 
5.  Test For Unsaturated Compound:   
     To the 2ml of extract 2ml of 
Potassium permanganate solution is 
added.  
 
Potassium 
permanganate is not  
decolourised 
 
Absence   of     
unsaturated 
compound 
6.  Test For Amino Acid: 
    2 drops of the extract is placed on 
a filter paper and dried well.. 
 
No Violet   colour 
developed 
 
Absence  of  Amino 
acids 
7. Test For Type Of Compound: 
    2ml of the extract is treated with 2 
ml of ferric chloride solution.  
No Brown    colour 
developed 
 
 
Absence of  Oxy  
quinole, epinephrine  
and  Pyro catechol 
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No red colour 
developed 
 
 
 
No violet colour 
developed 
 
No Blue colour 
developed. 
Anti pyrine, Alipathic 
amino acids and 
meconic acid are 
absent. 
 
Salicylate and 
resorcinol are absent. 
 
Morphine, Phenol 
cresol and 
hydroquinone are 
absent 
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RESULTS OF BIOCHEMICAL ANALYSIS 
 
ANALYTICAL TEST INFERENCE 
Sulphate Absence of Sulphate 
Chloride Presence of Chloride 
Phosphate Absence of  Phosphate     
Carbonate Presence of  Carbonate 
Fluoride &Oxalate Absence  of     fluoride and   oxalate 
Nitrate Absence   of   Nitrate 
Sulphide Absence of   Sulphide 
Nitrite Absence  of  Nitrite 
Borate Absence   of   Borate 
Lead Absence  of   Lead 
Copper Absence   of   Copper 
Aluminium Absence   of Aluminium 
Iron Presence of Iron 
Zinc Absence of  Zinc 
Calcium Absence of  Calcium 
Magnesium Absence    of Magnesium 
Ammonium Absence     of Ammonium 
Pottasium Absence of  Potassium 
Sodium Absence  of   Sodium 
Mercury Absence of  Mercury 
Arsenic Absence  of   Arsenic 
Starch Presence of   Starch 
Reducing sugar Presence of  Reducing sugar 
Alkaloids Presence of   Alkaloid 
Tannic acid Presence of  Tannic acid 
Unsaturated compound Absence of unsaturated compound  
Amino acid Absence  of  Amino acids 
Oxyquinole, Epinephrine, 
Pyrocatechol 
Absence of Oxy quinole, epinephrine and  Pyro 
catechol. 
 
 
 
 
PHYSICOCHEMICAL 
ANALYSIS 
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QUANTITAIVE ANALYSIS REPORT 
PHYSICO  CHEMICAL ANALYSIS OF KOOZHPANDA CHOORANAM 
 
S.NO Physico chemical Parameter Mean 
1. Loss on Drying at 105oC 8.359% 
2. Total Ash 10.696% 
3. Water soluble Ash 2.734% 
4. Acid Insoluble Ash 5.952% 
5. Water soluble Extractive 21.99% 
6. Alcohol Soluble Extractive 21.615% 
7. Assay for Calcium 0.501% 
8. PH 3.87 
 
HPTLC Report of Koozhpaanda chooranam 
Defatted Chloroform extract 
Solvent system: Chloroform: Ethyl acetate: Formic acid (7: 3: 2 drops) 
Track 1: 10 µl; Track 2: 15 µl   
 
 
   
UV 254nm UV 366nm After dipping in Vanillin-
sulphuric acid reagent 
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UV 254 nm UV 366 nm After dipping in Vanillin-sulphuric 
acid reagent 
Rf Colour Rf Colour Rf Colour 
0.18 Green 0.13 Pink 0.07 Purple 
0.25 Green 0.18 Pinkish white 0.25 Yellowish grey 
0.33 Green 0.23 Pink 0.29 Purple 
0.40 Green 0.25 Pinkish white 0.45 Magenta 
0.62 Green 0.33 Pale blue 0.54 Purple 
0.69 Green 0.43 Pale blue 0.62 Grayish yellow 
0.74 Green 0.52 Pale blue   
  0.61 Blue   
  0.88 Pink   
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Finger print profile and Rf table of 15 µl of defatted Chloroform extract of Koozhpaanda 
chooranam at 254 nm 
 
 
 
 
3D chromatogram of 10 and 15 µl of defatted Chloroform extractof Koozhpaanda chooranam 
at 254 nm 
 
 
 
 
  
 
OBSERVATION AND 
RESULTS 
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OBSERVATION AND RESULTS 
      The observation and results have been tabulated under the following headings.  
 1.  Gender distribution 
 2.  Kaalam distribution (According to age) 
 3.  Occupational status 
 4.  Dietary habits  
 5.  Marital status  
 6.  Habits 
 7.  Treatment History 
 8.  Family History 
 9.   Paruvakaalam (Season)  
10. Thinai (Land)  
11. Yakkai Ilakkanam (Physical Constitution) 
12. Gunam 
13. En Vagai thervugal 
14. Distribution by naadi 
15. Udal Kattugal 
16. Distribution of kosangal   
17. Distribution of Uyir thaathukal  
18. Distribution of Neerkkuri 
19. Distribution of Neikkuri 
20. Distribution of calculus in urinary system  
 21. Chronicity of illness 
 22. Distribution of cases by Clinical features  
 23. Improvement in clinical features       
 24. Improvement in USG abomen. 
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1. Distribution Of Cases By Gender 
 
            Gender             No of case      Percentage 
             Male               25           62.5% 
           Female               15           37.5% 
            Total              40           100% 
 
 
 
 
 
Inference:  
Among the 40 cases the prevalence of the disease was found to be higher in male i.e  
62.5% (25 cases).       
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2. Distribution Of Cases By Kaalam (According to Age) 
In Siddha literature human life has been divided into three periods as follows 
               1. Vaatham 
               2. Pitham 
               3. Kabam 
The duration of each period is said to be 33 years 
SI.No              Kaalam(Age)      No of cases       Percentage 
1       Vatha Kaalam(1-33 Years)             18              45% 
2       Pitha Kaalam(34-66 Years)               22              55% 
3       Kaba Kaalam(67-100 Years)              0               0% 
4                 Total                   40             100% 
 
 
 
 
Inference:  
Out of 40 cases, 22 case (55%) were found to be in pitha kaalam i.e 34 to 66 years and 
18cases (45%) were found to be in vatha kaalam i.e upto33 years.    
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3.Distribution Of Cases By Occupational Status 
 
SI.No           Nature of work   No of cases   Percentage 
1            Home Maker         14          35% 
2        Standing work style          4          10% 
3        Sedentary work style         10          25% 
4              Student         12          30% 
            Total         40         100% 
 
 
 
         
 Inference:  
The majority of patients in this study were home makers (35%).                           
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4. Distribution Of Cases By Dietary Habit 
 
              Dietery Habit         No of cases  Percentage 
               Vegetarian                4              10% 
           Non  vegetarian               36              90% 
                 Total               40             100% 
      
  
 
 
Inference:  
 Among the 40 cases, 36 cases (90%) were Non Vegetarian and 4 cases (10%) were 
vegetarian. 
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5. Distribution Of Cases By Marital status 
 
Marital status             No of cases             Percentage 
Married                 32                  80% 
Unmarried                  8                 20% 
Total                 40                100% 
 
 
 
 
 
Inference: 
Among 40 cases, 32 cases (80%) were married, 8 cases (20%) were unmarried. 
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6. Distribution Of Cases By Habits 
 
Habits     No of cases           Percentage 
Alcohol consumer         3                 7.5% 
Smoker         3                 7.5% 
Betel nut chewer         0                  0% 
 
 
 
 
 
Inference: 
  Among 40 cases, 3 cases (7.5%) were alcohol consumer, 3 cases (7.5%) were smoker. 
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7. Distribution Of Cases By Treatment history 
 
Treatment History No of Cases Percentage 
Yes 7 17.5% 
No 33 82.5% 
Total 40 100% 
 
 
 
 
Inference:  
Among 40 cases, 7 cases (17.5%) had taken allopathic treatment in the past and had 
discontinued the same. The rest of the 33 cases (82.5%) had not taken any other drugs prior 
to enrolling for the study. 
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 8. Distribution Of Cases By Family History 
            Among 40 cases, there was no family history. 
9.  Distribution Of Cases By Paruva kaalam (Season) 
 
SI.No                  Paruva Kaalam        No. of cases        Percentage 
1 Kaar Kaalam (Aug 17- Oct 17)                0               0% 
2             Koothir Kaalam (Oct 18  Dec 15)                0               0% 
3 Munpani Kaalam (Dec 16  Feb 12)                0               0% 
4 Pinpani Kaalam( Feb 13  Apr 13)               40              100% 
5 Elavenil Kaalam (Aprl 14  Jun 16)                0               0% 
6 Muthuvenil Kaalam (Jun 17  Aug 16)                0               0% 
              Total               40             100% 
 
 
 
Inference:  
Among the 40 cases all the 40 cases (100%) were admitted in Pinpani kaalam (Feb 13- 
Aprl13). 
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10. Distribution Of Cases By Thinai (Land) 
 
          Thinai (Land)               No of cases               Percentage 
   Kurinji (Hill)                    0                    0% 
   Mullai (Forest)                    0                    0% 
   Marutham (Fertile)                    6                   15% 
   Neithal(Coastal)                   34                   85% 
   Paalai(Desert)                    0                    0% 
            Total                    0                   100% 
 
 
 
 
Inference:  
Among the 40 cases 34 cases (85%) were from Neithal Thinai and 6 cases (15%) were from 
Maarutham thinai.     
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11. Distribution Of Cases By Yaakai 
 
       Yaakai 
  
           No of cases           Percentage 
        Vatham                26                   65% 
        Pitham                12                30% 
       Kapham                 2                5% 
       Total                40               100% 
 
 
 
 
 
Inference:  
Among 40 cases 26 cases (65%) were Vatha thegi, 12 cases (30%) were Pitha  thegi and    
2cases (5%) Were  Kapha thegi.        
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12.  Distribution Of Cases By Gunam (Quality and characters) 
 
 
                 Gunam              No of cases              Percentage 
        Sathuvagunam                   3                   7.5% 
        Rajogunam                  34                   85% 
        Thamogunam                   3                   7.5% 
        Total                  40                   100% 
 
   
 
       
  Inference:  
Out of 40 cases, 34 cases (85%) were found to posses Rajo gunam, 3 cases (7.5%) were 
found to posses Sathuva gunam and 3 cases were (7.5%) found to posses Thamo gunam.   
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13. Distribution Of Cases By En vagai Thervugal 
 
SI.No               En Vagai  Thervugal          No of cases       Percentage 
1                   Naa                   2                     5% 
2                 Niram                   0              0% 
3                Mozhi                   0              0% 
4                 Vizhi                   0              0% 
5                Sparisam                   0              0% 
6                 Malam                   0              0% 
7              Mothiram                  40            100% 
8               Naadi   
        a.Vathapitham                  32              80% 
        b.Pithavatham                  7              17.5% 
        c.Vathakabham                  1              2.5% 
        d.Pithakabham                  0               0% 
 
 
Inference: 
In En vagaithervukal, Mothiram was found to be affected in all the 40 cases (100%). Naa was 
affected in 2 cases (5%). 
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14. Distribution Of Cases By Naadi 
 
             Naadi                No of cases           Percentage 
           Vali Azhal                      32                   80% 
          Vali Iyyam                      1                  2.5% 
           Azhal vali                      7                   17.5% 
         Azhal Iyyam                     0                   0% 
            Iyya vali                     0                   0% 
           Iyya Azhal                     0                   0% 
              Total                    40                  100% 
 
 
 
Inference:  
Among the 40 cases Vali azhal naadi was felt in 32 cases (80%).Azhal Vali naadi was felt in 
7 cases(17.5%). Vali iyyam naadi was felt in 1 case (2.5%).     
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15. Distribution Of Cases By Udal kattukal 
 
SI.No                   Udal Kattugal             No of cases            Percentage 
     1                       Saaram                 40                  100% 
     2                       Senneer                  4                   10% 
     3                         Oon                  0                   0% 
     4                     Kozhuppu                  0                   0% 
     5                        Enbu                  0                   0% 
     6                       Moolai                  0                   0% 
     7          Sukkilam/ Suronitham                  0                                                                        0%
 
 
 
Inference:         
Among 40 patients, Saaram was affected (general tiredness) in all the 40 cases 
(100%).Senneer was affected (reduction in Hb level) in 4 cases (10%) .         
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16. Distribution Of Cases By Kosangal 
 
               Kosam                 No of cases             Percentage 
      Annamaya kosam                    28                   70 % 
      Pranamaya kosam                    2                    5% 
      Manomaya kosam                    0                    0% 
      Vignamaya kosam                   40                   100% 
      Anandamaya kosam                    0                    0% 
 
 
 
Inference: 
Among 40 cases, Vignanamaya kosam was affected (pain from loin to groin) in all the 40 
cases (100%), Annamaya kosam was affected (abdominal pain) in 28 cases (70%), 
Pranamaya kosam was affected (cold,cough) in 2 cases (5%), other kosangal Manomaya 
kosam, Anandamaya kosam were normal in almost all the 40 cases (100%).     
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17. Distribution Of Cases By Uyirthathukkal 
      Vatham 
SI.No       Classification of vatham           No of cases           Percentage 
     1             Praanan                 2                5% 
     2            Abaanan                 40               100% 
     3            Udhaanan                 4               10% 
     4            Samaanan                40               100% 
     5            Viyaanan                40               100% 
     6            Naagan                 0                0% 
     7            Koorman                 0                0% 
     8            Kirukaran                 0                0% 
     9            Devathathan                 0                0% 
    10            Dananjayan                 0                0% 
 
 
Inference:          
Among 40 cases, Abaanan (burning micturition), samaanan (Abanan,viyanan 
affected),viyaanan (pain from loin to groin) were affected  in all the 40 cases 
(100%).Udhaanan was affected(nausea and vomiting ) in 4 cases (10%), Praanan 
(cold,cough) was affected in 2 cases (5%). 
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Pitham 
 
SI.No      Classification of Pitham          No of cases          Percentage 
      1      Anarpitham                  28                 70% 
      2      Ranjagam                  4                 10% 
      3      Saathagam                 40                 100% 
      4      Alosskam                 0                 0% 
      5      Prasakam                 0                 0% 
 
 
 
 
Inference:   
Among 40 cases, Sathaga pitham was affected (unable to perform their routine duties) in all 
the 40 cases (100%).Anar pitham was affected (abdominal pain) in 28 cases (70%), Ranjaga 
pitham was affected (Hb level reduced) in 4 cases (10%). 
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Kabam 
 
SI.No               Classification of Kabam           No of cases        Percentage 
    1                  Avalambagam                   2               5%  
    2                   Kelethagam                   0               0% 
    3                    Pothagam                   0               0% 
    4                  Tharpagam                   0               0% 
    5                  Santhigam                   0               0% 
 
 
 
 
Inference:  
Avalambagam (Cold, cough) was affected in 2 cases (5%).  
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18. Distribution Of Cases By Neerkuri 
 
                 Neer           No of cases                Percentage 
               Yellow                    36                     90% 
           Straw Yellow                    4                    10% 
                Total                   40                    100% 
 
 
 
Inference:  
Colour- yellow coloured   urine was observed in 36 cases (90%) and straw coloured urine 
was observed in 4 cases (10%).                          
Volume - The volume of urine was reduced in amount in 15 cases (37.5%), rest of cases had 
normal urine volume.                           
Enjal- Enjal was found to be normal in almost all cases (100%).                                                                         
Manam, Edai, Nurai - No other changes were observed. 
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19. Distribution Of Cases By Neikuri   
        
            Types              No of cases               Percentage 
              Serpentine 
            (Vatha neer) 
                    6                     15% 
          Annular/ Ring fashion 
             (Pitha neer) 
                   20                    50% 
             Pearl shape 
             (Kaba neer) 
                  12                    30% 
             Thontham 
              
                   2                     5% 
              Total                   40                   100% 
 
 
 
 
Inference:  
Among  40 cases,in 6 cases (15%)the neikuri was observed as serpentine like (Vatha neer).In 
20 cases (50%) the neikuri was observed as annular like (Pitha neer).In 12 cases (30%) the 
neikuri was observed as pearl like (Kaba neer).In 2 cases (5%) the neikuri was observed as 
thontham type.  
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20. Distribution Of Cases By Urinary System 
 
               Kidney         No of cases          Percentage 
         Both Kidney                19             47.5% 
         Right Kidney                12             30% 
         Left Kidney                 9             22.5% 
         Right Ureter                 5             12.5% 
         Left Ureter                 3             7.5% 
 
 
 
 
Inference:  
Among 40 cases, 19 cases (47.5%) had Bilateral renal caculi,21 cases (52.5%) had Unilateral 
renal calculi,Out of them 12 cases (30%) in Right kidney and 9 cases (22.5%) in Left 
kidney,8 cases (20%) had Ureteric calculi.                                 
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21. Distribution Of Cases By Chronicity Of Illness 
 
SI.No   Duration of illness       No of cases           Percentage 
     1    0 to 3 months              35              87.5%
     2    4 to 6 months                4              10% 
     3    7 to 9 months               0               0% 
     4    Above 9 months               1              2.5% 
             Total              40             100% 
 
 
 
Inference:  
         Among 40 cases 0 to 3 months chronicity of illness was found in 35cases (87.5%), 4 to 
6 months chronicity of illness was found  in 4 cases (10%) , above 9 months chronicity of 
illness was found in1 case (2.5%) .  
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22. Distribution Of Cases By Clinical features 
 
   Clinical features               No of cases               Percentage 
Pain from loin to groin                   40                    100% 
Abdominal pain                   28                     70% 
Agonizing pain                   10                     25% 
Burning micturition                   35                     87.5% 
Oliguria                   15                     37.5% 
Nausea                   4                     10% 
Vomiting                   2                      5% 
Dysuria                   5                     12.5% 
 
 
Inference:  
In clinical features,all the 40 cases (100%) had pain from loin to groin region.35 
cases(87.5%) had burning micturition and 28 cases (70%) had abdominal pain,4 cases (10%) 
had nausea,10 cases (25%) had agonizing pain,2 cases (5%) had vomiting and 15 cases 
(37.5%) had oliguria .       
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23. Improvement In Clinical Features After Treatment 
 
            Improvement             No of Cases               Percentage 
               Good                    37                     92.5% 
            Moderate                    3                      7.5% 
              Poor                    0                      0% 
              Total                   40                    100% 
 
 
Inference:  
Symptoms such as burning micturition, abdominal pain, yellow coloured urination, oliguria, 
nausea, vomiting, agonizing pain were relieved in almost all the 40 cases (100%). Pain from 
loin to groin region was relieved in 37 cases (92.5%) except in 3 cases (7.5%) Pain from loin 
to groin region persisted.    
Improvement:   
Among 40 cases 37cases (92.5%) had clinically good improvement (symptoms completely 
relieved) after treated with trial drug, 3 cases (7.5%) had moderate improvement (symptoms 
reduced), there was nil poor improvement (symptoms not reduced).   
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24. Improvement In USG Abdomen 
Improvement No of cases Percentage 
Good 24 60% 
Moderate 9 22.5% 
Poor 7 17.5% 
Total 40 100% 
 
 
 
Inference: 
Among the 40 cases stone completely dissolved in 13 cases (32.5%), Size (>3mm)  and 
number of stone is reduced in 11 cases (27.5%) ,in 9 cases (22.5%) stone size was reduced 
less than 3mm, In 7 cases (17.5%) there was no changes in size of stone but clinical 
symptoms were completely relieved. Based on above results, 24 cases (60%) showed good 
improvement and 9 cases (22.5%) cases showed Moderate improvement, 7 cases (17.5%) 
showed  poor prognosis.     
           Good                normal study (stone completely dissolved)                            
                                      Reduced in its number                           
                                      Reduced its size more than3mm  
           Moderate       -   Reduced stone size less than 3mm   
            Poor              -  no change in stone size and increase in stone size.  
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STATISTICAL ANALYSIS 
 All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. 
The quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical significance. 
Paired 
treatment.  
st for renal calculi before and after treatment 
Group Mean Std t value  P Value 
Before 11.4025 6.798849 8.4271 
 
P<0.0001 
After 6.47 7.269473 
 
Renal calculi before treatment is 11.4025 and after treatment is 6.47 which is 
statistically significant (p<0.0001). 
treatment  
Group Mean Std t value  P Value 
Before 4.225 1.097491 23.4248 
 
P<0.0001 
After .1 .3789324 
 
Clinical symptoms before treatment is 4.225 and after treatment is .1 which is 
statistically significant (p<0.0001). 
 
 
 
 
 
 
 
 
 
LAB INVESTIGATION 
PARAMETERS 
  
BLOOD  INVESTGATION BEFORE AND AFTER TREATMENT 
SI 
NO 
OPD NO AGE/SEX            Hb gm%    TRBC/cumm 
       BT       AT          BT       AT   
1 H 19492 50/M 14.5 14.7 4.7 4.9 
2 H 15645 31/M 15 14.7 4.8 4.6 
3 H  20423 33/M 14.8 14.7 4.8 4.7 
4 H  16032 21/M 14.3 14.5 4.8 4.9 
5 H  19053 51/M 15 14.7 5.3 5.2 
6 H  18411 32/M 13.3 15 4.2 5.2 
7 H  13757 34/M 11.1 11.5 6.4 6.0 
8 H  23990 34/M 16.4 15.2 5.7 5.2 
9 H  01697 23/M 16.6 15 5.3 4.6 
10 H  24900 50/M 13.8 13.2 4.5 4.2 
11 H  23888 35/F 13 13.2 5 5.2 
12 H  11568 37/M 13.2 13.4 4.9 4.7 
13 H  18479 29/M 13.8 13.5 5.2 5.4 
14 H  05729 52/F 12.4 13 5 5.1 
15 H  25307 26/M 15.9 15.7 5.6 5.5 
16 H  21974 48/F 12 12.2 4.7 4.8 
17 H  27215 20/M 16.3 16.3 5.2 5 
18 H  20060 31/M 14 14.2 4.2 4.5 
19 H  25423 36/F 12.5 13.1 4.2 4.5 
20 H  01812 48/M 14.2 14.4 4.8 4.6 
21 H  13275 49/F 13.1 13.8 4.5 4.7 
22 H  27409 26/M 14.4 14.5 5 5 
23 H  23014 24/M 15.7 15.7 5 5.1 
24 H  27381 37/M 16.8 16.8 5.8 5.6 
25 H  21784 60/F 12.4 11.7 4.2 4.1 
26 H  25573 38/M 16.1 16 5.6 5.3 
27 H  30917 37/M 13.9 13.5 5.1 5 
28 H  31520 44/M 14.6 14.6 4.7 4.7 
29 H  31567 35/F 13.1 13.4 4.8 4.9 
30 H  32015 33/M 12.6 12.7 4.4 4.4 
31 H  31212 35/F 11.9 11.5 4.4 4.2 
32 H  33137 35/F 10.9 11.1 5 4.8 
33 H  34776 31/F 12.7 12 4.5 4.3 
34 H  29831 46/F 12.5 12.6 4 4.2 
35 H  41411 36/F 12.3 12 4.4 4.3 
36 H  39601 59/M 14.3 15.3 4.5 4.8 
37 H  24262 22/M 14.8 14.5 5.4 5.4 
38 H  34014 31/F 12.5 12.8 4.6 4.7 
39 H  41528 27/F 11.7 12.2 4.2 4.6 
40 H  42729 22/M 16.8 17.3 5.7 5.7 
 
 










USG ABDOMEN RESULTS BEFORE AND AFTER TREATMENT 
S. 
NO 
 
OPD NO AGE/SEX   
SIZE OF THE 
KIDNEY 
SITE OF THE 
CALCULUS 
NO OF 
CALCULUS 
SIZE OF THE 
CALCULUS 
HYDROURE 
TERO 
NEPHROSIS 
1 H 19492 50/M 
RT 
KIDNEY 
BT 10.9×4.5cm Lower pole 1 5.1mm - 
AT 9.5×3.8cm Lower pole 1 4.1mm - 
LT 
KIDNEY 
BT 10.5×5.3cm Mid pole calyx Lower pole calyx 2 
4.4mm, 
3.7mm - 
AT 9.8×4.2cm Mid mid calyx 1 3.1mm - 
2 H 15645 31/M 
RT 
KIDNEY 
BT 9×4.3cm - - - - 
AT 9×4.1cm - - - - 
LT 
KIDNEY 
BT 8.5×4.4cm 
 
Pelvis, Lower 
pole 
2 1.8cm, 6.8mm + 
AT 9×4cm Pelvis, Lower calyx 2 
1.7cm, 
7mm + 
3 H 20423 33/M 
RT 
KIDNEY 
BT 9.8×4.2cm Lower pole 1 5.3mm - 
AT 10.1×4.8cm Lower pole 1 3.5mm - 
LT 
KIDNEY 
BT 10.6×5.1cm Mid pole 1 4.1mm  - 
AT 10.5×6.4cm - - No e/o Calculi - 
4 H 16032  21/M 
RT 
KIDNEY 
BT 9.9×4.3cm Lower pole 1 4mm - 
AT 9.4×4.4cm - - Normal Study - 
LT 
KIDNEY 
BT 9×4.2cm - - - - 
AT 9.2×4.3cm - - - - 
5 H 19053 51/M  
RT 
KIDNEY 
BT 10.4×6cm Lower pole 1 4mm - 
AT 10×6.2cm - - Normal  study - 
LT 
KIDNEY 
BT 11×5.9.cm Left UVJ 1 5.8mm + 
AT 11.1×5.6cm - - Normal study 
 
- 
6 H 18411 32/M 
RT 
KIDNEY 
BT 10.9×4.3cm Inter pole 1 4mm - 
AT 11×4cm - - No e/o calculi - 
LT 
KIDNEY 
BT 11×5.5cm Inter pole 1 7mm - 
AT 11.2×5.3cm Inter pole 1 3mm - 
 
 
7 
 
 
H 13757 34/M 
RT 
KIDNEY 
BT 10×6.2cm Lower calyx 1 9mm - 
AT 10.7×4.3cm Lower calyx 1 7mm - 
LT 
KIDNEY 
BT 10.3×4.7cm - - -  - 
    
AT 9.8×4.9cm 
- - - - 
 
 
  
 
 
8 
 
 
H 23990 34/M 
RT 
KIDNEY 
BT 11.1×4.2cm Mid calyx 1 6mm - 
AT 11.3×4cm Mid calyx 1 4mm - 
LT 
KIDNEY 
BT 10×4.3mm - - - - 
AT 10.3×4.1cm - - - - 
 
9 
 
H 01697 23/M 
RT 
KIDNEY 
BT 11×4.6cm Mid calyx 1 6mm - 
AT 11.3×4.3cm Mid calyx 1 3mm - 
LT 
KIDNEY 
BT 11.2×6.5cm Mid calyx 2 3mm,4mm - 
AT 11×6.6cm Mid calyx 1 3mm - 
 
 
 
 
10 
 
 
 
 
H  24900 50/M 
RT 
KIDNEY 
BT 11.4×6cm Lower calyx, lower mid ureter 3 
5.2mm, 5.7mm, 
14.4mm + 
AT 11.1×6.6cm Lower calyx, lower mid ureter 3 
6mm, 5mm, 
12.2mm + 
LT 
KIDNEY 
BT 10.7×5.9cm Mid calyx, Lower calyx 3 
5.1mm, 
4.1mm,,5.1mm - 
AT 10.7×5.4cm Mid calyx, Lower calyx 3 
5mm, 
4.2mm - 
11 H  23888 35/F 
RT 
KIDNEY 
BT 11.2×4.5cm Mid calyx 1 6.1mm - 
AT 10.6×4.9cm - - Normal study - 
LT 
KIDNEY 
BT 11.8×6.1cm - - - - 
AT 11.2×6.3cm - - - - 
12 H  11568 37/M 
RT 
KIDNEY 
BT 8.8×3.7cm Upper calyx 1 6mm - 
AT 9.4×4cm Upper calyx 1 5mm - 
LT 
KIDNEY 
BT 9.3×4.8cm Upper calyx, Mid calyx 2 4mm, 6mm - 
AT 9.8×4.3cm Upper calyx, Mid calyx 2 4mm, 5mm - 
13 H  18479 29/M 
RT 
KIDNEY 
BT 10.1×5.6cm Upper calyx 1 6.1cm - 
AT 11×4.8cm Upper calyx 1 6.1cm - 
LT 
KIDNEY 
BT 10.7×4.9cm - - - - 
AT 10.3×5cm - - - - 
 
14 
 
H 05729 52/F 
RT 
KIDNEY 
BT 11.2×5.9cm Lower ureter 1 7.7mm + 
AT 11.8×5.9cm - - Normal study - 
LT 
KIDNEY 
BT 10×5cm Inter pole 1 4.7mm - 
AT 10×4.9cm Inter pole 1 3mm - 
 
15 
 
H  25307 
 
26/M 
 
RT 
KIDNEY 
BT 11.3×6.7cm Upper pole calyx 1 5mm - 
AT 10.6×4.6cm - - Normal study - 
LT 
KIDNEY 
BT 11.1×5.4cm - - Microlith - 
AT 10.9×4.7cm - - Normal study - 
 
16 
 
H  21974 48/F 
RT 
KIDNEY 
      
BT 9.9×4.7cm - - - - 
      
AT 9×5cm - - - - 
LT 
KIDNEY 
      
BT 10.3×5.1cm Lower pole 1 7.5mm - 
      
AT 10.4×4.9 Lower pole 1 6 mm - 
17 H  27215 
 
20/M 
 
RT 
KIDNEY 
BT 10.5×4.7cm Mid and lower pole 2 4.2mm,4.9mm + 
AT 10.7×4.6cm - - Microlith - 
LT 
KIDNEY 
BT 10.7×4.5cm - - - - 
AT 10.9×4.3cm - - - - 
18 H  20060 31/M 
RT 
KIDNEY 
BT 10×5cm Mid calyx, Lower calyx 2 6.6mm,7.4mm + 
AT 9.5×5.3cm Mid calyx, Lower calyx 2 6.6mm,7.4mm + 
LT 
KIDNEY 
BT 10.6×5.3cm - - - - 
AT 10.7×4.8cm - - - - 
 
19 
 
H  25423 
 
36/F 
 
RT 
KIDNEY 
BT 10.3×5.3cm Upper calyx 1 6×5mm - 
AT 10.3×4cm Upper calyx 1 3×4mm - 
LT 
KIDNEY 
BT 10.6×5.3cm Upper calyx Mid calyx 2 
6×5mm, 
4×4mm - 
AT 10.2×5cm Upper calyx 1 4×4mm - 
 
20 
 
H  01812 48/M 
RT 
KIDNEY 
BT 8.9×3.8cm Mid calyx 2 8mm,4.4mm - 
AT 9.8×3.8cm Mid calyx 1 4mm - 
LT 
KIDNEY 
BT 8.9×3.8cm - - - - 
AT 8.6×5.1cm - - - - 
21 H  13275 49/F 
RT 
KIDNEY 
BT 10×4.3cm - - - - 
AT 10×4.7cm - - - - 
LT 
KIDNEY 
BT 10×4.8cm Lower calyx 1 5.9mm - 
AT 10.2×4.6cm - - Normal study - 
22 H  27409 26/M 
RT 
KIDNEY 
BT 9.5×4.8cm mid ureter 1 4.5mm + 
AT 9.3×4.5cm - - Normal study - 
LT 
KIDNEY 
BT 9.7×5.6cm - - - - 
AT 9.9×5.3cm - - - - 
 
23 H  23014 24/M 
RT 
KIDNEY 
BT 10×4.6cm Lower pole 2 4.5mm, 5.7mm - 
AT 10.1×4.5cm Lower pole 2 4mm, 5.1mm - 
LT 
KIDNEY 
BT 9.3×4.4cm Mid pole 1 5.3mm - 
AT 9.2×5cm Mid pole 1 4mm - 
24 H  27386 37/M 
RT 
KIDNEY 
BT 10.1×5.6cm Upper pole 1 1cm - 
AT 10.5×5.8cm Upper pole 1 7mm - 
LT 
KIDNEY 
BT 10.7×4.9cm Mid pole 1 8.1mm - 
AT 10.2×4.5cm - - Normal study - 
 
25 
 
H  21784 
 
60/F 
 
RT 
KIDNEY 
BT 8.7×4cm RT UVJ 1 7mm + 
AT 8.7×4.3cm - - No e/o calculi - 
LT 
KIDNEY 
BT 8.7×4.3cm - - - - 
AT 8.6×4.6cm - - - - 
26 H  25573 38/M 
RT 
KIDNEY 
BT 11×4.5cm Mid pole 1 4mm - 
AT 11.1×5.2cm - - Normal study - 
LT 
KIDNEY 
BT 10.8×5.5cm Mid pole 1 5mm - 
AT 10.1×4.7cm - - Normal study - 
27 
 
H  30917 
 
37/M 
 
RT 
KIDNEY 
BT 9.9×5.1cm Lower pole 1 6mm - 
AT 10.7×5.3cm Lower pole 1 4mm - 
LT 
KIDNEY 
BT 11.4×5.2cm Upper pole, Lower pole 2 
3.8mm, 
1.1cm - 
AT 10.9×4.9cm Lower pole 1 8mm - 
28 H 31520 44/M 
RT 
KIDNEY 
BT 10.4×4.3cm - - - - 
AT 10.7×4cm - - - - 
LT 
KIDNEY 
BT 11.2×5.8cm LT  UVJ 1 6mm + 
AT 10.7×5.7cm - - Normal study - 
 
29 
 
 
H  31567 
 
 
35/F 
 
RT 
KIDNEY 
BT 10.6×4.8cm Mid pole 1 4.4mm - 
AT 12.7×4.2cm - - Normal study - 
LT 
KIDNEY 
BT 10.2×4.8cm - - - - 
AT 11.9×4.7cm - - - - 
30 
 H  32015 33/F 
RT 
KIDNEY 
BT 9.5×4.4cm Lower pole 1 4.9mm - 
AT 9.2×4.2cm Lower pole 1 3.4mm - 
LT 
KIDNEY 
BT 10×4.2cm - - - - 
AT 9.5×4.7cm - - - - 
31 H  33137  
30/F 
 
RT 
KIDNEY 
BT 9.9×5.1cm Mid calyx 1 5mm - 
AT 10.4×3.6cm Mid calyx 1 4.7mm - 
LT 
KIDNEY 
BT 9.9×4.9cm ureter 1 7mm - 
AT 10×4.3cm ureter 1 4.4mm - 
32 H  34776 31/F 
RT 
KIDNEY 
BT 9×4.4cm Upper pole, Lower pole 2 5.1mm, 8.3mm - 
AT 9.2×4.2cm Upper pole, Lower pole 2 5.2mm, 8.3mm - 
LT 
KIDNEY 
BT 10.8×4.5cm - - - - 
AT 10.9×4.5cm - - - - 
33 H  34776 31/F 
RT 
KIDNEY 
BT 8.4×4.6cm Middle calyx 1 6mm - 
AT 9.2×4cm Middle calyx 1 6mm - 
LT 
KIDNEY 
BT 10.8×4.5cm Middle calyx 1 7.8mm - 
AT 10.9×4.5cm Middle calyx 1 7.7mm - 
34 H  29831 46/F 
RT 
KIDNEY 
BT 10×4.7cm RT UVJ 1 8mm + 
AT 10.1×4.6cm - - Normal study - 
LT 
KIDNEY 
BT 11×5.7cm - - - - 
AT 11.3×5.2cm - - - - 
35 
 
H  41411 
 
36/F 
 
RT 
KIDNEY 
BT 10.7×3.7cm Upper polar calyx 1 4mm - 
AT 10.4×4cm - - Normal study - 
LT 
KIDNEY 
BT 11.5×4.8cm - - - - 
AT 11.2×5cm - - - - 
 
36 
 
H  39601 59/M 
RT 
KIDNEY 
BT 10.1×3.4cm Mid pole 1 6mm - 
AT 10.5×3.2cm Mid pole 1 5mm - 
LT 
KIDNEY 
BT 9.2×4.7cm - - - - 
AT 9.4×4.7cm - - - - 
37 
 
H  24262 
 
22/M 
 
RT 
KIDNEY 
BT 9.4×4.7cm Mid pole 1 4.2mm - 
AT 9.2×4.7cm - - Normal study - 
LT 
KIDNEY 
BT 9.6×5.2cm - - - - 
AT 9.3×5cm - - - - 
38 H  34014 31/F 
RT 
KIDNEY 
BT 9.8×4.3cm Mid pole calyx 1 3.6mm - 
AT 10.1×4.1cm Mid pole 1 Microlith - 
LT 
KIDNEY 
BT 10.2×4.2cm Upper pole calyx, Lower pole calyx 2 
4.2mm, 
4.9mm - 
AT 9.3×4.9cm Lower pole 1 3.7mm - 
39 
 
H 41528 
 
27/F 
 
RT 
KIDNEY 
BT 9.2×4.4cm 
Upper pole, 
Lower pole 
 
2 4.1mm, 3.2mm - 
AT 9.7×4.2cm 
Upper pole, 
Lower pole 
 
2 4.1mm,3.2mm - 
LT 
KIDNEY 
BT 9.8×.4.5cm 
Upper pole, 
Lower pole 
 
2 5.4mm, 3.6mm - 
AT 9.2×4cm Upper pole, Lower pole 2 5.4mm, 3.6mm - 
40 H  42729 22/M 
RT 
KIDNEY 
BT 9.5×4.8cm Mid pole calyx 1 8mm - 
AT 9.8×4.4cm Mid pole calyx 1 8mm - 
LT 
KIDNEY 
BT 10.6×5cm Lower pole calyx 1 6mm - 
AT 10.2×4.8cm Lower pole calyx 1 6mm - 
 
BT- Before Treatment, AT-After Treatment, RT- Right Kidney, LT- Left Kidney 
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DISCUSSION 
The main aim of the treatment is to evaluate the therapeutic effect of the trial drug 
Koozhpaanda Chooranam (internal) in the disease azhal kalladaippu.The clinical features of 
azhal kalladaippu can be correlated with renal calculus in Modern science.As per yugi 
vathiya chinthamani text, Azhal kalladaippu is charecterised by oliguria,urethral pain which 
mimics the  pain caused by the insertion of iron rod in the urethra,sweating all over the 
body,anuria,agonizing pain,blood stained calculus stagnated in urethra.  
The trial drug was prepared in Gunapadam lab of National Institute of Siddha after the 
authentication of the raw drugs by the concerned department. The trial drug was prepared by 
standard operating procedure as mentioned in the protocol.   
The biochemical (qualitative) analysis were done at the laboratory of NIS. It revealed 
the presence of effective minerals. Physico chemical (quantitative) analysis and HPTLC were 
done at SCRI. 
The clinical study was conducted with a well defined protocol and a proper proforma 
after the approval of the Institutional Ethical Committee (IEC).After the screening of 60 cases 
reporting at the OPD of department of Maruthuvam, 40 cases were inducted  to the 
trial.Before enrollment to the trial the informed consent was obtained from the patients. 
The patient were treated for a period of 48 days with Koozhpaanda Chooranam 
(internal) at the dose of 1.5g, twice a day with the adjuvant of Hot water.  
Clinical assessment was done during each visit in OPD patients (8 days once) and the 
data were noted in the prescribed  proforma.  
Laboratory investigation & USG abdomen were done on 0th day and 48th day of the 
trial for OPD patients. All the patients were put under observation for 2 months follow up 
period without the trial drug treatment.   
THE OBSERVATIONS DISCUSSED BELOW:  
Gender Distribution:  
The majority affected was male i.e.25 cases (62.5%) and in female it was 15cases (37.5%)  
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Inference:  
Testosterone may cause increased oxalate production in men.  
Women have higher urinary citrate concentration.   
Kaalam distribution : (according to age)  
Among 40 cases, 22 cases (55%) were found to be in pitha kaalam (34-66 yrs of age ) 
and 18 cases(45%) in vatha kaalam (upto 33 yrs)  
Inference:  
The peak incidence of renal calculi occurs between 20 and 40 years of age.As per the 
Rathina suruka naadi this period falls in pitha kaalam (34-66 years) of  life.  
Occupational Reference:  
Home makers accounts for highest number of occurence i.e 14 cases (35%).  
Dietary Habit:  
Among the 40 cases, 36 cases (90%) were non-vegetarian and 4 cases (10%) were 
vegetarian. 
Inference:  
Animal protein contain oxalates,calcium,phosphate,and other elements often lead to 
an excess excretion of them in urine.High intake of animal protein causes high urinary 
oxalate ,low PH ,low urinary citrate and High intake of salt causes hypercalciuria.However ,a 
reduced calcium diet can increase the risk of further stone formation.  
Marital status 
Among 40 cases, 32 cases(80%) were married, 8 cases (20%) were unmarried. 
 Habits: 
Among 40 cases, 3 cases (7.5%) were alcohol consumer, 3 cases  ( 7.5%) were 
smoker. 
 
 
 
118 
 
Treatment History: 
 Among 40 cases, 7 cases (17.5%) had taken allopathic treatment in the past and had 
discontinued the same. The rest the 33 cases (82.5%) had not taken any other drugs prior to 
enrolling for the study.                 
 Family History: 
Among 40 cases, there was no family history. 
Distribution of cases by Paruvakaalam(Seasons):  
In this study, 40 cases (100%) were reported in Pinpani kaalam (Feb 13- Apr 13).  
Thinai Distribution:  
In this study, 34 cases (85%) were reported from Neithal land (Coastal region), 6 
cases (15%) were from Maarutham thinai.      
Inference:  
In Siddha, it was mentioned that Neithal is a land which is responsible for vatha 
disease.Mineral content of water in this Neithal land may contribute to the formation of 
kidney stones.  
Yakkai Distribution:  
Among 40 cases, 26 cases (65%) were Vatha thegi, 12 cases (30%) were Pitha thegi 
and 2 cases (5%) was Kapha thegi.  
Gunam Distribution:  
Among 40 cases under the analysis were predominantly of Rajo Gunam was assessed 
from the interrogation and other observation.  
Distribution Of Cases By Envagai Thervugal (Eight- Fold Examination)  
In En vagaithervukal, Mothiram was found to be affected in all the 40 cases (100%). 
Naa was affected in 2 cases (5%). 
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Distribution Of Cases By Naadi:  
In this study,Vali Azhal naadi was felt in 32 cases(80%),Azhal Vali naadi was felt in 
7cases(17.5%),Vali Iyyam naadi was felt in 1case (2.5%).  
Distribution Of Cases By Udal Kattukal:  
Among 40 patients, Saaram was affected (general tiredness) in all the 40 cases 
(100%).Senneer was affected (reduction in Hb level) in 4 cases (10%) .  
Distribution Of Cases By Kosangal:      
Among 40 cases, Vignanamaya kosam was affected (pain from loin to groin) in all the  
40 cases (100%), Annamaya kosam was affected (abdominal pain) in 32 cases (80%), 
Pranamaya kosam were affected (cold, cough) in 2 cases(5%),other kosangal manomaya 
kosam, Anandamaya kosam were normal in almost all the 40 cases(100%).   
Derangement Of Vatham:  
Abaanan (burning micturition), samaanan (Abaanan,viyaanan affected), viyaanan 
(pain from loin to groin) were affected  in all the 40 cases (100%).Udaanan was 
affected(nausea and vomiting) in 4cases(10%).   
Derangement Of Pitham:    
Sathaga pitham was affected (unable to perform their routine duties) in all the 40 
cases (100%), Anar pitham was affected (abdominal pain) in 28 cases(70%) , Ranjaga pitham 
was affected(Hb level reduced) in 4 cases (10%) 
Derangement Of  Kabam                                                                                                                                           
Avalambagam was affected (Cold, cough) in 2 cases (5%).  
Distribution Of Cases By Neerkuri:   
Colour- yellow coloured  urine was observed in 36 cases (90%) and straw   coloured 
was observed   in 4 cases (10%).                           
Volume- The volume of urine was reduced in amount in 15 cases (37.5%), rest of 
cases had  normal urine volume.                            
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Enjal - Enjal was found to be normal in almost all cases (100%).                                                                   
Manam, Edai,Nurai - No other changes were observed.  
 Distribution Of Cases By Neikuri:  
Among  40 cases,in 6 cases(15%) the neikuri was observed as serpentine like(Vatha 
neer).In 20 cases(50%) the neikuri was observed as annular like(Pitha neer).In 12 cases(30%) 
the neikuri was observed as pearl like(Kaba neer). In 2 cases (5%) the neikuri was observed 
as thontham type.   
Distribution Of Calculus In Urinary System:     
Among  40 cases,19 cases (47.5%) had Bilateral renal caculi,21 cases(52.5%) had 
Unilateral renal  calculi,Out of them 12 cases (30%) in Right kidney and  9 cases (22.5%)in 
Left kidney, 8 cases (20%) had Ureteric calculi.                                
Distribution Of Cases By Chronicity Of Illness:   
Among 40 cases (100%) 0 to 3 months chronicity of illness was found in 35 cases 
(87.5%),4 to 6 months chronicity of illness was found in 4 cases (10%),  above 9 months 
chronicity of illness was found in 1 case (2.5%) 
Clinical Features (Before Treatment):  
In clinical features,all the 40 cases (100%) had pain from loin to groin 
region.35cases(87.5%) had burning micturition and 28 cases(70%) had abdominal pain,4 
cases(10%) had nausea,10 cases (25%) had agonizing pain,2 cases(5%) had vomiting and 15 
cases(37.5%) had oliguria. 
Outcome:                                                                                                                       
Primary Outcome Observation:  
Result From USG Abdomen After Treatment:  
 All the 40 cases were taken ultra sonography, after the completion of the trial drug treatment.  
 Among the 40 cases stone completely dissolved in 13 cases (32.5%)   
 Size (>3mm) and number of stone is reduced in 11cases (27.5%)   
 In 9 cases (22.5%) size of the stone was reduced less than 3mm.  
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 In 7cases (17.5%) there was no changes in size of stone but clinical symptoms were 
completely relieved. Based on above results, 24cases (60%) showed good improvement and 
9cases (22.5%) showed moderate  improvement, 7 cases (17.5%) cases showed poor 
prognosis.  
Good results normal study (stone completely dissolved)                         
Reduced in its number                         
Reduced its size more than 3mm  
Moderate- Reduced its size less than 3mm  
 Poor- no change in stone size and increase in stone size.  
Secondary Outcome Observation:  
Improvement In Clinical Feature:   
symptoms such as Burning micturition,abdominal pain,yellow coloured urination, 
oliguria, nausea, vomiting and agonizing pain were relieved in almost all the 40 cases(100%). 
Pain from loin to groin region was relieved in 37 cases (92.5%).except in 3 cases (7.5%) the 
Pain from loin to groin region   persisted.  
Improvement:  
Among 40 cases 37 cases (92.5%) had clinically good improvement(symptoms 
completely relieved) after treated with trial drug,3 cases (7.5%) had moderate improvement 
(symptoms reduced), there was nil poor improvement.  
Biochemical study 
             Qualitative analysis of Koozhpaanda chooranam reveals that the trial medicine 
contains the following: 
 Chloride 
 Carbonate 
 Iron 
 Starch 
 Alkaloid 
 Reducing sugar 
 Tannic acid  
  
 
 
SUMMARY 
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SUMMARY 
 The aim of the study is to evaluate the therapeutic efficacy of the drug Koozhpaanda 
chooranam (internal) in Azhal kalladaippu.  
 Before initiating the clinical trial, approval was got from the Institutional Ethical 
committee(NIS/IEC/8-14/4-26-8-2014) for conducting the  clinical studies 
respectively by submitting the well defined protocol and proforma.  
 The raw drugs were authenticated by the concerned department and the trial drug was 
prepared by the investigator in the Gunapadam lab of National Institute of Siddha as 
per the standard operating procedure mentioned in the protocol.  
 The biochemical (qualitative) analysis were done at the bio chemistry lab of National 
Institute of Siddha. Physico chemical (quantitative) analysis and HPTLC were done at 
SCRI, Arumbakkam, Chennai. 
 For clinical study 60 cases were screened based on inclusion and exclusion criteria at 
the OPD of Department of Maruthuvam, NIS.Out of 60 cases 40 cases were recruited 
for the clinical trial.Clinical diagnosis of Azhal kalladaippu was made by both Siddha 
and modern methodology.    
 Before initiating the trial informed consent was obtained from the patients.  
 A day before starting the trial drug treatment, purgation as given (Agathiya kulambu 
130mg with sangankuppi juice) to correct the elevated mukkutrams.  
 The patients  were treated for a period of 48 days.The trial medicine selected for 
internal treatment was Koozhpaanda chooranam (internal medicine) at the dose of 
1.5g twice a day with adjuvant of hot water referred under Siddha 
.  
 Required laboratory investigations were carried out before and after treatment and the 
concerned data was recorded in the proforma.  
 Clinical assessment was done during each visit in OPD patients (8 days once) and the 
data was noted in the prescribed proforma.  
 During the study period there was no event of any adverse reactions owing to the drug 
and disease.  
 The biochemical study of the trial drug reveals the presence of Chloride, Iron, Tannic 
acid, Reducing sugar etc.  
 Statistical analysis showed significant difference between before and after treatment 
in the kidney stone size(p<0.0001) and symptoms(p<0.0001)  
 
 
123 
 
  37 cases (92.5%) had clinically good improvement (symptoms completely reduced) 
after treated with trial drug, 3 cases (7.5%) had moderate improvement (symptoms 
reduced).  
 All the 40 cases were taken ultra sonography, after the completion of the trial drug 
treatment.  
 Among the 40 cases stone completely dissolved in 13cases (32.5%)   
 Size (>3mm) and number of stone is reduced in 11cases (27.5%)   
 In 9 cases (22.5%) size of the stone was reduced less than 3mm.  
 In 7cases (17.5%) there was no changes in size of stone but clinical symptoms were   
completely relieved.  
Based on above results,24 cases (60%)  showed good improvement and 9 
cases(22.5%)  showed moderate  improvement,7cases (17.5%) cases showed poor 
prognosis.                                                                                                       
     Good results normal study (stone completely dissolved)                         
     Reduced in its number                        
     Reduced its size more than 3mm      
 Physico chemical analysis: 
 
 
 
 
 
 
 
 
 HPTLC REPORT: 
HPTLC fingerprint at 254 nmUV  showed highest peak in 8th peak (0.56Rf, 31.54% 
area ) which could serve    as a marker and and it is responsible for biological action. 
                                         
S.NO Physico chemical Parameter Mean 
1. Loss on Drying at 105oC 8.359% 
2. Total Ash 10.696% 
3. Water soluble Ash 2.734% 
4. Acid Insoluble Ash 5.952% 
5. Water soluble Extractive 21.99% 
6. Alcohol Soluble Extractive 21.615% 
7. Assay for Calcium 0.501% 
8. PH 3.87 
  
 
 
CONCLUSION 
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CONCLUSION 
 
 The aim of the study was to evaluate the therapeutic efficacy of the trial drug 
Koozhpaanda chooranam (internal) in Azhal Kalladaippu.  
 Clinical study revealed the therapeutic efficacy of the trial drug was read from USG 
Abdomen. 24 cases (60%) showed good improvement, 9 cases (22.5%) showed 
moderate improvement and 7 cases (17.5%) showed poor prognosis.  
 After treatment 37 cases (92.5%) showed clinically good improvement (symptoms 
completely reduced) after treatment,3 cases (7.5%) had moderate improvement.  
 There were no adverse reaction complained during the trial.  
 Therewere no recurrence of Renal stone with follow up period of two months. 
 Statistical analysis showed  significant difference between before and after treatment 
in the kidney stone size (p<0.0001) and symptoms (p<0.0001)  
  Because of the encouraging clinical outcome, the study may be further carried out 
with the same drug in large number of cases in future.  
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
CHOORNAM  
 
   FORM I -  SCREENING AND SELECTION PROFORMA                
  
1. O.P No:  ________________                                                     2. S.No: ________    
   
3. Name   : _______________________________                       4. Age (years):                   5. Gender: Male/ Female   
  
6. Contact No: __________________________ 
 
7. Address:      
              
8.INCLUSION CRITERIA: 
  Patients who will fulfill any of the following criteria will be included in the study:                                                
 Age:20-60 yrs            Yes / No                                                                                       
 Sex: Both sex          Yes / No 
 Patients who are having the classical symptoms of abdominal pain, distension, 
 pain from loin to groin,pain in urethra, agonizing pain, dysuria, oliguria, yellow coloured  Yes/No 
urination, burning micturition, haematuria, nausea, vomiting.             
 Patient with renal calculus detected on USG Abdomen,                       Yes / No 
 Patient willing to sign the informed consent stating that he/she will conscientiously  
stick to the treatment during 48 days but can opt out of the trial of his/her    Yes/No             
own conscious discretion. 
 Patient who are willing to take Ultrasonography investigation (USG- Abdomen/ KUB)   Yes / No 
 and provide blood for lab investigation 
    9.EXCLUSION CRITERIA: 
 Stone size >10mm,<4mm                                                                                                                        Yes / No                                                                                                                     
 Diabetes mellitus                                                                                                                                      Yes / No 
 Hypertension                                                                                                                                            Yes / No 
 Chronic kidney disease                                                                                                                             Yes / No 
 Cardiac disease                                                                                                                                         Yes / No      
 Pregnancy and lactation                                                                                                                            Yes / No                                                                                            
 Presence of any associated severe systemic illness like CA                                                                     Yes / No                                                                                                                     
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10.ADMITTED TO TRAIL:              YES                          NO                                           If Yes Serial No: 
 
Date:  
Station:  
Signature of the Investigator 
 
Signature of the Lecturer:                                                                                                          Signature of the HOD 
 
                                                                    :       
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
THE 
DRUG  
FORM II-CASE RECORD FORM 
 
1. Serial No:   _______________         2. OP/IP No: ---------- 
3. Name: ________________               4. Gender:   Male / Female 
 
5. Age (years): _________   DOB            
                                                                         Date         Month                  Year 
6. Address:     -------------------------------------- 
                      ------------------------------------- 
                      ------------------------------------- 
7. A) Occupation: -----------------------------             B) Nature of work ----------------- 
  
8. Educational Status:   A) Illiterate                  B) Literate          
 
9. Height:  --------- cms                10.Weight: ---------- kg 
 
11. Complaints and Duration:   
________________________________________________________________________ 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
12. Habit of 
          A) Smoking                    1. Yes; duration ________ years; Number-            2.No 
   B) Tobacco chewing       1. Yes; duration ________ years                             2.No                                         
                C) Betel chewing            1. Yes; duration ________ years                             2.No 
                D) Alcoholism                1. Yes; duration ________ years; Quantity-      ml 2.No 
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13. Dietary style:  A. Pure vegetarian             B. Non-vegetarian              C. mixed diet 
 
14. Drug History: Had the patient been treated before with allopathic drug?  A) Yes              2) No 
                                     
15 MARITAL STATUS:      1.Married   2.Unmarried   
 
                                               No of children:              male:                   female: 
                                            
16. FAMILY HISTORY: 
 
      Whether this problem runs in family?                         1. Yes                               2.No   
  
       If yes, mention the relationship of affected person(s)        ------------------------- 
                                                                                                   ------------------------- 
                                             
17. MENSTRUAL HISTORY:  
                                              
18. BOWEL HABITS & MICTURITION:  Normal  
 
            History of habitual constipation    1.Yes                      2.No                                                             
 
            History of frequent diarrhoea        1.Yes                      2.No                                                         
 
            History of frequent dysuria           1.Yes                      2.No                
            (Burning micturition/haematuria) 
 
19. PSYCHOLOGICAL STATE: 
                   
            Normal                                          Anxiety                          Depression 
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20.SIDDHA SYSTEM OF EXAMINATION: 
 ENVAGAI THERVU:[EIGHT-FOLD EXAMINATION] 
 
 I.NAADI: [PULSE PERCEPTION] 
 0th day 8th day             16th  day               24th day        32nd day 40th day 48th day 
Vali        
Azhal        
Iyyam        
Vali Azhal        
Azhal vali        
Iyya vali        
Vali Iyyam        
Azhal Iyyam        
Iyya Azhal        
 
II.NAA:[TONGUE] 
 0th day 8th day             16th  day               24th day         32nd day 40th day 48th day 
Colour normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ 
Red 
pale/yellow 
Taste Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour/ 
Pungent/ 
Bitter/None 
Sweet/Sour
/ Pungent/ 
Bitter/None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
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Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
III.NIRAM:[COMPLEXION]    
0th day 8th day 16th day 24th day   32nd day 40th day  48th day 
Dark/pale/ 
Yellow tinted/ 
whitish brown 
Dark/pale/ 
Yellow 
tinted/ 
whitish 
brown 
Dark/pale/ 
Yellow 
tinted/ 
whitish 
brown 
Dark/pale/ 
Yellow 
tinted/ 
whitish 
brown 
Dark/pale/ 
Yellow 
tinted/ 
whitish 
brown 
Dark/pale/ 
Yellow tinted/ 
whitish brown 
Dark/pale/ 
Yellow tinted/ 
whitish brown 
 
IV.MOZHI:[VOICE] 
0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
                     
V.VIZHI:[EYES] (Lower palpebral conjunctiva)     
0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
normal/ Red 
pale/yellow 
normal/Red 
pale/yellow 
normal/Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
normal/ Red 
pale/yellow 
                                                   
 VI. MALAM:[BOWEL HABITS / STOOLS] 
 0th day   8th day 2ndwk 24th day  32nd day 40th day 48th day 
Colour Dark/pale/ 
yellow/ 
Red 
Dark/ 
pale/ 
yellow/ 
Red 
Dark/ 
pale/ 
Yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Dark/pale/ 
yellow/ 
Red 
Consistency Solid/ Solid/ Solid/ Solid/ Solid/ Solid/ Solid/ 
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Semisolid/
Watery 
Semisoli
d/Watery 
Semisoli
d/Watery 
Semisolid/
Watery 
Semisolid/ 
Watery 
Semisolid/Wat
ery 
Semisolid/Wate
ry 
stool  bulk                         Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation   Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Diarrhea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
VII.MOOTHIRAM:[URINE EXAMINATION]     
Neerkkuri 0th day   8th day  16th 
day 
 24th day  32nd day 40th day 48th day 
Niram 
[Colour]   
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal 
clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Yellow/ 
Red/ 
White/ 
Straw 
coloured/ 
Crystal clear 
Manam 
[Odour] 
Present/ 
Absent 
 Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ Absent 
Nurai 
[Froth] 
Nil/ 
Reduced/ 
Increasd 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gravity]                               
Normal/ 
Increa/Re
duced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased/
Reduced 
Normal/ 
Increased/Re
duced 
Normal/ 
Increased/Red
uced 
Normal/ 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ Absent 
Volume   Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
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Neikkuri  0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
Serpentine 
fashion 
at___mints at___ mints at___ mints at___ mints at___ mints at___ mints at___ mints 
Annular/ 
Ringed 
fashion 
at___mints at___ mints at___ mints at___ mints at___ mints at___ mints at___ mints 
Pearl 
beaded 
fashion    
at___mints at___ mints at___ mints at___ mints at___ mints at___ mints at___ mints 
Mixed 
fashion 
at___mints at___ mints at___ mints at___ mints at___ mints at___ mints at___ mints 
Other 
fashion 
at___mints at___ mints at___ mints at___ mints at___ mints at___ mints at___ mints 
 
VIII. SPARISAM:[PALPATORY  PERCEPTION] 
0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
Warmth/ 
Hot/ 
cold/ Sweat 
Warmth/ 
Hot/cold/ 
Sweat 
Warmth/Hot 
/cold/ Sweat 
Warmth/Hot/ 
cold/ Sweat 
Warmth/Hot 
/cold/ Sweat 
Warmth/Hot 
/cold/ Sweat 
Warmth/Hot 
/cold/ Sweat 
 
 THEGI:[ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
 NILAM: [ LAND WHERE PATIENT LIVED MOST]  
               
Kurinji                      Mullai                 Marutham                  Neithal                    Paalai   
(Hilly terrain)          (Plains)                (Coastal belt)            (Aridregions)           (Forest range) 
 
 KAALAM: [SEASON] 
Kaarkalam   Pinpanikalam      
Koothirkalam                 Ilavenil 
Munpanikalam                             Muthuvenil 
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GUNAM:[CHARACTER] 
 
Sathuvam                        Rasatham                       Thamasam    
 
IYMPORIGAL:[SENSORY ORGANS] 
 
 0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
 Normal/  
Affected      
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Mei [Skin        
Vaai 
[Buccalcavity]
  
              
Kan [Eyes] 
 
              
Mooku[Nose] 
 
              
Sevi [ear] 
 
                
 
IYMPULANGAL:[MOTOR ORGANS] 
 0th day 8th day 16th day 24th day 32nd day 40th day 48th day  
 Normal/  
Affected      
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Kai [upperlimb]        
Kal [lowerlimb]        
Vai[Buccal 
cavity] 
       
Eruvai  
[excretory 
organ] 
       
Karuvai 
[Reproductive 
organ] 
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KOSAM:[SHEATHS] 
 
 
0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
 Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Normal/  
Affected       
Annamaya kosam 
 
       
Pranamaya 
Kosam 
       
Manonmayakosam 
 
       
Vingyanamaya 
kosam 
       
Anandhamaya 
kosam 
       
 
MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
 
A) VATHAM:                                                                          
 0th day 8th day 16th day 24th day 32nd day  40th day 48th day 
 Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected       
Praanan        
Abaanan        
Samaanan        
Udhaanan        
Viyaanan        
Naahan        
Koorman        
Kirukaran        
Devathathan        
Dhananjeyan        
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B) PITHAM:               
 0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
 Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected       
Normal/  
Affected      
Normal/  
Affected      
Analapitham        
 Prasakam        
Ranjakam        
Aalosakam        
Saathakam        
 
C) KABAM:                        
 0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
 Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Avalambagam        
Kilethagam        
Pothagam        
Tharpagam         
Santhigam        
                
SEVEN DHATHUS:[SEVEN SOMATIC COMPONENTS]                                         
 0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
 Normal/  
Affected      
Normal/ 
Affected 
Normal/ 
Affected 
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Normal/  
Affected      
Saaram[chyme]        
Senneer[Blood]         
Oon[Muscle]        
Kozhuppu[Fat]        
Enbu[Bones]        
Moolai[Bonemarrow]        
Sukkilam/ 
Suronitham  
[Genital discharges] 
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SYSTEMIC EXAMINATION: 
 0th day 8th day 16th day 24th day  32nd day 40th day 48th day 
CardioVascular 
System  
       
Respiratory  
System    
       
Gastrointestinal 
System 
       
Central Nervous 
System  
       
Endocrine Syste        
 
GENERAL EXAMINATION: 
 0th day 8th 
day 
16th day 24th day  32nd day 40th day 48thday 
Height (cms)        
Weight (kg)        
Temperature(°F)           
Pulse rate (per min)        
Heart rate (per min)        
Respiratory rate(per 
min) 
       
Blood 
pressure(mm/Hg) 
       
Pallor        
Jaundice        
Cyanosis        
Lymphadenopathy        
Pedal edema        
Clubbing        
Jugular vein pulsation        
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CLINICAL SYMPTOMS: 
 0th day 8th 
day 
16th 
day 
24th day  32nd day 40th day 49th day 
Abdominal pain        
Pain from loin to groin         
Agonizing pain        
Pain in urethra        
Yellow coloured 
urination 
       
Burning micturition        
Oliguria        
Dysuria        
Abdominal distension        
Nausea & Vomiting        
Haematuria        
                   
USG- Whole Abdomen: 
 
Date:     
Station:                                                        
                                           
Signature of the Investigator: 
Signature of the Lecturer:      Signature of the HOD: 
 
 
  
 
 
138 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
 
FORM III   LABORATORY PARAMETERS-CHART 
1. OP No: ________                          2.S. No:                                         
4. Name: ________________                 5. Age:   _______ years      6. Gender: M/F    
BLOOD INVESTIGATION 
0th DAY 
Date: 
49th day 
Date 
NORMAL VALUES 
HB ( gms%)   M:14-18 ;W:11-15 
T.RBC(milli/cu.mm)   M:4.5-6.5 ;W:3.5-5.5 
 
ESR (mm) 
½ hr.    
1 hr.   M:0-10 ;W:0-20 
T.WBC (cu.mm) 
 
 
DIFFERENTIAL 
COUNT (%) 
                       
4000-11,000 
 
Polymorphs   40-75 
Lymphocytes   20-35 
Monocytes   2-10 
Eosinophils   1-6 
 Basophils   0-1 
BT (per min)   2-6 
Clotting time   3-8 
Blood glucose (mg/dl) 
Fasting   80-120 
PP   <130 
Random   <140 
Lipid profile (mg/dl) 
Serum cholesterol   150-250 
HDL   30-60 
LDL   Upto 130 
VLDL   40 
TGL   Upto 160 
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RFT (mg/dl) 
Blood urea   16-50 
Serum creatinine   0.6-1.2 
Serum Uric acid    M:3-9 ;W: 2.5-7.5 
LFT (mg/dl) 
Total bilirubin   0.3-1 
Direct bilirubin   0.1-0.3 
Indirect bilirubin   0.2-0.8 
Serum total 
protein   6-8 
Serum Albumin   3.5-5.5 
Serum globulin   2-3.5 
Fibrinogen(g/dl)   0.2-0.4 
Serum calcium   9-11 
Serum 
phosphorous 
  2-5 
SGOT (IU/L)   0-40 
SGPT (IU/L)   0-35 
Alkaline 
phosphatase 
(kingÅ units) 
  80-290 
 
URINE INVESTIGATION 
Before TMT 
Date: 
After TMT 
Date: 
                    Albumin   
Neerkkuri   
Niram   
Manam   
Nurai   
Edai   
Enjal   
Neikkuri   
Fasting sugar   
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PP sugar   
Random Sugar   
Deposits   
Bile salts   
Bile pigments   
Urobilinogen   
Culture & sensitivity   
MALAM   
Ova   
Cyst   
Occult blood   
 
SCAN: USG ABDOMEN 
 
Specific investigation 
 
Size of the 
kidney 
 
site of the 
calculus 
 
No of calculus 
 
Size of the 
calculus 
 
 
Hydro 
nephrosis 
 
 
 
Rt 
kidney 
Before 
treatment   
(0th day) 
 
     
After 
treatment 
(49th day) 
 
     
 
 
 
 
Lt 
kidney 
Before 
treatment   
(0th day) 
 
     
After 
treatment 
(49th day) 
     
 
Date: 
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                                             
    Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
 
                                                     FORM IV  (DRUG COMPLIANCE FORM) 
S. NO: ---------   OPD/IPD NO  : ---------------  NAME :-----------------------  
Name Of The Drug: KOOZHPAANDA CHOORNAM , 1.5gm,twice a day with hot water 
On 0th day Date                  ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 8th day-Date:                 ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 16th day -Date:              ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 24th day-Date:                ;Drug issued:  (Nos)   /   Drug returned:    (Nos) 
On 32nd day-Date:               ;Drug issued:                    (Nos)   /   Drug returned:       (Nos) 
On 40th day-Date:               ;Drug issued:                   (Nos)   /   Drug returned:       (Nos) 
On 48thday-Date:                ;Drug issued:                   (Nos)   /   Drug returned:       (Nos) 
Day  Date   Morning Evening 
Day 1    
Day2    
Day3    
Day4    
Day5    
Day6    
Day7    
Day8    
Day9    
Day10    
Day11    
Day12    
Day13    
Day14    
Day15    
Day16    
Day17    
Day18    
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Day19    
Day20    
Day21    
Day22    
Day23    
Day24    
Day 25    
Day26    
Day27    
Day28    
Day29    
Day30    
Day31    
Day32    
Day33    
Day34    
Day35    
Day36    
Day37    
Day38    
Day39    
Day40    
Day41    
Day42    
Day43    
Day44    
Day45    
Day46    
Day47    
Day48    
 
Station: 
Date:                                        
Signature of the Investigator: 
Signature of the Lecturer:                                                                  Signature of the HOD      
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
  
FORM V- INFORMATION SHEET 
Name of the Principal Investigator: Dr.M.Ponmozhi 
Name of the Institution                  :  National Institute of Siddha, 
                                                            Tambaram Sanatorium, 
                                                            Chennai-47. 
 I, Dr.M.Ponmozhi, studying M.D(Siddha) in National Institute of Siddha, Chennai. The disease called 
Azhal kalladaippu  (Renal calculi) is formed by the sedimentation of crystalline mineral materials 
within the kidney or urinary tract.. It includes the symptoms like oliguria, urethral pain mimics pain 
caused by an insertion of  burning iron rod in the urethra,  sweating all over body, anuria, agonizing 
pain, blood stained calculus stagnated in urethra. This condition is being treated in NIS with many 
siddha formulations. As a part of M.D(S) research programme and developing new efficacious 
KOOZHPAANDA  formulation for treating the 
condition. This formulation has been mentioned in siddha literature and empirical evidence with 
contemporary tools is required for documentation. You can receive medicines free of cost. The 
duration of treatment period is 48 days. You have to visit OPD every week and collect the drugs for 8 
days. The diagnostic tests will be carried out free of cost. We will assess the effect of treatment after 
completion of 48 days of treatment using clinical and lab parameters. 
 In this regard, we need to ask you few questions. We will maintain confidentiality of your comments 
and data obtained from you. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study. 
 Taking part in this study is voluntary. No compensation will be paid to you for taking part in this study. 
You can choose not to answer any specific question. There is no specific benefit for you if you take 
part in the study, but you will be under our clinical monitoring and specific attention will be given for 
your health. Taking part in the study may be of benefit to the community, as it may help us to develop 
medicine for Azhal kalladaippu. In case of any adverse symptoms during the treatment viz, which are 
expect, acute renal colic i.e. severe pain caused by the kidney stone and associated with nausea, 
vomiting and fever  in few patients during the treatment, shall be reported to PIs and care will be taken 
in our regular OPD for relief. You can withdraw from the study at the midst of treatment period, if you 
are not interested to continue and you will receive our usual treatment without any precondition. 
 The information we will collect in this study, will remain between you and the principal investigator. 
We will not write your name on different forms which sent to different investigating/analysis sections 
and we will use a code instead given by the principal investigator. Only the principal investigator will 
know the key to this code which will be kept in safe custody. If you agree to be a participant in this 
study, you will be screened as per the study protocol.  
 If you wish to find out more about this study before taking part, you can ask me all the questions you 
want or contact Dr.M.Ponmozhi, PG scholar cum principal investigator of this study, attached to the 
National Institute of Siddha, Chennai (Mobile phone no:9566194860). You can also contact the 
Chairman/Member-secretary of Ethics committee, National Institute of Siddha, Chennai  600047, Tel 
no: 91-44-22511611, for rights and participation in the study. 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
              «§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
§¿¡öì¸¡É º¢ò¾ ÁÕó   ÀÃ¢¸Ã¢ôÒò            
¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
                     FORM V- ¾¸Åø ÀÊÅõ 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡ª÷ ¦ÀÂ÷ :  Dr. Á.¦À¡ý¦Á¡Æ¢ 
  
 ¿¢ÚÅÉò¾¢ý ¦ÀÂ÷       : §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
                            ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ 
                            ¦ºý¨É 47 
 
Dr. Á.¦À¡ý¦Á¡Æ¢ ¬¸¢Â ¿¡ý §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø Àð¼
  §À¡ýÈ 
. ­ó§¿¡ö  §À¡ø 
 
§À¡ø §À¡Ð §À¡ýÈ
§¾¡üÚÅ¢ìÌõ. ­ó§¿¡öìÌ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ÀÄ º¢ò¾ ÁÕóÐ¸û 
ÀÂýÀÎò¾ôÀðÎ ÅÕ¸¢ýÈÐ. º¢ò¾ ÁÕòÐÅ Àð¼ §ÁüÀÊôÀ¢ø, ¬öÅ¢ý ´Õ ÀÌ¾¢Â¡¸ Ò¾¢Â 
ÁÕóÐ¸¨ª ÀÂýÀÎòÐõ §¿¡ì¸¢ø ÁÕó¾¢¨É ­ó§¿¡öìÌ ÅÆí¸ ÀÃ¢óÐ¨Ã 
¦ºö¸¢§È¡õ. ­ó¾ ÁÕó¾¢ý ¦ºöÓ¨È, «ª×, «ÛÀ¡Éõ ÁüÚõ ÁÕòÐÅ ÀÂý¸û «¨ÉòÐõ 
«í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûªÐ. ±ó¾Å¢¾ ¸ð¼½ÓÁ¢ýÈ¢ ¾¡í¸û ­ó¾ 
ÁÕó¾¢¨É ¦ÀüÚì¦¸¡ûªÄ¡õ. ­ó¾ ¬öÅ¢ø ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ ¿¡ð¸û ¬Ìõ. Å¡Ãõ 
´ÕÓ¨È §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉìÌ §¿Ã¢ø ÅóÐ 8 ¿¡ð¸Ùì¸¡É ÁÕó¾¢¨É ¦ÀüÚì¦¸¡ûª 
§ÅñÎõ. ­ó¾ ¬ö× ºõÀó¾Á¡É ¬öÅ¸ ÀÃ¢§º¡¾¨É¸û ¸ð¼½Á¢ýÈ¢ ¦ºöÂôÀÎõ. ¿¡ð¸û 
ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ ÓÊó¾ À¢ÈÌ §¿¡öì¸¡É ÌÈ¢Ì½í¸û ÁüÚõ ¬öÅ¸ ÀÃ¢§º¡¾¨É¸û 
­ÅüÈ¢ý ÓÊ×¸ª¢ý «ÊôÀ¨¼Â¢ø ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢Èý ¸ñ¼È¢ÂôÀÎõ.  
 
­ó¾ ¬ö× ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨ª ¾í¸ª¢¼õ §¸ð¸ ­Õì¸¢§Èý. ¾í¸ª¢¼Á¢ÕóÐ 
¦ÀÈôÀÎõ ¸ÕòÐì¸û ÁüÚõ ÌÈ¢ôÒ¸û «¨ÉòÐõ ¿õÀ¢ì¨¸Â¡¸ À¾¢× ¦ºöÂôÀÎõ.­ó¾ ¬öÅ¢ø 
¾í¸¨ª ¯ðÀÎò¾¢ì¦¸¡ûÅ¾¢ý ãÄõ ±ó¾ Å¨¸Â¢Öõ À¡¾¢ôÒìÌûª¡¸ Á¡ðË÷¸û ±É ¯Ú¾¢ 
«ª¢ì¸¢§Èý. 
±ó¾Å¢¾ ÅüÒÚò¾ÖÁ¢ýÈ¢, ­ó¾ ¬öÅ¢ø Àí§¸ü¸×õ, ­ó¾ ¬ö× ºõÀó¾Á¡¸ §¸ð¸ôÀÎõ 
§¸ûÅ¢¸ÙìÌ À¾¢ø ÜÈ×õ ¾í¸ÙìÌ ÓØ Í¾ó¾¢Ãõ «ª¢ì¸ôÀÎ¸¢ÈÐ. ­ó¾ ¬öÅ¢ø Àí§¸üÀ¾üÌ 
±ó¾ ºýÁ¡ÉÓõ ÅÆí¸ôÀ¼Á¡ð¼¡Ð.  ¬É¡ø, ¬ö× ÓØÅÐõ ±ÉÐ §ÁüÀ¡÷¨ÅÂ¢Öõ, ¾í¸û 
¯¼ø ¿Äý ÌÈ¢ò¾ ¾É¢ ¸ÅÉò¾¢Öõ ¬ö× §Áü¦¸¡ûªôÀÎõ. §¿¡öì¸¡É Ò¾¢Â 
ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢È¨É ºã¸ò¾¢üÌ ¯½÷òÐõ Å¨¸Â¢ø ­ó¾ ¬ö× §Áü¦¸¡ûªôÀÎ¸¢ÈÐ.­ó¾ 
¬öÅ¢¨Éò ¦¾¡¼Ã ¾í¸ÙìÌ Å¢ÕôÀõ ­ø¨Ä¦ÂÉ¢ø, ±ô¦À¡ØÐ §ÅñÎÁ¡ÉÖõ ¬öÅ¢ý 
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­¨¼Â¢ø Å¢Ä¸¢ì¦¸¡ûª×õ, ­õÁÕòÐÅÁ¨ÉÂ¢ø ÅÆí¸ôÀÎõ ­ó§¿¡öì¸¡É ÅÆì¸Á¡É 
ÁÕóÐ¸¨ª ¦ÀüÚì¦¸¡ûª×õ «È¢×Úò¾ôÀÎ¸¢È£÷¸û. 
       ­ó¾ ¬öÅ¢ø §º¸Ã¢ì¸ôÀÎõ Å¢ÀÃí¸û «¨ÉòÐõ ¾í¸ÙìÌõ Ó¾ý¨Á ¬Ã¡öîº¢Â¡ªÃ¡É 
±ÉìÌõ ­¨¼Â¢ø ­Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. §¸ûÅ¢ À¾¢ø ÅÊÅò¾¢ø ¾í¸ª¢¼õ §¸ûÅ¢¸û 
§¸ð¸ôÀÎõ. «¨ÉòÐô ÀÊÅí¸ª¢Öõ ¾í¸ª¢ý ¦ÀÂ÷ ¾Å¢÷ì¸ôÀðÎ ¬öÅ¡ªÃ¡ø ¾í¸Ùì¦¸É 
¾É¢ì ÌÈ¢Â£Î ÅÆí¸ôÀÎõ. «ó¾ì ÌÈ¢Â£Î ¬öÅ¡ªÕìÌ ÁðÎ§Á ¦¾Ã¢ó¾¾¡¸ ­ÕìÌõ. ¿£í¸û 
­ó¾ ¬öÅ¢ø Àí§¸ü¸ Å¢ÕôÀôÀð¼¡ø, ¾¢ð¼ Å¨Ã× ÀÊ §¾÷× ¦ºöÂôÀÎÅ£÷¸û. 
¿£í¸û ­ó¾ ¬öÅ¢ø Àí§¸üÌõ Óý, ­ó¾ ¬öÅ¢¨Éô ÀüÈ¢Â §ÁÖõ Å¢ÀÃí¸û ¦ÀÈ 
§ÅñÎ¦ÁÉ Å¢ÕôÀôÀð¼¡ø, ­ó¾ ¬öÅ¢ý Ó¾ý¨Á ¬Ã¡öîº¢Â¡ª÷ ÁüÚõ §¾º¢Â º¢ò¾ 
ÁÕòÐÅÁ¨É, Àð¼ §ÁüÀÊôÒòÐ¨È Á¡½Å÷ Dr  Á.¦À¡ý¦Á¡Æ¢ ¬¸¢Â ±ý¨É ±ýÈ 
±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûªÄ¡õ. §ÁÖõ, ¿£í¸û ­ó¾ ¬öÅ¢ø, ¯í¸ªÐ Àí§¸üÒ ÁüÚõ ¯Ã¢¨Á 
ÀüÈ¢ ¦¾Ã¢óÐ ¦¸¡ûª §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨É, ¾¨ÄÅ÷/¦ºÂüìÌØ ¯ÚôÀ¢É÷ «Å÷¸¨ªÔõ  91-
44-22511611 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûªÄ¡õ.   
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
 
FORM VI-INFORMED CONSENT FORM 
CERTIFICATE OF CONSENT 
I have read the foregoing information, or it has been read to me. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my satisfaction.  
            I   consent voluntarily to participate as a participant in this study and understand that I 
have the   right to withdraw from the study at any time without in any way it affecting my further 
medical care . 
"I have received a copy of the information sheet/consent form". 
In case of illiterate participant 
             
the individual has had the opportunity to ask questions. I confirm that the individual has given 
 
Date: 
 Signature of a witness  
           
                                                                                                                      Left thumb Impression of the   
                                   Participant    
           (Selected by the participant bearing no connection with the survey team) 
Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Investigator:                         
Signature of the Lecturer:                                                                         
                                                                                                            Signature of the HOD 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡º ÀñÊ¾÷ ÁÕòÐÅÁ¨É, ¦ºý¨É - 47. 
Àð¼ §ÁüÀÊôÒ ÁÕòÐÅòÐ¨È 
   §¿¡öì¸¡É     ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì 
¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É  ´ôÒ¾ø  ÀÊÅõ 
FORM  VI-  ´ôÒ¾ø ÀÊÅõ 
                ¿¡ý §ÁüÜÈ¢Â  ¾¸Åø  ÀÊÅò¨¾ ÀÊòÐ «øÄÐ ÀÊì¸ §¸ðÎ 
¦¸¡ñ§¼ý. Ð ¦¾¡¼÷À¡É Å¢ªì¸í¸¨ªÔõ §¸ðÎ ¦¾Ã¢óÐ ¦¸¡ñ§¼ý. ±ó¾Å¢¾ 
ÅüÒÚò¾Ä¢ýÈ¢, ±ý ¦º¡ó¾ Å¢ÕôÀò¾¢ý §ÀÃ¢ø ±ý¨É ó¾ ¬Ã¡öîº¢ìÌ ¯ðÀÎò¾ ±ý 
ÓØÁÉ§¾¡Îõ ÍÂ¿¢¨É§Å¡Îõ ºõÁ¾õ ¦¾Ã¢Å¢ì¸¢§Èý. ±ÉìÌ Å¢ÕôÀÁ¢øÄ¡¾ Àðºò¾¢ø 
ó¾ ¬Ã¡öîº¢Â¢ø ÕóÐ ±ý¨É ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢ÎÅ¢òÐ ¦¸¡ûÙõ 
¯Ã¢¨Á¨Â ¦ÀüÚû§ªý ±ýÀ¨¾Ôõ «È¢§Åý.  
  §¾¾¢:                                                           ¨¸¦Â¡ôÀõ: 
  ¼õ:                                                           ¦ÀÂ÷     : 
                                                      º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ:                       
                                                                     ¦ÀÂ÷  :              
                                                                 ¯È×Ó¨È  :    
 
 
 
 
                                                                                §¿¡Â¡ª¢Â¢ý ¼Ð¨¸ ¦ÀÕÅ¢Ãø§Ã¨¸ 
 
                                      
                                       ÁÕòÐÅ÷ ¨¸¦Â¡ôÀõ 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600 047. 
 
                               DEPARTMENT OF  MARUTHUVAM 
 
CALCULI) AND 
 
Name of Principal Investigator:     Reg. No: 
 
          FORM - WITHDRAWAL FORM 
 
 
2. OP / IP NO: ......................................    
   
 
5.GENDER:...........                           
 
 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                          Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI  600 047. 
 
                                   DEPARTMENT OF  MARUTHUVAM 
 
 
Name of Principal Investigator:     Reg. No :  
 
FORM ADVERSE REACTION FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
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NATIONAL PHARMACOVIGILANCE PROGRAMME FOR  
SIDDHA DRUGS 
 
 
 
Please note:  i.  All consumers / patients and reporters information will remain con idential. 
         ii. It is requested to report all suspected reac ons to the concerned, even if  
             it does not have complete data, as soon as possible. 
Peripheral Center code:     State:  
 
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / 
Female  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle  
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug  1 Drug  2 Drug  3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
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b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or used 
as self medication.  
d) Any other relevant information. 
 
5. Treatment provided for adverse reaction: 
 
6. The result of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition    
 
Any Others  
 
9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
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11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E  mail if any : 
 
 
Signature of the reporter:       Date: 
Please send the completed form to:  
           The Director 
            National Institute of Siddha, 
                                                       (Pharmacovigilance Regional Centre For Siddha Medicine), 
                                                       Tambaram Sanatorium, Chennai-600 047. 
                                                            (O) 044-22381314       Fax : 044  22381314 
        Website : www.nischennai.org  
        Email: nischennaisiddha@yahoo.co.in   
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
 
 
 
 
Name & address of the RRC-ASU / 
PPC-ASU 
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month of observation /occurrence of ADR 
This filled-in ADR report may be sent within one  
 
 
 
 
 
 
 
 
Date:                                                                              
Sta on:  
         
Date :      
Sta on: 
Signature of the Inves gator: 
Signature of the Lecturer:                                                                                        
                                                                                                                                              Signature of the HOD 
  
Who Can Report?     
 Any Health care professionals like Siddha Doctors / Nurses / Siddha 
Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 
fullest extent.  
 Submission of report will be taken up for remedial measures only not for 
legal claim  
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI  47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
 
FORMVIII-DIETARY ADVICE FORM 
NIS NO: NIS/IEC 
 
     Need to drink: 
 For a day, drink 3-4 liters of water 
 Barley rice water 
 Nerunjil kudineer 
 Kollu kudineer 
 Tender coconut 
     Vegetables:    
                           
                          Plantain stem, Broad beans. 
     Fruits:   
                          Water melon, Papaya, Guava, Lemon. 
    Greeny leaves: 
                         Indian spinach, Kasini keerai, Keerai thandu. 
     Seeds: 
                          Cumin seeds, Cucumber seeds. 
   
 Tomato, Cabbage, Cauliflower, Potato, Peas, Mushrooms, Greens 
 Grapes, Pine apple 
 Milk, Coffee, Tea, Preserved cool drinks, Alcohol 
 Non veg foods, Egg, Ice cream, chocolate, Tamarind, Pepper.  
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É-47 
«§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
¦À¡ÐÁÕòÐÅò Ð¨È 
§¿¡öì¸¡É º¢ò¾  ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò 
¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ÀÊÅõ  
                 ÀÊÅõ VIII- ¯½× ÀÃ¢óÐ¨Ã ÀÊÅõ 
                        IEC NO: NIS/IEC 
«Õó¾ §ÅñÊÂ¨Å: 
 ¾¢ÉÓõ 3-4 Ä¢ð¼÷ ¿£÷ «Õó¾ §ÅñÎõ 
 À¡÷Ä¢ ¸ïº¢  
 ¦¿Õïº¢ø ÌÊ¿£÷ 
 ¦¸¡ûÙ ÌÊ¿£÷ 
 ­ª¿£÷ 
 ¸¡ö¸û: 
Í¨Ãì¸¡ö, âº½¢ì¸¡ö, Óûªí¸¢, ¦ÅûªÃ¢, §¸Ãð, ¦Åñ¨¼ì¸¡ö,    
Å¡¨Æò¾ñÎ, «Å¨Ã 
 
 ÀÆí¸û: 
¾÷âº½¢, ÀôÀ¡ª¢, ¦¸¡öÂ¡, ±ÖÁ¢î¨º 
 ¸£¨Ã¸û: 
Àº¨Ä, ¸¡º¢É¢, ¸£¨Ãò¾ñÎ 
 Å¢¨¾¸û: 
º£Ã¸õ, ¦ÅûªÃ¢Å¢¨¾ 
 
¾Å¢÷ì¸ §ÅñÊÂ¨Å: 
  
          ¾¢Ã¡ð¨º, «ýÉ¡º¢, Òª¢. 
 À¡ø, ¸¡À¢, Ë, À¾ôÀÎò¾Àð¼ À¡Éí¸û, ÁÐÀ¡Éõ.  
 º¡ì§Äð, Á¢ªÌ. 
 
 
 
 
 
CERTIFICATES 
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